Massenspektrometrische Analyse des DNA Metabolismus by Kosmatchev, Olesea
  
  
  
                                                                                          
  
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
 
I 
  
 
  
 
II 
  
 
 
  
 
1 
  
 
  
 
2 
  
 
 
 
  
 
3 
  
  
 
4 
  
  
 
5 
  
  
 
6 
  
  
 
7 
  
  
 
8 
  
  
 
9 
  
  
 
10 
  
  
 
11 
  
  
 
12 
  
  
 
13 
  
  
 
14 
  
  
 
15 
  
  
 
16 
  
  
 
17 
  
  
 
18 
  
  
 
19 
  
  
 
20 
  
  
 
21 
  
  
 
22 
  
  
 
23 
  
  
 
24 
  
  
 
25 
  
  
 
26 
  
  
 
27 
  
  
 
28 
  
  
 
29 
  
  
 
30 
  
  
 
31 
  
  
 
32 
  
72  nature chemical biology |  VOL 14 | JANUARY 2018 | www.nature.com/naturechemicalbiology
article
published online: 27 november 2017 | doi: 10.1038/nchembio.2531
Modification of genomic cytosine modulates the interaction of DNA-binding factors with the genome, thus affecting gene expression and chromatin structure1,2. The primary 
and most prevalent modification is methylation to mdC, which 
in mammals is catalyzed by the DNA methyltransferases Dnmt1, 
Dnmt3a and Dnmt3b, at least partly in co-operation with the cata-
lytically inactive Dnmt3l3. Because Dnmt1 is a maintenance methyl-
transferase that copies the methylation pattern during replication, 
the information that this pattern conveys is inherited through cell 
division. Genomic mdC can be iteratively oxidized to hmdC4,5, 
fdC6,7 and cadC7,8 by the Ten-eleven translocation (Tet) family of 
α-ketoglutarate-dependent dioxygenases (Fig. 1a). These oxidized 
cytidine derivatives are prominently detected in DNA isolated from 
neuronal tissues5,9,10 and in the genome of embryonic stem cells 
(Fig. 1b), in which their levels change during differentiation4,7,11. For 
example, hmdC can reach levels of up to 1.3% per deoxyguanosine 
(dG) in DNA isolated from brain12. Although the presence of mdC 
and hmdC is believed to influence the transcriptional activity of 
genes13,14, no clear function has yet been assigned to the higher oxi-
dized modifications fdC and cadC. Recent reports, however, show 
that fdC is a stable15, or at least semi-stable16, base in the genome. 
These discoveries and the identification of specific reader proteins 
that recognize fdC and cadC suggest that they might have regulatory 
purposes as well17–20. So far, however, fdC and cadC are mainly con-
sidered to be intermediates of an active demethylation process that 
allows cells to replace mdC by a canonical dC nucleotide20–22. One 
such scenario involves fdC and cadC as substrates of the thymine-
DNA glycosylase (Tdg), which cleaves the corresponding glyco-
sidic bond. This converts fdC and cadC into abasic sites, which are 
further processed through base excision repair (BER) as depicted 
in Figure 1a. This Tdg-initiated process establishes an active de- 
methylation pathway, ultimately incorporating unmodified dC 
nucleotides at former fdC and cadC sites8,23. A problem associated 
with this mechanism is that the removal of every mdC creates a 
potentially harmful single-strand break intermediate. If an mdC is 
close to the first in the opposite DNA strand, even double strand 
breaks may be generated. In addition to these concerns, it was shown 
that both maternal and paternal genomes of mouse zygotes undergo 
active demethylation independently of Tdg24. To explain such an 
excision-independent demethylation and provide an alternative to 
generating harmful repair intermediates, it was suggested that fdC 
and cadC may directly deformylate and decarboxylate, respectively, 
under C–C bond cleavage (Fig. 1a)9,25. Indeed, chemical pathways 
that allow such a direct deformylation and decarboxylation of fdC 
and cadC have been described26,27. These pathways involve addi-
tion of a helper nucleophile to the C6 position of fdC and cadC 
in a Michael-addition-type reaction followed by deformylation or 
decarboxylation and final elimination of the helper nucleophile26. 
The chemistry is therefore quite similar to the known reaction 
mechanisms employed by the Dnmt proteins3. Although chemically 
plausible, it is unclear whether such direct C–C bond cleavage reac-
tions occur within the genome28. This process would provide a new 
and harmless way to convert mdC back into dC in the genome with-
out forming potentially harmful abasic site intermediates.
Here we report a sensitive MS-based isotope tracing study inves-
tigating whether a C–C bond cleavage reaction occurs on fdC bases 
(Fig. 1c). We supplemented the medium of cultured mammalian 
cells with synthetic isotope- and fluorine-labeled fdC derivatives to 
metabolically integrate the nucleosides as reporter molecules into 
their genome. After isolation of the genomic DNA, the levels of the 
modified dC derivatives were measured by ultra-high performance 
liquid chromatography coupled to tandem mass spectrometry 
(UHPLC–MS/MS), thereby tracing isotopically or fluorine-labeled 
dC derivatives.
RESULTS
Isotopically labeled fdC is directly converted into dC
We started the study with a [13C5][15N2]fdC (1; Fig. 2a), in which all 
five C-atoms of the ribose ring were exchanged with 13C and the two 
in-ring nitrogen atoms replaced with 15N (Supplementary Note). 
This provides compound 1, which is seven mass units heavier than 
naturally occurring fdC and hence easily distinguishable by MS. The 
large mass difference allows exact tracing of all transformations that 
may take place on this base with high sensitivity, because the natural 
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(cadC) in DNA. It was proposed that fdC and cadC deformylate and decarboxylate, respectively, to dC over the course of 
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abundance of such highly isotopically modified dC derivatives is 
essentially null. Possible transformations are the deformylation of 
1 to [13C5][15N2]dC (2) and its deamination to [13C5][15N2]dU (3), 
followed by methylation of 3 to [13C5][15N2]dT (4). Alternatively, 
compound 1 can deaminate to [13C5][15N2]fdU (5) and, finally, the 
deformylated compound 2 can be methylated to [13C5][15N2]mdC 
(6). Analysis of the MS pattern of 1 showed that cleavage of the 
glycosidic bond is the dominant fragmentation pathway. This leads 
to a clearly detectable fingerprint mass transition of m/z = 263.1 
to m/z = 142.1 (Fig. 2b). Detection of the demodified product 
dC 2 would be possible on the basis of its mass transition from 
m/z = 235.1 to m/z = 114.0. For the experiment, we added 1 to the 
medium of mouse embryonic stem cells (mESCs) under prim-
ing conditions. After 3 d, the genomic DNA was isolated using a 
standard protocol and digested to the individual nucleosides. The 
obtained nucleoside mixture was analyzed by UHPLC coupled to a 
triple quadrupole mass spectrometer. We noted that 1 was indeed 
metabolically incorporated into the genome of mESCs. The mass 
transition of 1 (m/z = 263.1 to m/z = 142.1) was clearly detectable 
at a retention time of 5.50 min under our conditions (Fig. 2b). By 
using the mass transitions specific for all the expected natural dC 
derivatives, we were also able to detect next to 1, natural mdC, 
hmdC and fdC (Fig. 1b).
Analysis of the nucleoside mixtures revealed the presence of a 
new isotope-labeled dC derivative at a retention time of 1.95 min 
displaying the expected mass transition (m/z = 235.1 to m/z = 114.0) 
for 2, showing that [13C5][15N2]fdC is indeed demodified (Fig. 2c). 
To unequivocally prove the identity of 2, an even heavier isotopically 
modified dC isotopologue, [13C9][15N3]dC (7), with a characteristic 
MS transition of m/z = 240.1 to m/z = 119.1 (Supplementary Results, 
Supplementary Fig. 1), was used as an internal standard. Compound 
7 was added to the nucleoside mixture and it eluted at the same reten-
tion time as 2 (Fig. 2c), confirming that the UHPLC–MS/MS signal at 
1.95 min is caused by 2. Exact quantification of the conversion 
showed that when 1 was supplied to mESC cultures at 50 μM for 3 d, 
steady state incorporation levels of about 3–5 × 10−7 of [13C5][15N2]fdC 
per deoxynucleoside (dN) in genomic DNA were reached (Fig. 2d). 
We observed higher levels of product 2 (up to a factor of 10), as 
shown in Figure 2d.
Whereas we can exclude spontaneous deformylation of 1 based 
on previous stability studies26, 2 can in principle form either by 
C–C bond cleavage in the genome or at the level of the soluble 
nucleoside/nucleotide pool. Conversion of 1 in the soluble pool 
to 2 would then be followed by metabolic incorporation of the 
2-triphosphate into the genome. It is known that soluble 2 is the 
substrate for other metabolic processes such as deamination to 3 
(catalyzed by cytidine deaminase and deoxycytidylate deaminase), 
which is followed by methylation by thymidylate synthase to give 4 
(refs. 29,30). To distinguish the two possible conversion scenarios 
(genomic DNA or soluble pool), we reasoned that if 1 is converted 
into 2 in the soluble pool, we would find compounds 3 and, particu-
larly, 4 in the genome.
To investigate the behavior of soluble dC, we cultured mESCs 
in the presence of an isotopically labeled dC derivative, [13C9][15N3]
dC, and indeed detected the expected presence of the correspond-
ing isotopically labeled deamination products [13C9][15N2]dT and 
[13C9][15N2]dU (8 and 9, respectively) in the genome (Fig. 2e). In con-
trast, when 1 was supplied to mESC cultures, we detected next to 2 
only the direct deamination product 5 in the genome, but not 3 and 
4 (Fig. 2d). Even after three consecutive days of feeding compound 
1 to mESCs, we were unable to detect even traces of 4 in the genome. 
This argues against formation of 2 in the soluble pool. We next 
Dnmt's Tet1–3 Tet1–3
a
–HCOOH
Endonucleases, repair polymerase, ligase
Direct deformylation/decarboxylation
Tdg Tdg
b
BER
Direct
–CO2
in vivo deformylation
via C–C-bond cleavage
Isotope-labeled fdC or
2′-fluoro-fdC
Incorporation 
into DNA
– HCOOH
Total digest
UHPLC/MS2
c
mdC hmdC fdC cadC
M
od
ifi
ca
tio
n/
dN
 (l
og
)
10–2
10–3
10–6
O
OH
HO 15N
15N
NH2
O
O
H
(F)
15N
15N
NH2
O
O
H
15N
15N
NH2
O
O
ODNA
DNAO N
N
NH2
O
O
ODNA
DNAO N
N
NH2
O
O
ODNA
DNAO N
N
NH2
O
OH
O
ODNA
DNAO N
N
NH2
O
O
H
O
ODNA
DNAO
OH
O
ODNA
DNAO N
N
NH2
O
O
OH
dC mdC
hmdC fdC cadC
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analyzed the soluble nucleoside/nucleotide pool directly for the 
content of 2 after feeding of 1 (Supplementary Fig. 2). To this end, 
we fed 1 to mESCs over 3 d. The cells were washed extensively and 
finally resuspended in 50% (v/v) MeCN to extract soluble meta-
bolites. After further purification by solid-phase extraction, the 
nucleotides were dephosphorylated to nucleosides. Analysis of this 
solution by UHPLC–MS/MS did not give any signal for 2. All these 
control experiments suggest that 1 undergoes C–C bond cleavage to 
2 directly in the genome and not in the soluble pool, although the 
latter scenario cannot be fully ruled out because of the complexity 
of the metabolic pathways (Supplementary Fig. 3). Interestingly, 
we also noted the presence of the remethylated product 6 in the 
genome of mESCs fed with 1, but because of the low signal intensity 
we were unable to obtain quantitative data (Fig. 2d).
2′-fluorinated cytosines detect biochemical conversions
To reach higher sensitivity, we experimented with various other iso-
tope-labeled fdC derivatives, and finally found that 2′-fluorinated 
dC derivatives 10–17 are excellent probe molecules (Fig. 3a and 
Supplementary Fig. 4). The exchange to an F-atom makes the 
compound 18 atom units heavier. The compounds also have a 
slightly shifted retention time (Fig. 3b) and give sharp signals in 
the UHPLC–MS/MS analysis because of a glycosidic bond that is 
more labile in the MS-fragmentation step. Furthermore, the 2′-(R)-
configured compounds are well tolerated by the cells used for this 
study. The F-substituent does affect the ability of the molecule to 
undergo further biochemical conversions, but the effect is small. 
(R)-2′-F-dC (10), for example, is efficiently methylated by DNA 
methyltransferases31 and (R)-2′-F-mdC (11) is also oxidized to (R)-
2′-F-hmdC (12) by the Tet enzymes (Fig. 3a,c), although a reduced 
speed of oxidation is observed32.
To show that the fluorinated compounds are valid probe 
molecules, we first added 10 to the mESC culture at 0.5 μM, 1.0 μM 
or 2.5 μM for 3 d. Under these conditions, UHPLC–MS/MS analysis 
of the isolated genomic DNA showed a clear dose-dependent 
integration of 10 into the genome, up to 1 × 10−3 per dN. We next 
searched for other 2′-fluorinated pyrimidine nucleosides and 
detected a dose-dependent presence of (R)-2′-F-dU (13) and (R)-
2′-F-dT (14), which was formed by deamination of 10 to 13 fol-
lowed by methylation to 14 (Fig. 3c). In addition, we detected a 
dose-dependent formation of (R)-2′-F-mdC and (R)-2′-F-hmdC, 
confirming that compound 10 is biochemically converted, as 
expected (Fig. 3c).
To quantify the levels of methylation, we synthesized the isotope-
labeled compounds (R)-2′-[D3]F-mdC (18), (R)-2′-[15N2]F-dC (19) 
and (R)-2′-[15N2]F-fdC (20) and used them as internal standards for 
quantification (Fig. 3a). Upon feeding mESCs with 1 μM 10 for 3 d, 
we detected around 3% (±0.5%) of 11 relative to 10, which is similar to 
proportions observed for the natural bases (Supplementary Fig. 5).
(R)-2′-F-fdC is converted into (R)-2′-F-dC in mESCs
To study the direct C–C bond cleavage process, we again cultured 
mESCs in the presence of (R)-2′-F-fdC (15; 350 μM for 3 d), iso-
lated the DNA and analyzed the nucleoside composition. Next to 
genomic (R)-2′-F-fdC (5.7 × 10−7/dN), we detected (R)-2′-F-dC at a 
level of 7.3 × 10−6/dN (Fig. 3d). Because the nucleosides 13 and 14 
were not detected, we suspected again that the observed reaction of 
15 to 10 occurs directly within the genome. The detection limit of 
13 and 14 is, however, around 5 fmol, and so the compounds may 
just escape observation.
To substantiate the conclusion that genomic 15 undergoes 
intragenomic C–C bond cleavage to 10, we first assessed whether 
15 can spontaneously deformylate. To investigate this possibility, we 
heated an aqueous solution of 15 to 60 °C for 3 d; however, we did 
not detect compound 10. We also incubated 15 in culture medium 
for 3 d and were unable to detect any 10. Finally, we added a 28-mer 
oligonucleotide containing a single 15 to culture medium for 3 d, 
then re-isolated the DNA strand and searched for 10. Formation 
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of 10 was again not detected. Together, these experiments exclude 
background deformylation.
We next analyzed the possibility that 15 is contaminated with 
traces of 10. To this end, the purity of 15 was checked by MS, and 
indeed, 10 was not found. To exclude the presence of even traces 
of 10 below the detection limit, we performed three consecutive 
HPLC purifications of 15. This compound 15 is well separable 
from 10 because 10 elutes 7.50 minutes earlier than 15 during the 
HPLC purification (Fig. 3e). Feeding of the material 15 obtained 
from three consecutive purifications resulted in unchanged values 
of genomic 10, arguing against the possibility that the detected 10 is 
an accumulated impurity (Fig. 3f).
To further substantiate that the C–C bond cleavage does not 
occur in the soluble nucleoside/nucleotide pool, we added 10 to the 
mESC culture for 3 d. UHPLC–MS/MS analysis of the soluble pool 
allowed us to detect 10, 14 and, in traces, 13 (Fig. 3g). However, 
when we repeated the study with 15 (Fig. 3h), we detected just 15 in 
the soluble pool plus the deaminated compound (R)-2′-F-fdU (17), 
but not 10. We next determined the medium concentration of 10 
that would be needed to reach the measured value for genome-inte-
grated 10 (7.3 × 10−6/dN; Fig. 3d) and found that a concentration of 
5–10 nM would be required (Supplementary Fig. 6) in the soluble 
pool. With a detection limit of 30 amol for 10 (40 μL injection), this 
is a concentration at which 10 is unambiguously detectable.
All of these control experiments support the idea that the C–C 
bond cleavage to F-dC occurs within the genome. Interestingly, upon 
feeding of 15 to mESCs, we also detected the methylated derivative 
11, demonstrating that the demodified product 10 is methylated 
to 11 in the genome. Using the isotopically labeled internal stan-
dards (R)-2′-[D3]F-mdC, (R)-2′-[15N2]F-dC and (R)-2′-[15N2]F-fdC 
(Fig. 3a), we found that remethylation of 10 results in levels of 2.8% 
(±0.3%) F-mdC (Fig. 3d), which is only slightly lower compared to 
the level observed with direct feeding of 10 (Supplementary Fig. 5).
To study the time dependence of the C–C bond cleavage process, 
we fed compound 15 and measured the genome-integrated levels of 
15, 10 and 11. Already at 0.5 h, we detected a stable incorporation 
of 15 (Fig. 4a). The C–C bond cleaved product 10 appeared after 
about 1 h and the levels increased steadily (Fig. 4b). After about 4 h, 
we saw the first remethylated product 11 (Fig. 4c). If 10 was a con-
tamination in the preparation of 15, we would expect faster incor-
poration kinetics. When we fed both 15 and 10 simultaneously, a 
steady increase in the level of 10 was already observed after 5 min 
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(Supplementary Fig. 7), confirming that our probe nucleosides are 
quickly incorporated into the genome. These data show that the 
C–C bond cleavage is a rapid process.
Dnmt or Tet enzymes are not required for demodification
To investigate whether the remethylation of 10 is driven by the 
known DNA methyltransferases and whether these are involved 
in demodification, we added 15 (350 μM for 3 d) to mESCs defi-
cient in all active DNA methyltransferases Dnmt1, Dnmt3a and 
Dnmt3b (Dnmt triple knockout (TKO)) and analyzed the DNA. In 
this experiment, the demodified product 10 is again detected, but 
the methylated product 11 is not seen (Fig. 4d and Supplementary 
Fig. 8), showing that DNA methyltransferases are responsible for 
methylation of 10 and are not required for demodification of 15. 
We finally investigated whether the Tet enzymes are involved in 
demodification of 15. However, repeating the feeding experiment 
with mESCs lacking all three members of the Tet family (Tet TKO) 
resulted in full demodification activity (Fig. 4e and Supplementary 
Fig. 9). The fact that the conversion of 15 to 10 does not change 
in the absence of Tet proteins is particularly noteworthy. Because 
Tet enzymes were shown to accept 11 as a substrate and convert 
it into 12, 15 and (R)-2′-F-cadC 16 (ref. 32), we can exclude the 
possibility that the observed C–C bond cleavage is in fact a Tet-
dependent decarboxylation of 16. Indeed, this result implies either 
that 15 is directly deformylated to 10 or that factors other than Tet 
enzymes can oxidize 15 to 16, which would then be decarboxy-
lated to 10. Ascorbic acid has been shown to increase Tet enzymatic 
activity in vitro and the levels of oxidized mdC derivatives in vivo33–35. 
Ascorbic acid treatment of mESC cultures fed with 15 indeed 
resulted in increased levels of naturally occurring fdC and cadC, 
but had no effect on conversion of 15 into unmodified product 10 
(Supplementary Fig. 10). This further supports that demodifica-
tion of 15 to 10 does not depend on the enzymatic activity of the 
Tet enzymes.
Finally, we tested whether conversion of 15 into 10 occurs in 
nonpluripotent cells by feeding 15 to cell lines representing a variety 
of cell types (Fig. 4f and Supplementary Fig. 11). Albeit to various 
degrees, we detected the conversion of 15 to 10 in all these cell lines, 
arguing that this is rather widespread in mammalian cell types. 
In summary, our data prove that fdC is converted into dC in vivo 
through C–C bond cleavage and strongly suggest that this conver-
sion is an intragenomic process.
DISCUSSIoN
In recent years, several mechanisms for active erasure of cytosine 
methylation from the genome have been proposed25. Among these, 
the best-established mechanism entails Tet-mediated iterative oxi-
dation of mdC to fdC or cadC followed by the replacement of these 
higher oxidized derivatives with unmodified dC through BER36. 
Considering the frequent occurrence of mdC in high-density clus-
ters and prevalent symmetrical configuration at CpG sites in verte-
brate genomes, a BER-based erasure mechanism poses a substantial 
risk of creating clustered single and double strand breaks with 
potentially deleterious consequences. It is possible that excision of 
fdC and cadC by Tdg, processing of the abasic site and insertion of 
unmodified dC are orchestrated by a single multimolecular com-
plex, thus allowing tight control of strand breaks. Alternatively, it is 
also conceivable that to minimize the potentially deleterious conse-
quences of BER, complementary mechanisms are in place to remove 
fdC and cadC that do not involve DNA repair. In this context, it 
should be kept in mind that Tet3-dependent active demethylation of 
maternal and paternal genomes in the mouse zygote may not require 
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Figure 4 | Demodification of 2′-fluorinated fdC is a rapid process, does not require Dnmt or Tet enzymes and occurs also in somatic cell types.  
(a–c) Time-course study showing the genomic build-up of F-fdC 15 (a), F-dC 10 (b) and F-mdC 11 (c) upon metabolic labeling with 15. LOD, limit of 
detection. (d-f) Genomic levels of 15 and 10 upon metabolic labeling of Dnmt triple knockout (TKO) mESCs (d), Tet TKO and corresponding wild-type 
mESC lines (e) and various somatic cell lines (f) with 15. Genomic levels of 11 are also shown in d. In all panels, mean values and s.d. of technical triplicate 
measurements from single representative experiments are shown. Data from two additional independent experiments are shown in Supplementary 
Figures 8 and 9.
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Tdg24. With an isotope-tracing experiment using labeled dC-derived 
nucleosides in combination with highly sensitive UHPLC–MS/MS 
detection, we show here that in mammalian cells fdC is converted 
to dC while the glycosidic bond is kept intact. Evidence is provided 
to support the theory that the C–C bond cleavage reaction hap-
pens when fdC is located inside the genome. This establishes an 
intragenomic demodification process independent of DNA repair. 
We also show that this process does not require any of the Tet-family 
enzymes. Therefore, unless other factors are able to oxidize fdC to 
cadC, this demodification process is likely a direct deformylation of 
fdC. Although we have firmly established the occurrence of a C–C 
bond cleavage of fdC or cadC to dC, the mechanism of this process 
remains to be defined, including the identification of the factors that 
mediate the demodification reactions.
We would like to emphasize that in our approach the probe 
nucleosides are randomly incorporated into the genome through 
DNA replication. Consequently, we cannot determine the sequence 
and genomic context wherein the demodification of fdC or cadC to 
dC takes place. Obviously, this would require a sequencing approach 
that allows identification of the converted dC bases. In addition, we 
detected conversion of 2′-fluorinated fdC to 2′-fluorinated dC in 
mESCs and different somatic cell types. This indicates that the abil-
ity to carry out the demodification reaction may be widespread in 
mammalian cells and tissues rather than being restricted to events of 
active genomic demethylation known to occur in specific develop- 
mental and tissue contexts. Assuming that the deformylation of 
fdC to dC establishes an active demethylation pathway, we need to 
emphasize that deformylation reactions and deformylases are wide-
spread in nature. A prominent example is the enzyme lanosterol 
14α-demethylase (CYP51A1), which oxidizes the C14α methyl 
group of lanosterol to a formyl group to achieve deformylation under 
concomitant introduction of a double bond (dehydrating deformy-
lation). This enzyme, a P450-type monooxygenase, contains a heme 
cofactor that seems to utilize a nucleophilic Fe peroxyl anion species 
to attack the substrate37,38. Another well studied enzyme that cata-
lyzes deformylation is the aldehyde-deformylating deoxygenase, 
which again uses a nucleophilic metal bond peroxyl anion radical 
as the attacking species. This enzyme shortens fatty acid chains by 
oxidizing the terminal methyl group to a formyl group, which is fol-
lowed by deformylation39,40. In contrast to fdC, these deformylation 
reactions take place on formyl groups attached to saturated C atoms, 
whereas in fdC the formyl group is linked to an aromatic hetero-
cycle. Such structures are known for decarboxylations, and they are 
catalyzed by the enzymes orotate41 and isoorotate42 decarboxylase. 
Indeed, it was suggested that the isoorotate decarboxylase could be 
a blueprint for a putatively existing cadC decarboxylase43. Our data 
now support the idea that fdC and possibly also cadC are converted 
to dC by a direct C–C bond cleavage. The questions as to when and 
where these reactions occur in vivo now require the identification of 
putative catalytic factors.
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Chemical synthesis. Synthetic schemes, detailed procedures and characteriza-
tion of synthesized products can be found in the Supplementary Note. Unless 
noted otherwise, all reactions were performed using flame- or oven-dried 
glassware under an atmosphere of nitrogen. Compounds 7 (B.A.C.H. UG) and 
10 (Carbosynth) were commercially available. 15 was synthesized as previously 
described in the literature32. Identities of these compounds were confirmed 
by NMR and LC–MS/MS. Molsieve-dried solvents were used from Sigma-
Aldrich, and chemicals were bought from Sigma-Aldrich, TCI, Carbolution 
and Carbosynth. Technical grade solvents were distilled before extraction or 
chromatography of compounds. Reaction controls were performed using TLC 
Plates from Merck (Merck 60 F254), flash-column chromatography purifica-
tions were performed on a Merck Geduran Si 60 (40–63 μM). Visualization 
of the developed TLC plates was achieved through UV absorption or through 
staining with Hanessian’s stain. NMR spectra were recorded in deuterated sol-
vents on Varian VXR400S, Varian Inova 400, Bruker AMX 600, Bruker Ascend 
400 and Bruker Avance III HD. HR–ESI–MS spectra were obtained from a 
Thermo Finnigan LTQ FT-ICR. Infrared (IR) spectroscopic measurements 
were performed on a PerkinElmer Spectrum BX FT-IR spectrometer with a 
diamond ATR (attenuated total reflection) unit. HPLC purifications were 
performed on a Waters Breeze system (2487 dual array detector; 1525 binary 
HPLC pump) using a Nucleosil VP 250/10 C18 column from Macherey Nagel, 
HPLC-grade MeCN was purchased from VWR.
Cell culture. Basal medium for mESC culture was DMEM high glucose contain-
ing 10% FBS, 2 mM L-glutamine, 100 U/mL penicillin, 100 μg/mL streptomycin, 
1× MEM Non-essential Amino Acid Solution and 0.1 mM β-mercaptoethanol 
(all from Sigma). All mESC lines were maintained in their naïve state on gela-
tin-coated plates by supplementing basal medium with 1,000 U/mL LIF (ORF 
Genetics), GSK3 inhibitor CHIR99021 at 3 μM and Mek inhibitor PD0325901 
1 μM (“2i”). Metabolic labeling experiments with fluorine- or isotope-labeled 
nucleosides were performed by plating mESCs in priming conditions consist-
ing of basal mESC medium supplemented with 3 μM CHIR99021 and Wnt 
pathway inhibitor IWR1-endo at 2.5 μM as previously reported44. Under these 
conditions primed cells remained pluripotent for at least seven days as deter-
mined by epifluorescence with an Oct4-YFP knock-in cell line45. Priming and 
labeling was performed for 3 d. Over this period naturally occurring genomic 
mdC and hmdC (Fig. 1b) reached levels similar to those recently reported 
for epiblast-like cells, which are regarded as the closest in vitro counterpart 
to noncommitted post-implantation epiblast46,47. All inhibitors were pur-
chased from Selleckchem. Dnmt TKO J1 mESCs were described in ref. 48. Two 
independent sets of Tet TKO and respective wt mESC lines were used: wt #17 
and Tet TKO #3 were reported in ref. 49 and wt #4 and Tet TKO #29 were 
described in ref. 50. J1 mESCs are from the 129/Sv/Jae strain, while all Tet TKO 
and corresponding wt mESC lines are from mixed genetic backgrounds.
The time-course experiment was performed by culturing J1 mESCs under 
priming conditions for 48 h. The medium was exchanged to priming medium 
containing 350 μM F-fdC and cells were harvested after 0.5, 1.0, 2.0, 4.0, 8.0, 
16 and 24 h, as described.
RBL-2H3, HeLa, NIH3T3 and Neuro-2a cells were cultured in DMEM 
high glucose containing 10% FBS, 2 mM L-glutamine, 100 U/mL penicillin, 
100 μg/mL streptomycin. CHOK1 cells were maintained in DMEM/F12 sup-
plemented as reported above for the other somatic cell lines. ENC1 neural stem 
cells were cultured as previously described51. Cells were exposed to labeled 
nucleosides for 4 (RBL-2H3 and NIH3T3), 5 (CHO-K1), 6 (Neuro-2a) and 
7 d (HeLa and ENC1).
Labeled nucleosides were added to the culture medium at the following 
concentrations: F-fdC (15), 350 μM; F-dC (10), 0.5, 1.0 and 2.5 μM; [13C5][15N2]
fdC (1), 50 μM; [13C9][15N3]dC (7), purchased from B.A.C.H. UG), 100 μM.
Isolation of genomic DNA. Cultures were washed with PBS and lysed by 
adding RLT buffer (Qiagen) containing 400 μM each of 2,6-di-tert-butyl-4-
methylphenol (BHT) and desferoxamine mesylate (DM) directly to the plates. 
Isolation of genomic DNA was performed with Zymo-Spin V, V-E or IIC-XL 
columns according to the instruction of the ZR-Duet DNA/RNA MiniPrep Kit 
(Zymo Research) with the following modifications. DNA was sheered by bead 
milling in 2 mL microfuge tubes using one 5-mm diameter stainless steel bead 
per tube and a MM400 bead mill (Retsch) set at 30 Hz for 1 min. Lysates were 
then loaded onto spin columns and the bound material was first incubated 
for 15 min with Genomic Lysis Buffer (Zymo Research) supplemented with 
0.2 mg/mL RNase A (Qiagen). After washing genomic DNA fragments were 
eluted with water containing 0.4 μM of each BHT and DM.
DNA digestion. 0.5–10 μg of genomic DNA in 35 μL H2O were digested as 
follows: An aqueous solution (7.5 μL) of 480 μM ZnSO4, containing 42 U 
nuclease S1 (Aspergillus oryzae, Sigma-Aldrich), 5 U Antarctic phosphatase 
(New England BioLabs) and specific amounts of labeled internal standards 
were added, and the mixture was incubated at 37 °C for 3 h. After addition 
of 7.5 μL of a 520 μM [Na]2-EDTA solution, containing 0.2 U snake venom 
phosphodiesterase I (Crotalus adamanteus, USB corporation), the sample was 
incubated for 3 h at 37 °C or overnight and then stored at −20 °C. Prior to 
UHPLC–MS/MS analysis, samples were filtered by using an AcroPrep Advance 
96 filter plate 0.2 μm Supor (Pall Life Sciences).
LC/MS-MS analysis of DNA samples. Quantitative UHPLC–MS/MS analy-
sis of digested DNA samples was performed using an Agilent 1290 UHPLC 
system equipped with a UV detector and an Agilent 6490 triple quadru-
pole mass spectrometer. Prior to every measurement series, external cali-
bration curves were measured to quantify the levels of the F-nucleosides 
(Supplementary Fig. 12). Additionally, (R)-2′-[15N2]F-dC (19), (R)-2′-[15N2]
F-hmdC (37) and (R)-2′-[15N2]F-fdC (20) were used to validate the result-
ing peaks by co-injection. For exact quantification of fluorinated nucle-
osides also internal quantification with stable isotope dilution techniques for 
F-fdC, F-dC and F-mdC were developed (Supplementary Fig. 13). Natural 
nucleosides were quantified with the stable isotope dilution technique. An 
improved method, based on earlier published work26,28,52–54 was developed, 
which allowed the concurrent analysis of all nucleosides in one single ana-
lytical run11. The source-dependent parameters were as follows: gas tem-
perature 80 °C, gas flow 15 L/min (N2), nebulizer 30 psi, sheath gas heater 
275  °C, sheath gas flow 11 L/min (N2), capillary voltage 2,500 V in the positive 
ion mode, capillary voltage −2,250 V in the negative ion mode and nozzle volt-
age 500 V. The fragmentor voltage was 380 V/ 250 V. Delta EMV was set to 500 
(positive mode) and 800 (negative mode). Compound-dependent parameters 
are summarized in Supplementary Tables 1–4. Chromatography was per-
formed by a Poroshell 120 SB-C8 column (Agilent, 2.7 μm, 2.1 mm × 150 mm) at 
35 °C using a gradient of water and MeCN, each containing 0.0085% (v/v) formic 
acid, at a flow rate of 0.35 mL/min: 0–4 min; 0– 3.5% (v/v) MeCN; 4–7.9 min; 
3.5–5% MeCN; 7.9–8.2 min; 5–80% MeCN; 8.2–11.5 min; 80% MeCN; 11.5– 
12 min; 80–0% MeCN; 12–14 min; 0% MeCN. The effluent up to 1.5 min 
and after 12 min was diverted to waste by a Valco valve. The autosampler was 
cooled to 4 °C. The injection volume was 39 μL.
Quantification of nucleosides. Prior to every sample set, calibration curves 
to quantify all fluorine labeled nucleosides were measured under the same 
conditions and settings. All calibration curves are valid within the range of 
1-500 fmol with five measuring points and measured as technical triplicates. 
Supplementary Fig. 12 shows representative calibration curves for all Fluoro-
nucleosides used for the quantification.
To obtain the internal calibration curves for exact quantification, we 
analyzed each standard, namely (R)-2′-[15N2]F-fdC (20; n = 205 fmol), 
(R)-2′-[15N2]F-dC (19; n = 793 fmol) and (R)-2′-[D3]F-mdC (18; n = 461 fmol), 
in comparison to the corresponding nonlabeled nucleoside with constant 
concentration. Technical triplicates were measured, and the linear regres-
sion was applied using Origin 6.0 (Microcal). Therefore, the ratio of the 
area under the curve of unlabeled nucleoside (A) to the labeled standard 
(A*) was plotted against the ratio of the amount of unlabeled nucleoside 
(n) to the labeled one (n*) (see Supplementary Fig. 13). Acceptable preci-
sion (<20% relative s.d. within each triplicate) and accuracy (80%–120%) 
was achieved for all three calibration curves. The accuracy is calculated as 
the ratio of the measured to the calculated ratios of the areas (A/A*) under 
the curves in percent. The ratios of the areas (A/A*) can be calculated by 
using the linear equations for the corresponding ratio of amount (n/n*). 
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The lower limit of detection was defined as the detected amount, which 
is three times higher than the blank response (LOD). The lower limit of 
detection (LLOQ) and the upper limit of detection (ULOQ) are the lowest 
and the highest amounts (n) and the ratio of the amounts (A/A*) fulfilling the 
requirements of the corresponding linear equation, respectively.
Nucleoside stability test. Compounds 1 and 15 were incubated at 100 μM in 
mESC culture medium at 37 °C and 5% CO2 for 3 d. For the recovery of the nucl-
eosides Supel-Select SPE HLB cartridges from Sigma-Aldrich were used. Prior 
to use, the cartridges were equilibrated with MeOH, followed by acidified H2O 
(with HCl to pH = 4). The pH of the samples was adjusted to 4, and the acidic 
solution was loaded on the cartridges. After washing with 10 mL of H2O, the 
cartridges were dried in vacuo. The nucleosides were eluted with MeOH/MeCN 
(1:1), evaporated to dryness via speedvac and resuspended in H2O.
Oligonucleotide stability test. An oligonucleotide (6.9 pmol) containing one 
F-fdC (28-mer) was incubated in mESC culture medium at 37 °C and 5% CO2 
for 3 d. For the recovery of the oligonucleotide, Oligo Clean & Concentrator 
from Zymo Research was used according to the manual. The resulting oligonu-
cleotide was dissolved in H2O and digested as described for genomic DNA.
Extraction of nucleoside/nucleotide soluble pools. J1 mESCs were plated 
under priming conditions (as described above) for 3 d. The culture medium 
was supplemented with 1.0 μM F-dC (10), 50 μM [13C5][15N2]fdC (1) or 350 μM 
F-fdC (15). Cells were washed twice with PBS (Sigma-Aldrich), harvested 
by trypsinization and pelleted by centrifugation for 3 min at 300g. 500 
μL ice-cold 50% (v/v) acetonitrile was added dropwise to the pellet and 
vortexed55. The mixture was incubated on ice for 10 min. The insoluble 
fraction was then separated from the soluble pool by centrifugation for 
10 min at 21,000 × g at 0 °C. The supernatant was removed and used for 
nucleoside isolation. The soluble fraction containing the nucleosides was 
dried by lyophilization and metabolites were purified using Supel-Select 
SPE HLB cartridges (as described in the nucleoside stability test) before 
UHPLC–MS/MS analysis.
Life Sciences Reporting Summary. Further information on experimental 
design and reagents is available in the Life Sciences Reporting Summary.
Data availability. The data that support the findings of this study are available 
from the corresponding author upon reasonable request.
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1.   Sample size
Describe how sample size was determined. In most cases cell culture experiments were independently repeated two to four 
times and samples from each experiment were measured as technical triplicate. 
Exceptions: Figures 2d, 3c, 3e-h, 4a-c and 4f. These were single experiments 
measured as technical triplicate. In these cases accurate (repeated) quantification 
was not considered crucial as it would not affect the fundaments of our story and  
Fig. 4f just points to deformylation occurring in other types of cells as well.
2.   Data exclusions
Describe any data exclusions. No data was excluded.
3.   Replication
Describe whether the experimental findings were 
reliably reproduced.
The data was reliably reproduced.
4.   Randomization
Describe how samples/organisms/participants were 
allocated into experimental groups.
Describe how samples were allocated to groups. If allocation was not random, 
describe how covariates were controlled. If this is not relevant to your study, explain 
why.
5.   Blinding
Describe whether the investigators were blinded to 
group allocation during data collection and/or analysis.
Describe the extent of blinding used during data acquisition and analysis. If blinding 
was not possible, describe why OR explain why blinding was not relevant to your 
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Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
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For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the 
Methods section if additional space is needed). 
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same 
sample was measured repeatedly
A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one- or two-sided (note: only common tests should be described solely by name; more 
complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted
A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
`   Software
Policy information about availability of computer code
7. Software
Describe the software used to analyze the data in this 
study. 
Microsoft Excel, Origin, Agilent MassHunter Analysis (Quant)
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made 
available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for 
providing algorithms and software for publication provides further information on this topic.
`   Materials and reagents
Policy information about availability of materials
8.   Materials availability
Indicate whether there are restrictions on availability of 
unique materials or if these materials are only available 
for distribution by a for-profit company.
No restrictions.
9.   Antibodies
Describe the antibodies used and how they were validated 
for use in the system under study (i.e. assay and species).
No antibodies were used.
10. Eukaryotic cell lines
a.  State the source of each eukaryotic cell line used. Stated for mESCs and NSCs (ENC1) in the Methods and Acknowledgments sections. 
CHO-K1, HeLa, Neuro2a, RBL-2H3, NIH3T3 were provided from stock centers (ATCC 
and its distributors).
b.  Describe the method of cell line authentication used. Describe the authentication procedures for each cell line used OR declare that none 
of the cell lines used have been authenticated OR state that no eukaryotic cell lines 
were used.
c.  Report whether the cell lines were tested for 
mycoplasma contamination.
Not systematically, only some of the cultures were tested.
d.  If any of the cell lines used are listed in the database 
of commonly misidentified cell lines maintained by 
ICLAC, provide a scientific rationale for their use.
No commonly misidentified cell lines were used.
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Policy information about studies involving animals; when reporting animal research, follow the ARRIVE guidelines
11. Description of research animals
Provide details on animals and/or animal-derived 
materials used in the study.
For laboratory animals, report species, strain, sex and age OR for animals observed 
in or captured from the field, report species, sex and age where possible OR state 
that no animals were used.
Policy information about studies involving human research participants
12. Description of human research participants
Describe the covariate-relevant population 
characteristics of the human research participants.
Provide all relevant information on human research participants, such as age, 
gender, genotypic information, past and current diagnosis and treatment 
categories, etc. OR state that the study did not involve human research 
participants.
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5‑Formyl- and 5‑Carboxydeoxycytidines Do Not Cause Accumulation
of Harmful Repair Intermediates in Stem Cells
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Markus Müller, and Thomas Carell*
Center for Integrated Protein Science at the Department of Chemistry, LMU Munich, Butenandtstrasse 5-13, Munich 81377,
Germany
*S Supporting Information
ABSTRACT: 5-Formyl-dC (fdC) and 5-carboxy-dC (cadC)
are newly discovered bases in the mammalian genome that are
supposed to be substrates for base excision repair (BER) in the
framework of active demethylation. The bases are recognized
by the monofunctional thymine DNA glycosylase (Tdg),
which cleaves the glycosidic bond of the bases to give
potentially harmful abasic sites (AP-sites). Because of the
turnover of fdC and cadC during cell state transitions, it is an
open question to what extent such harmful AP-sites may
accumulate during these processes. Here, we report the development of a new reagent that in combination with mass
spectrometry (MS) allows us to quantify the levels of AP-sites. This combination also allowed the quantiﬁcation of β-elimination
(βE) products, which are repair intermediates of bifunctional DNA glycosylases. In combination with feeding of isotopically
labeled nucleosides, we were able to trace the intermediates back to their original nucleobases. We show that, while the steady-
state levels of fdC and cadC are substantially increased in Tdg-deﬁcient cells, those of both AP- and βE-sites are unaltered. The
levels of the detected BER intermediates are 1 and 2 orders of magnitude lower than those of cadC and fdC, respectively. Thus,
neither the presence of fdC nor that of cadC in stem cells leads to the accumulation of harmful AP- and βE-site intermediates.
■ INTRODUCTION
The loss of a base is a major damaging event in the genome
that leads to the formation of an abasic site (AP-site). Abasic
sites are formed spontaneously or during base excision repair,
when cells remove damaged bases from the genome.1 This
repair process requires the action of speciﬁc DNA glycosylases,
which recognize the damaged base (Figure 1A).2−4 Two
diﬀerent types of repair glycosylases are known. Monofunc-
tional glycosylases produce AP-sites (Figure 1A, step a) that are
subsequently removed by the action of endonucleases such as
the apurinic/apyrimidinic endonuclease (Ape) 1 (Figure 1A,
step b),5,6 which introduces a free 3′-OH-group and a 5′-
phosphate ester (5′-dRP) that is further processed by the action
of polymerase β (Pol β). Bifunctional glycosylases catalyze a β-
elimination (βE) reaction (Figure 1A, step c), which gives
transient βE-intermediates. These can then be converted into a
single nucleotide gap by a subsequent δ-elimination reaction
(Figure 1A, step d). Both steps (c and d) are carried out by the
bifunctional glycosylases.7
Recently, it was discovered that the monofunctional
glycosylase Tdg (Thymine DNA glycosylase)8,9 removes the
newly discovered bases 5-formyl-cytosine (fdC)10 and 5-
carboxy-cytosine (cadC).9,11 Pronounced amounts of these
bases can be found particularly in stem cells, and fdC was
recently also discovered in the genome of brain cells.12−14
Because fdC and cadC are supposed to be intermediates of an
active demethylation process, the data suggest that Tdg-
mediated base excision repair contributes to epigenetic
reprogramming. One of the main questions associated with
the Tdg-mediated repair process is to what extent potentially
harmful AP- and βE-site intermediates are generated in the
genome in response to the presence of fdC and cadC.
Here, we report the development of reagent 115 (Figure 1B)
that in combination with highly sensitive UHPLC-triple
quadrupole mass spectrometry (MS)16 enables quantiﬁcation
of both AP-sites and βE intermediates with unprecedented
sensitivity (∼100 intermediates per genome). The method was
used to quantify the steady-state levels of AP- and βE-sites
during BER of fdC and cadC.
■ RESULTS AND DISCUSSION
Design and Synthesis of a Probe for MS-Based Abasic
Site Quantiﬁcation. Reagent 1 contains a reactive hydroxyl-
amine unit, able to form stable and deﬁned reaction products
with the aldehydic form of both AP-sites and βE-intermedi-
ates.17,18 We discovered that the formed adducts (Figure 1B)
do not disturb the action of hydrolytic enzymes (Supporting
Information, section 3.8), so that the formed reaction products
can be excised quantitatively from the genome. To achieve
ultrahigh sensitivity, we developed the reagent for triple-
quadrupole MS detection. In this method, not only is the
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molecular mass of the analyte observed, but also a speciﬁc mass
transition that arises when the parent ion fragments. 1 therefore
contains a triazole heterocycle that fragments in the triple
quadrupole MS via collision-induced dissociation (CID) to give
a loss of N2. The permanent positive charge that was designed
into 1 ensures highest possible sensitivity in the mass
spectrometer and was found to be beneﬁcial, assuring fast
reaction with the AP- and βE-sites that are embedded in the
negatively charged DNA duplex. The coupling to mass
spectrometry is essential to distinguish AP- and βE-
intermediates, which has not been possible to date with
previously established methods.17,19,20
The synthesis of reagent 1 is shown in Scheme 1. It starts
with p-azidoaniline 2, which is reacted with trimethylamino
glycine 3 using TBTU as the coupling reagent to give the azido-
amide 4. A stable isotopologue of reagent 1a, needed for exact
MS-based quantiﬁcation (vide infra), is at this step accessed via
a (CD3)3-glycine derivative, which introduces nine D atoms
making 1b 9 au heavier (1b). O-(Carboxymethyl)-
hydroxylamine 5 was in parallel Trt-protected to 6,21 and 6
was reacted with propargyl amine using again TBTU as the
coupling reagent to give the alkyne 7. Reaction of 4 with 7 via a
Cu(I)-catalyzed azide−alkyne click reaction furnished the
triazole 8. Cleavage of the Trt-group under harsh acidic
conditions provided the reagents 1 in a light (CH3, a) and a
heavy version (CD3, b), with a Δm/z = 9 in just ﬁve steps with
a total yield of 47%.
The reagent was puriﬁed twice by reversed phase HPLC to
establish a purity of >99.9%. For exact mass spectrometry-based
quantiﬁcation, we next needed to prepare the AP- and βE-site
reaction products with 1 in unlabeled (a) and isotopically
modiﬁed (b) versions to be used as internal standards. We
reacted both isotopologues 1a/b with 2′-deoxyribose, which
provided the AP-site reaction products 9a/b. To prepare the βE
products 10a/b, we reduced the acetonide-protected methyl-
ester 11 with DIBAL-H to the allyl alcohol, which was
subsequently oxidized selectively to the aldehyde 12 using the
Dess−Martin reagent. Reaction of 12 with reagent 1a/b and
ﬁnal cleavage of the acetonide protecting group furnished the
desired compounds 10a/b, in a light and heavy version,
respectively. Compounds 9a/b and 10a/b were ﬁnally puriﬁed
by reversed phase HPLC to purities >99.9%.
We next developed the MS method (Figure 2A). Analysis of
the AP-site reaction product 9a provided a symmetric signal (at
t = 9.5 min, for gradient see Supporting Information, section
3.3) for the MS transitions m/z = 478.2 → 450.2 (quantiﬁer)
and m/z = 478.2 → 192.1 (qualiﬁer) caused by the two
molecular fragments formed after CID fragmentation. One
fragmentation is caused by the loss of N2, and the second
fragmentation involves the formation of an aryl radical.
The ﬁrst MS transition (quantiﬁer) was used for exact
quantiﬁcation, while the second MS transition (qualiﬁer) is
needed for additional structure validation. The isotopologue 9b
showed the expected mass transitions m/z = 487.3 → 459.3
and m/z = 487.3 → 201.2. Similar data were obtained for the
βE-reaction product 10a and its isotopologue 10b (Figure 2A).
We next performed a dilution experiment with 9a and 10a and
found that we could detect the compounds within a limit of
detection of only 110 amol. This is due to the fact that 1 was
designed so that its AP- and βE-adducts 9 and 10 have
advantageous ionization (permanent positive charge) and
fragmentation (triazole that leads to a neutral loss of N2)
Figure 1. Mechanism of the base excision repair process. (A)
Chemistry of BER with formation of AP- and βE-sites. Blue pathway:
Monofunctional glycosylases act in concert with Ape1 and Pol β. Red
pathway: Bifunctional glycosylases. (B) Depiction of reagent 1 and of
the reaction products that are formed when 1 reacts with AP- and βE-
sites.
Scheme 1. Synthesis of 1 (Red) in a Light (1a) and Heavy
(1b) Form and of the Light and Heavy Internal Standards
9a/b and 10a/b (Blue)a
a(i) TBTU, DIPEA, DMF, rt, 16 h, 90%; (ii) Trt-Cl, NEt3, pyridine, rt,
22 h, 74%; (iii) propargylamine, TBTU, DIPEA, DCM, rt, 15 h, 92%;
(iv) 7 + 4a/b, CuBr·SMe2, H2O/DCM (1:1), rt, 16 h, 77%; (v) 6 M
HCl, DCM/H2O (1:1), rt, 1 h, quant.; (vi) H2O, 30 °C, 16 h, HPLC,
15%; (vii) (1) DIBAL-H, DCM, −78 °C to rt, (2) DMP, DCM, 0 °C
to rt, o/n, 47% over two steps; (viii) (1) 1a/b, CHCl3/H2O (1:1), rt,
16 h, 68%, (2) pTSA·H2O, H2O, 25 °C, o/n, HPLC (2×), 14%.
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properties that allow for ultrasensitive detection in a triple
quadrupole mass spectrometer.
To investigate if the reagent is able to detect AP-sites directly
in DNA, we prepared oligodeoxynucleotides with a single dU
base (Figure 2B). To this DNA strand we added the U-cleaving
monofunctional glycosylase UDG (uracil DNA glycosylase) to
generate a deﬁned AP-site (Supporting Information, section
3.6). We added 1a, digested the DNA with a mixture of the
enzymes nuclease S1, Antarctic phosphatase, and snake venom
phosphodiesterase, added a deﬁned amount of the internal
standard 9b, and quantiﬁed generated AP-sites using our
developed method (Figure 2C; Supporting Information,
section 3.8). Indeed, we clearly detected the AP-site adduct
9a at the expected level, showing that 1a reacts quantitatively
under mild conditions and that the reaction product is excised
quantitatively. Furthermore, we treated an 8oxo-dG containing
oligodeoxynucleotide with human 8-oxoguanine DNA glyco-
sylase 1 (OGG1) and observed the formation of both an AP-
and a βE-site (Supporting Information, section 3.7).
Quantiﬁcation of Abasic- and βE-Sites in Mouse
Embryonic Stem Cells. To assess the utility of the method
(derivatization plus mass spectrometry), we next measured the
steady-state levels of AP- and βE-sites in mouse embryonic
stem cells (mESC). Here, the removal of fdC and cadC by BER
may lead to a particular increase of the levels of BER
intermediates.22−24 Alternatively, it was shown that Tdg
forms a complex with the ten-eleven translocation dioxygenase
(Tet) 1 and Ape1 and possibly also with the nei endonuclease
VIII-like (Neil) 1 and 2 enzymes. In these scenarios, BER takes
place in a tight complex that does not allow accumulation of
AP-sites.25,26 Naiv̈e cultures of mESCs were primed for 5
days.27 To measure the steady-state level of AP- and βE-sites,
we treated the isolated genomic DNA before digestion with 1a.
To the digestion mixture were added the internal standards 9b
and 10b in deﬁned amounts, and the mixture was analyzed and
quantiﬁed by UHPLC-MS.
It should be noted that this method does not allow the
distinction between AP- and 5′-dRP-sites. As shown in Figure
3A, we measured a total of 8.8 × 10−7 AP- and 1.7 × 10−6 βE-
sites per dN, which is comparable to the levels in other cell
types (Figure S4). These quantitative data show that in mESCs
the steady-state levels of total AP- and βE-sites are quite
substantial. Our data are slightly lower as compared to data
obtained previously.17,19,20 While AP-sites also form by
spontaneous depurination, this is not possible for βE-sites,
showing that DNA glycosylases generate quite a number of
harmful intermediates that need to be further processed. We
measure a steady-state level of around ∼9200 βE-sites per
genome in mESCs. Several control experiments show that these
intermediates are not generated during DNA isolation,
handling, or derivatization (Supporting Information, sections
2.5 and 3.9). For example, to exclude that the measured AP-
Figure 2. (A) Fragmentation pattern of 9a/b and 10a/b, which give
deﬁned daughter ions after loss of N2 or an aryl radical. (B) Reaction
of reagent 1 with a deﬁned AP-site created inside a DNA duplex.
Quantiﬁcation of the reaction product 9a after the treatment of the
oligodeoxynucleotide with 1a. (C) UHPL-chromatogram of the
canonical bases plus the AP (9a)- and βE-site (10a) reaction products
formed with reagent 1a.
Figure 3. Quantiﬁcation of BER intermediates and isotope tracing
studies. (A) Quantitative data of global levels of AP- and βE-sites from
mESCs. Inhibition and knockdown of Ape1 yields an increased
amount of AP-sites. (B) Feeding of mESC cultures with labeled
nucleosides results in the formation of ribose-labeled AP- and βE-site
products 9* and 10*, which are ﬁve mass units heavier than unlabeled
products.
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and βE-intermediates are formed during the treatment of
genomic DNA with 1a, we incubated genomic DNA over
diﬀerent time points with 1a and quantiﬁed the levels of AP-
and βE-sites (Figure S9). Increasing levels of AP- and βE-sites
were not detected even after a prolonged reaction time (up to
60 min), excluding this possibility. To exclude that the AP-sites
are generated during the DNA isolation procedure, we studied
how the major AP-endonuclease Ape128 inﬂuences the levels of
AP-sites (Figure 3A).
This enzyme is known to operate together with monofunc-
tional glycosylases to convert AP-sites into single nucleotide
gaps. It is known that Ape1 and Tdg interact and that the
release of Tdg from the AP-site depends on the presence of
Ape1.29 We therefore added the Ape1 inhibitor CRT004486730
to mESC cultures and measured the levels of AP-sites after
treatment for 48 and 60 h. As shown in Figure 3A, we see a
clear increase of AP-sites by a factor of 3−4, conﬁrming that
AP-sites accumulated when the activity of Ape1 is inhibited. On
the basis of similar signal intensities, we concluded that the
amount of βE-sites stayed unchanged in this experiment. We
also down-regulated Ape1 expression using esiRNA in the last 2
days of priming. qPCR studies conﬁrmed that the esiRNA
approach reduces the expression level of Ape1 by 50%. This led
to a 30% increased AP-site level (Figure 3A, right panel). These
data show that our method is able to report the diﬀerential
formation of BER intermediates in vivo.
Tracing Studies with Isotopically Labeled Nucleo-
sides. We next analyzed the formation of AP- and βE-sites at
the diﬀerent types of DNA bases with a particular emphasis on
dC and its derivatives mdC, hmdC, fdC, and cadC. To this end,
we prepared four diﬀerent mESC cultures and added either
isotopically labeled dA*, dC*, dG*, or dT* nucleosides, in
which all of the 12C atoms were exchanged against 13C.
Correspondingly, the AP- and βE-sites formed from these bases
are ﬁve atom units heavier than those obtained from unlabeled
material (Figure 3B).
We ﬁrst determined the steady-state levels of mdC, hmdC,
fdC, and cadC. For this we isolated and digested the genomic
DNA using a standard protocol (Supporting Information,
sections 2.3 and 3.2). The obtained levels are as expected with
fdC = 1.5 × 10−6/dN and cadC = 8.9 × 10−7/dN (Figure 4).
Next, we monitored the eﬃciency of incorporation. We saw for
13C10-dG an incorporation of 93%.
13C9-dC was incorporated to
40%, and the 13C9-dT almost fully replaced dT (97%
incorporation). Interestingly, no signiﬁcant incorporation of
dA was observed, making any study of this base impossible. We
next performed exact quantiﬁcation of the AP- and βE-sites at
dG*, dT*, and dC* and normalized the obtained values for
direct comparison. For BER at dG, which is known to be prone
to oxidative damage and spontaneous depurination,31 we saw
comparable amounts of AP- and βE-sites. We measured 2.7 ×
10−7 sites per dN, which corresponds to a steady-state level of
around ∼1500 AP- and βE-sites derived from dG (Figure 4).
The high level of βE-sites is consistent with the known BER
repair pathway of the main oxidative lesion 8-oxoG that
involves the action of the bifunctional DNA glycosylase Ogg1.32
At dT, the levels of the βE-sites are below 10−8 per dN,
which amounts to less than ∼100 βE-intermediates per
genome. This level is below the lower limit of quantiﬁcation
(LLOQ) of our reagent and mass spectrometry-based method
(Figure 4). AP-sites deriving from dT were not detectable at all.
The data show that spontaneous cleavage of the glycosidic
bond of dT and BER at this base is a minor process.
Most interesting are the very low levels of AP-sites detected
at dC* (below LLOQ). βE-sites are in contrast clearly
measurable, and with 1.2 × 10−7 per dN they are about one-
half of those measured for dG*. dC and its derivative mdC are
prone to both spontaneous deamination33,34 and oxidation.35 It
has been recently reported that deamination preponderantly
contributes to mutational load in tissues. Under cell culture
conditions, however, oxidation seems to be the major source of
DNA damage.36 All known DNA glycosylases that process
mismatches generated by deamination of dC-bases are
monofunctional (uracil-N glycosylase (Ung) 2, single-strand
speciﬁc monofunctional uracil DNA glycosylase (Smug) 1, Tdg,
and methyl-binding domain glycosylase (Mbd) 4). Oxidized
dC-bases are in contrast repaired by bifunctional Neil family
DNA glycosylases.37 The occurrence of oxidative damage in
cultured cells is therefore consistent with higher levels of βE-
products relative to AP-sites stemming from dC-type bases.
To study how mdC and its oxidized derivatives hmdC, fdC,
and cadC contribute to the level of βE-sites, we repeated the
dC* feeding study with mESCs lacking all three DNA
methyltransferases (Dnmts). Indeed, these cells lack any
genomic mdC, and, consequently, the oxidized bases hmdC,
fdC, and cadC are not detected anymore. Despite this, we saw
no AP- and βE-site changes, arguing that at the steady state the
overwhelming majority of βE-sites are generated from canonical
dC, for example, by oxidative damage. Obviously, if BER is low,
the small amounts of fdC and cadC that are present in the wild
type may provide only small amounts of AP- and βE-sites that
are negligible. If BER is however a major process, the fact that
we do not see changing AP- and βE-site levels could
alternatively imply that the formed AP-sites are immediately
processed.
To study this phenomenon in more detail, we next fed dC*
to mESCs lacking the Tdg enzyme to interrogate the putative
BER complex. We ﬁrst measured the levels of fdC and cadC
and saw the expected increase of fdC and cadC levels (Figure
4). Despite this, we again see unchanged levels of AP- and βE-
sites. This inability to detect any signiﬁcant change despite
higher levels of fdC (2 × 10−5 per dN) and cadC (2.5 × 10−6
per dN) is puzzling. It may suggest that single nucleotide BER
is no longer occurring or that fdC or cadC is removed by
alternative pathways such as long patch BER or noncanonical
Figure 4. Quantiﬁcation of labeled AP- and βE-intermediates of the
isotope tracing studies and quantiﬁcation of the fdC and cadC content
in Tdg wt and KO cells. n.d., not detectable. (i) Levels were over the
LOD, but under LLOQ.
Journal of the American Chemical Society Article
DOI: 10.1021/jacs.7b04131
J. Am. Chem. Soc. 2017, 139, 10359−10364
10362
mismatch repair.38,39 Interestingly, in an experiment where we
used the Ape1 inhibitor CRT0044867 and fed dC*, analysis of
the labeled AP-sites did not show an increase as well. The
measured levels stayed below the LLOQ (Figure S1A). We did
detect, however, a small increase of the global AP-sites (Figure
S1B). Because Ape1 is supposed to be in complex with Tdg, to
quickly convert AP-sites, this lack of increase is surprising.
Our data are consistent with either a scenario in which the
Tdg generated BER intermediates at fdC and cadC are quickly
turned over without Ape1 or in which other processes remove
fdC and cadC.
■ CONCLUSION
In summary, we report the development of reagent 1 that reacts
quickly with aldehydes such as those formed during BER in the
genome. The reagent 1 undergoes an eﬃcient CID derived
neutral molecule loss in the MS, which allows the ultrasensitive
detection of AP- and βE-BER intermediates with 100 amol
sensitivity. This, together with the feeding of isotopically
labeled nucleosides, allowed us to show that removal of the
epigenetically relevant bases fdC and cadC proceeds without
the accumulation of signiﬁcant amounts of these potentially
harmful BER intermediates in the genome of stem cells.
Alternatively, it may be that the BER-based removal of fdC and
cadC is less important than thought. Further studies are now
needed to fully decipher the BER processes that operate on fdC
and cadC during the enigmatic process of active epigenetic
demethylation.40,41
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Quantitative LC–MS Provides No Evidence for m6dA or m4dC in the
Genome of Mouse Embryonic Stem Cells and Tissues
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Abstract: Until recently, it was believed that the genomes of
higher organisms contain, in addition to the four canonical
DNA bases, only 5-methyl-dC (m5dC) as a modified base to
control epigenetic processes. In recent years, this view has
changed dramatically with the discovery of 5-hydroxymethyl-
dC (hmdC), 5-formyl-dC (fdC), and 5-carboxy-dC (cadC) in
DNA from stem cells and brain tissue. N6-methyldeoxyadeno-
sine (m6dA) is the most recent base reported to be present in the
genome of various eukaryotic organisms. This base, together
with N4-methyldeoxycytidine (m4dC), was first reported to be
a component of bacterial genomes. In this work, we inves-
tigated the levels and distribution of these potentially epigeneti-
cally relevant DNA bases by using a novel ultrasensitive
UHPLC–MS method. We further report quantitative data for
m5dC, hmdC, fdC, and cadC, but we were unable to detect
either m4dC or m6dA in DNA isolated from mouse embryonic
stem cells or brain and liver tissue, which calls into question
their epigenetic relevance.
The genetic material of living organisms is constructed from
the four canonical nucleobases dA, dC, dG, and dT, which
establish the sequence information that, in multicellular
organisms, is stored in the nucleus of every cell (Figure 1).
In addition to the canonical bases, the methylated dC base 5-
methyldeoxycytidine (m5dC) is frequently found.[1] The
presence or absence of this base in specific promoter seg-
ments determines whether the gene is actively transcribed or
silenced.[1] The cell-type-specific distribution of m5dC thus
determines the identity of a given cell. Recently, 5-hydrox-
ymethyldeoxycytidine (hmdC) was found as a sixth base of
the genetic system[2,3] and in 2011, 5-formyldeoxycytidine
(fdC)[4,5] and 5-carboxydeoxycytidine (cadC)[5,6] were also
discovered, particularly in DNA isolated from stem cells, but
also in brain DNA. It is currently believed that fdC and cadC
are intermediates in an active demethylation process that
allows cells to change the methylation pattern and hence the
activity state of specific genes.[7,8] For fdC, separate epigenetic
functions are also envisaged.[9]
While the genomes of bacteria are known to also contain
N4-methyldeoxycytidine (m4dC)[10] and N6-methyldeoxyade-
nosine (m6dA),[11] attempts to detect these bases in the DNA
of higher organisms have failed until recently.[12–15] m6dA has
now been found in algae (0.4 mol% m6dA/A),[12] fruit flies
(0.001%-0.07% m6dA/A),[14] and C. elegans (0.01%-0.4%
m6dA/A),[13] and its presence has even been reported in the
DNA of vertebrates (0.00009% in X. laevis[16] and 0.00019–
0.003% of dA in murine cells and tissue[17]). These discov-
eries, especially concerning the DNA of vertebrates, have
spurred a worldwide research interest in unraveling the
function of these new bases in human genomic DNA.[18–20]
In this study, we developed an ultrasensitive triple
quadrupole mass spectrometry (QQQ-MS) method, which
in combination with ultra-high-pressure chromatography
(UHPLC) enables m4dC and m6dA to be searched for and
quantified in parallel to the more established new epigenetic
DNA marks m5dC, hmdC, fdC and cadC.
Figure 1. Depiction of the four canonical DNA bases and the epige-
netic DNA marks m5dC, hmdC, fdC, and cadC, as well as the bases
m6dA and m4dC together with the synthesized isotopologues.
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For the quantitative measurements, we first chemically
synthesized the two isotopologues of m6dA and m4dC shown
in Figure 1 as internal standards for the analytical method.
The prepared compounds D3-m
6dA and 15N2-m
4dC are three
and two mass units heavier, respectively, than the natural
bases. Despite these molecular-weight differences, they have
identical properties during the UHPL chromatography step
so that they strictly coelute with their natural counterparts,
thus allowing them to enter the mass spectrometer at exactly
the same time as the internal standards. The availability of
these isotopologues makes the method highly reliable and
strictly quantitative. The syntheses of the two compounds,
together with all analytical data, are given in the Supporting
Information.
We first benchmarked our study with an investigation of
genomic DNA isolated from the unicellular green algae
Chlamydomonas reinhardtii and the cyanobacterium Syne-
chocystis. In both cases, DNAwas isolated after cell lysis using
a standard method (see the Supporting Information). The
isolated DNA was subsequently digested with a mixture of
three commercially available digestion enzymes (Nuclease
S1, Antarctic Phosphatase, and Snake Venom Phosphodies-
terase; see the Supporting Information). We next added the
isotope-labelled standards D3-m
6dA and 15N2-m
4dC to the
obtained digestion mixture and performed UHPLC-QQQ
analysis. For the mass spectrometry detection, we selected
fragmentation of the glycosidic bond as the indicative and
hence recorded mass transition. This is m/z= 266.12!150.08
for m6dA and m/z= 269.14!153.10 for its isotopologue D3-
m6dA. For m4dC, we also used fragmentation of the glycosidic
bond, which gives a mass transition of m/z= 242.11!126.07
for the natural compoundm4dC andm/z= 244.11!128.07 for
its isotopologue 15N2-m
4dC (Figure 2A).
We next modified the reported UHPLC-QQQ method[10]
for the simultaneous quantification of m4dC and m6dA,
together with the other epigenetically relevant bases m5dC,
hmdC, fdC, and cadC. To this end, the UHPLC gradient was
fine-tuned to enable full separation of all six compounds.
Finally, we measured precise calibration curves for all of the
compounds (see Figures S1 and S2 in the Supporting Infor-
mation). This subsequently allowed exact quantification of all
of the discussed epigenetic DNA marks in a given sample
(Figure 2B–D).
Since m4dC and m6dA are well known in bacteria, we first
analysed the cyanobacterium Synechocystis (PCC6803), and
we indeed found both bases (Figure 2B). The base m6dAwas
detected at a level of 8.4  103 per dN and for m4dC we
measured a value of 5.9  103 per dN. The constitutional
isomer m5dC and all other dC-derived epigenetic DNAmarks
were detectable, but were not quantified in this experiment.
Next, we analyzed two different strains of Chlamydomo-
nas reinhardtii (CC-3491 and wt 7d+), in which m6dA has just
recently been discovered,[12] and the levels of m6dA were
determined to be 8.4  104 per dN for CC-3491 and 6.9  104
per dN for wt 7d+ (Figure 2C). This corresponds to about
3000 m6dA bases per Chlamydomonas genome (genome size
1.2  108), which at 0.7% of the dA is a relatively high
number. In both strains, m4dC was not detected, thus showing
that this base is unlikely to be a component of the genetic
material of Chlamydomonas. This is interesting because
Synechocystis is considered a relative of the chloroplasts
present in Chlamydomonas.
With these positive results in hand, we extended our study
to mouse embryonic stem cells (ESCs; wt J1, Figure 2D).
m6dA in particular was recently reported to occur as an
epigenetically relevant DNA mark in mouse ESCs (mESC
cell line wt TT2).[17] When performing the measurements, we
turned the mass spectrometer to maximum sensitivity. But
even in this mode, we were unable to detect a signal for m6dA
within the detection limits of our system Table S2. In contrast,
the other epigenetically relevant bases hmdC, fdC, cadC, and
even the oxidative lesion 8-oxodG, which we also quantified
in parallel, were clearly detectable. The 8-oxodG level was
4.8  105 per dN. The rare and difficult to detect cadC was
clearly seen even at levels of only 9.0  108 per dN. For m6dA,
in contrast, a signal did not appear. We also re-measured wt
TT2 cells as described and still did not detect m6dA over
background levels (see Figure S4).[17] To obtain unequivocal
proof that m6dA is not present in stem cells, we added 13CD3-
methionine to the mESC culture. Methionine provides the
methyl group for the biosynthesis of m6dA. With 13CD3-
methionine, this would lead to an m/z-shift of + 4. We tuned
the mass spectrometer to the new m/z-transition and again
were unable to see any signal for 13CD3-m
6dA (Figure S8).
We subsequently turned our attention to adult mouse
tissue and analysed DNA isolated from liver and whole brain
Figure 2. A) Fragmentation patterns of m4dC and m6dA. B–D) Quanti-
tative data of the bases m4dC and m6dA in Synechocystis (B), Chlamy-
domonas (C) and of these bases and the other epigenetic DNA marks
hmdC, fdC, cadC, and m5dC in mouse embryonic stem cells (D).
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(Figure S3) using our UHPLC-QQQ method. Figure 3 shows
the data obtained from mouse liver. The middle column
shows the data we obtained for hmdC. The already reported
D2-
15N2-hmdC standard elutes at a retention time of 2.25 min
and shows the expected fragmentation of the glycosidic bond,
providing the fragmentation signature m/z= 262.12!146.07,
which allowed assignment of the signal. The naturally
occurring hmdC is detected at exactly the same retention
time with a mass transition of m/z= 258.11!142.06, thus
unequivocally demonstrating the presence of hmdC in murine
liver DNA. Regarding the different monomethylated dC
compounds m5dC and m4dC (left column), the epigenetic
DNA mark m5dC is clearly detected at a retention time of
3.2 min, but for m4dC with a retention time of 3.5 min, there is
obviously no signal present.
The m6dA data are highly interesting (Figure 3 right
column). While the D3-m
6dA standard was clearly detectable
at a retention time of 10.1 min, the unlabelled m6dA provided
a very weak signal. We then performed a control experiment
to determine the limit of detection
and investigated the digestion so-
lution alone, which contains all of
the commercial enzymes but no
isolated DNA (red chromato-
gram). A weak signal for m6dA
was again detectable at a retention
time of 10.1 min. After subtracting
this background signal (red) from
the measured chromatogram
(blue), we obtained the black line
showing that the original signal at
10.1 min is purely caused by back-
ground derived from the enzyme
mixture. Here it is important to
note that most of these proteins
are recombinant proteins obtained
from bacterial expression systems
and bacterial DNA contains plenty
of m6dA. To support the evidence
that m6dA is not present in verte-
brate DNA, we performed the
same experiment with HeLa cells
and also observed no signal for
m6dA (Figure 3B).
We then determined our limit
of detection for m6dA to be 3.5 
107 per dN, which corresponds to
170 m6dA bases per murine
genome. This is a very small
number and demonstrates the
excellent sensitivity of our
method. It shows that the maxi-
mum number of m6dA that could
be theoretically present and would
not be detectable by our method is
less than 170 m6dA bases per
genome, which led us to conclude
that m6dA is likely not epigeneti-
cally relevant but rather formed as
a DNA lesion, perhaps by mis-
guided methyltransferases. Spiking
tests with synthetic nucleoside and
DNA from Chlamydomonas nevertheless confirmed the
sensitivity of the method, since the input amount equalled
the found amount (see Figure S6).
To find a potential source for m6dA in mESC DNA that
could explain previous sequencing data,[17] we thought that
m6dA-containing bacterial DNA that gets degraded could
provide the m6dA nucleoside, which then might get incorpo-
rated into mESC DNA. This is indeed a possibility. When we
added the m6dA nucleoside to a mESCs culture, we indeed
saw incorporation of some m6dA into the genome (Fig-
ure S7).
Figure 3. A) Chromatograms of the mass signal of mouse liver DNA. UHPLC-QQQ data obtained for
m5dC and m4dC (left), hmdC (middle), and m6dA (right, blue line) and their corresponding isotopic
standards are shown. Additionally, for m6dA, the chromatogram for the digest blank is shown (red
line) and a computed baseline (black line), which was determined by subtracting the digest blank
from the sample. B) A chromatogram of the mass signal from UHPLC-QQQ data obtained for m6dA
in DNA from HeLa cells.
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We also cannot fully exclude the possibility that the
presence of few m6dA bases, at levels below our detection
limit, could have a biological function. In addition, it is
possible that at certain stages of organismal development,
certain methyltransferases are activated that may induce high
m6dA levels at specific time points that may have escaped our
detection.[18] Our data, however, show clearly that the
maximum possible levels of m6dA in the analysed organisms
and mESCs under normal conditions are far lower than so far
believed.
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base in the mouse genome. It appears
that in vertebrates, the levels of this
modified base, and that of N4-methyl-
deoxycytidine, are much lower than pre-
viously thought.
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Methylcytosine is an epigenetically important nucleobase associated with the control of transcriptional activity, genomic imprinting, X-chromosome inactivation and 
suppression of transposable elements1. Controlled formation and 
removal of mC at specific genomic loci is critical for correct genome 
programming or reprogramming during cellular differentiation2. 
Recently, it was discovered that Tet proteins (Tet1–3) oxidize mC 
to give the oxidized C-derived nucleobases hmC3, 5-formylcytosine 
(fC)4,5 and 5-carboxycytosine (caC)5,6, whose biological functions 
are still yet unclear (Fig. 1a)7. As fC and caC are both removed 
by thymine DNA glycosylase (Tdg)6,8, it is currently assumed that 
they serve as intermediates of an active DNA demethylation pro-
cess involving base excision repair. In addition to these oxidized 
C derivatives, cells also contain oxidized T nucleobases such as hmU 
and fU. These compounds are currently known as oxidative lesions 
that are thought to form upon the reaction of T with reactive oxygen 
species (ROS)9,10. It was recently suggested that hmU might also be 
produced by deamination of hmC, a hypothesis that remains con-
troversial11–14. Deamination of hmC, situated in a base pair with G 
(hmC:G), would give rise to hmU:G mismatches, which are known 
substrates for the DNA glycosylases Tdg, Smug1, Mbd4, Ung2 
(ref. 15), Neil1 and Nthl1 (ref. 16). Deamination of hmC:G to 
hmU:G followed by mismatch repair would therefore establish an 
alternative pathway to active demethylation (Fig. 1a).
To unravel the origin of oxidized nucleobases, and of hmU 
in particular, in DNA from mESCs, we performed isotope trac-
ing and quantitative MS studies using the chemically synthesized 
isotopologs of mC, hmC, fC, caC, hmU and fU as internal standards 
(Fig. 1b and Supplementary Results, Supplementary Fig. 1). For 
the assessment of oxidation products that are formed by the action 
of ROS, we additionally quantified 8-oxo-G because 8-oxo-G is a 
well-established ROS reaction product formed from G17,18. We show 
here that hmU is generated enzymatically from thymidine during 
stem cell differentiation by the action of the Tet enzymes. A pro-
teomic analysis provides new insight into how genomic hmU can 
influence the binding of chromatin remodeling proteins and tran-
scription factors.
RESULTS
hmU is present at elevated levels in mESCs
We first created an inventory of the named nucleosides 
(Supplementary Fig. 1) in mESCs (Fig. 1c) and adult cortex tissue 
(Fig. 1d). In mESCs, we observed that hmC is, as expected, the most 
abundant oxidized pyrimidine (10% relative to mC), followed by fC 
(~1–2% of hmC). The ROS marker 8-oxo-G was detected at simi-
lar levels (~45% of fC), showing that nonenzymatic, ROS-induced 
oxidations of nucleobases are important processes, as expected. We 
also found relatively high levels of fU (22% of fC). Clearly detect-
able were also caC and hmU. hmU, which is at the center of this 
study, was unequivocally detected, as shown by its retention time 
and its specific fragmentation pattern, which were found to be iden-
tical with that of the internal standard [D2]hmU (Fig. 1e). Notably, 
both caC and hmU were present in comparable amounts (5% 
of fC). In adult mouse cortex DNA (Fig. 1d; for other tissues see 
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Ten eleven translocation (Tet) enzymes oxidize the epigenetically important DNA base 5-methylcytosine (mC) stepwise 
to 5-hydroxymethylcytosine (hmC), 5-formylcytosine and 5-carboxycytosine. It is currently unknown whether Tet-induced 
oxidation is limited to cytosine-derived nucleobases or whether other nucleobases are oxidized as well. We synthesized 
isotopologs of all major oxidized pyrimidine and purine bases and performed quantitative MS to show that Tet-induced 
oxidation is not limited to mC but that thymine is also a substrate that gives 5-hydroxymethyluracil (hmU) in mouse 
embryonic stem cells (mESCs). Using MS-based isotope tracing, we show that deamination of hmC does not contribute to the 
steady-state levels of hmU in mESCs. Protein pull-down experiments in combination with peptide tracing identifies hmU as a 
base that influences binding of chromatin remodeling proteins and transcription factors, suggesting that hmU has a specific 
function in stem cells besides triggering DNA repair. 
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Supplementary Fig. 2), the hmC levels are very high (13% rela-
tive to mC), as previously reported19–21. In contrast, fC was detected 
only in very small amounts (0.03% relative to hmC), and caC was 
not observed at all22. The detected amounts of 8-oxo-G and fU are 
comparable. Notably, the detected levels of hmU in the cortex were 
significantly lower compared to that in mESCs (27%; P = 2.2 × 10−4 
by Student’s t-test). Because the detected levels of 8-oxo-G were 
similar in the cortex (Fig. 1d) and in mESCs (Fig. 1c), the elevated 
hmU levels in mESCs cannot be explained by greater ROS-induced 
damage in mESCs and must have a different origin.
We next investigated this in more detail and quantified the levels 
of hmU in three different mESC lines (WT01, J1 and R1) and in 
a variety of tissues (Fig. 2a). Clearly, the hmU levels were higher 
in mESCs than in somatic tissues by factors of 2–15. The detected 
hmU levels correspond roughly to 500–1,700 hmU bases per 
genome in tissue and 2,900–7,800 in mESCs (Fig. 2a) depending on 
the cell type and growth conditions. We cannot explain these differ-
ences by elevated oxidative stress levels in mESCs (Supplementary 
Fig. 3). We next analyzed the levels of C, mC and the oxidized 
pyrimidines hmC, fC, hmU and fU as well as 8-oxo-G in somatic 
tissues (Supplementary Fig. 2) and performed a correlation and 
cluster analysis to reveal relationships of the modification levels 
(Fig. 2b). The data analysis confirmed that the low levels of hmU 
in somatic tissues correlate strongly (significant on a level <0.001) 
with the levels of fU and 8-oxo-G within a separated cluster. 
This result showed that in somatic cells, hmU and fU are ROS-
induced reaction products. If we assume that in somatic tissues 
hmU is exclusively formed by ROS, the data showed that in mESCs, 
70–80% of the detected hmU is produced by ROS-independent 
processes (Supplementary Fig. 3).
hmU formation by oxidation of T
To analyze the origin of the oxidized nucleobases in mESCs, we per-
formed isotope tracing experiments (Fig. 3a–c and Supplementary 
Fig. 4). Substitution of L-methionine with [methyl-13CD3]L- 
methionine ([13CD3]L-Met) in the growth medium is known to give 
the labeled S-adenosylmethionine cofactor, which is needed for the 
conversion of C to mC. Replacement of L-Met by [13CD3]L-Met for 5 d 
(2 passages) in the medium at a concentration of 0.2 mM furnished 
89% labeled [13CD3]mC, 88% labeled [hydroxymethyl-13CD2]hmC 
and 93% labeled [formyl-13CD]fC (Fig. 3b and Supplementary 
Fig. 4). Within the detection limit (7 and 50 molecules per 108  
nucleosides, respectively), no incorporation of the isotopes 13C and 
D into hmU and fU was observed, showing that hmC is not the pre-
cursor of hmU. We next added isotope-labeled [13C,15N2]thymidine 
([13C,15N2]T) to the growth medium and observed ~76% of label 
incorporation into T, hmU and fU (Fig. 3a, Supplementary Fig. 4  
and Supplementary Table 1). The combined data showed that 
hmU is not generated by deamination of hmC but by oxidation of 
T (T → hmU; Fig. 3c). Consequently, all of the detected hmU 
b
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Figure 1 | Metabolism of cytosine derivatives, their detection by LC-UV-ESI-MS/MS and levels in mESCs and mouse cortex. (a) potential active 
demethylation pathways. (b) overlaid lc/uv and lc/MS/MS chromatograms of a representative dnA sample from meScs. the dotted lc/uv 
chromatogram of c, G, t and A is scaled arbitrarily; the overlaid lc/MS/MS chromatograms of hmc, mc, fc and 8-oxo-G are scaled to the left y axis; the 
lc/MS/MS chromatograms of cac, hmu and fu are scaled to the right y axis. Red chromatograms refer to the corresponding labeled internal standards 
depicted in Supplementary Figure 1. Au, arbitrary units. (c,d) dnA modification levels per nucleoside (n) in meScs (c; Wt01, n = 7) and 3-month-old 
mouse cortex tissue (d; n = 3). depicted are mean values ± s.d. (e) Representative lc/MS/MS chromatograms for identification and quantification of 
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(and also fU) resides in an A base pair context (hmU:A). In this 
base pair, hmU is repaired by Smug1 but not Tdg12. This was con-
firmed by siRNA-mediated knockdown of Smug1 in mESC cells 
and HEK-293T cells. Indeed, the hmU level increased in these cells 
(Supplementary Fig. 5).
The fact that we were unable to detect hmU derived from 
hmC deamination, which would be situated in a base pair with G 
(hmU:G), could also be explained by very fast repair. If repair of the 
hmU:G base pair is extremely efficient, for example, because deami-
nation and glycosylase-based repair occurs in a tight complex of the 
involved enzymes, we would be unable to detect this type of hmU 
because of low steady state levels. Indeed, it was proposed that hmC 
deamination and hmU excision requires a complex of the cytidine 
deaminase Aid and the glycosylase Tdg12. To assess this possibility, 
we performed isotope tracing experiments using [13CD3]L-Met in 
Tdg−/− mESCs stably complemented with either empty vector (con-
trol) or a minigene expressing a catalytically incompetent Tdg at 
near-endogenous levels. These cells are able to form the Aid–Tdg 
complex, but the Tdg is inactive, which should give elevated hmU 
levels if deamination occurs. In both cell lines, we detected high 
levels of labeled hmC. In the control cells, [hydroxymethyl-13CD2]
hmU was not detected. However, in the cell line complemented 
with inactive Tdg, some labeled [hydroxymethyl-13CD2]hmU was 
indeed observed, albeit only in small amounts (~7% of total hmU 
and ~0.06% of total hmC; Supplementary Fig. 6). Thus, the Tdg 
protein is required for deamination of hmC to hmU. In wild-type 
(WT) mESCs, the hmU:G mismatches are obviously repaired so 
quickly that they do not contribute to steady state levels of hmU. 
All of the detected hmU was derived from T oxidation and resided 
in hmU:A base pairs.
Tet enzymes form hmU in correlation with mC oxidation
We next investigated whether enzymatic oxidation or ROS-
dependent processes are responsible for the observed oxidation of 
T to hmU. To this end, we studied mESCs with genetic or func-
tional depletions of Tet or DNA methyltransferase (Dnmt) 
enzymes (Fig. 4). Although hmU levels were maintained at nor-
mal levels in the severely hypomethylated, Dnmt-depleted cell 
lines, they were substantially reduced upon knockdown of Tet1 
and Tet2. As the levels of fU and 8-oxo-G remained unaffected, 
the data establish that, though both hmU and fU are generated by 
T oxidation, their formation must occur by two independent pro-
cesses in mESCs. The data supported the idea that fU is a ROS-
created lesion similar to 8-oxo-G9,10,17,18, whereas most hmU is 
generated by Tet-induced oxidation of T.
In support of enzymatic T oxidation by Tet proteins, ectopic 
expression of the catalytic domain of Tet1 (Tet1cd) in HEK-293T 
cells led to a 65-fold increase for both hmC and hmU levels. This was 
not observed when a catalytic mutant of Tet1 (Tet1cm) was expressed 
(Supplementary Fig. 7a). To determine whether under these condi-
tions hmU is generated by deamination, as previously suggested11,12, 
we again replaced natural L-Met with [13CD3]L-Met in the medium, 
but we did not detect incorporation of heavy isotopes into hmU, 
providing evidence that the elevated hmU levels do not originate 
from hmC deamination (Supplementary Table 1). Finally, we con-
firmed enzymatic generation of hmU in vitro by incubating recom-
binant Tet1cd with a plasmid that was premethylated by bacterial 
methyltransferase M.SssI. In addition to oxidation of mC to hmC, 
fC and caC, we detected hmU at a prominent level of 9% relative to 
hmC (Supplementary Fig. 7b), showing that the catalytic center of 
the Tet enzymes clearly has the capacity to oxidize T to hmU.
To further confirm that hmU is formed in mESCs in the process 
of epigenetic reprogramming, we analyzed the dynamic changes of 
mC and all of the oxidized pyrimidines plus 8-oxo-G during dif-
ferentiation. It was recently shown that mC and hmC levels sharply 
increase when mESCs maintained in the naive state are shifted to a 
primed state in serum-containing medium23–25. To investigate global 
kinetics of all of the Tet-generated oxidation products under more 
physiologically relevant priming conditions, we used established 
protocols based on serum-free N2B27 medium for differentiation 
of naive mESCs into states resembling that of post-implantation 
epiblasts26,27. mESCs were first grown for several passages in the 
presence of MEK and GSK3 inhibitors (dual inhibition or 2i condi-
tions) and LIF to induce a hypomethylated state resembling that of 
the naive epiblast23–25. The data in Figure 5a are averaged from three 
independent differentiation experiments, each performed with two 
cell lines in the absence of growth factors. First, we observed that 
the fU and 8-oxo-G levels stayed constant (Fig. 5a), in line with the 
idea that both are ROS-derived products. In contrast, fC and caC 
levels peaked at about 8 h. Both hmU and hmC also peak between 
8 h and 16 h. Isotope tracing with [13CD3]L-Met under these condi-
tions provided no evidence for switched-on deamination of hmC to 
hmU (Supplementary Table 1). At these peak levels, we estimated 
that mESCs contain roughly 110,000 fC bases, 4,400 caC bases and 
Figure 2 | hmU is present at elevated levels in mESCs compared to tissue. 
(a) hmu levels per genome in meScs (nWt01 = 7 replicates, nJ1 = 2, nR1 = 3) 
and mouse tissue (3-month-old individuals, n = 3). levels per genome 
were obtained considering a mouse genome size of 2.7 × 109 base pairs. 
depicted are mean values ± s.d. the differences between meScs and 
mouse tissues are significant (P = 2.9 × 10−5 to 3.6 × 10−2; unpaired  
two-tailed t-test) except for Wt01 and hippocampus (P = 0.292) or 
heart (P = 0.069). these exceptions are due to higher hmu levels in the 
hippocampus and heart caused by higher background oxidation (higher 
8-oxo-G levels). hmu levels normalized to oxidative background (8-oxo-G) 
levels are in Supplementary Figure 3. nS, not significant. (b) unsupervised 
clustering analysis of pearson correlation coefficients of 24 data sets of 
selected mouse organs at a defined time point (3-month-old individuals: 
cortex, hippocampus, cerebellum, heart, liver and kidney). discussed 
correlations are strong to very strong (pearson coefficient >0.7) and 
significant on a level <0.001.
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14,000 hmU bases per genome, showing that, at its peak level, hmU 
is three times more abundant than caC. The dynamic peaking data 
allowed us to estimate half-life times for fC (7 h), caC (5 h) and hmU 
(4 h) during the differentiation process (Supplementary Fig. 8). 
Using the dynamic quantitative data, we performed a correlation 
and cluster analysis of the DNA modification levels (Fig. 5b). Three 
independent clusters were obtained. One cluster involves members 
of cytosine methylation (and demethylation) dynamics, including 
C, mC, fC and caC, but, to our surprise, not hmC. Instead, hmC 
groups with hmU. We therefore concluded that the formation 
of these modifications is tightly coupled by the action of the Tet 
enzymes. The ROS-induced lesions fU and 8-oxo-G form the third, 
well-separated cluster. Notably, hmU does not correlate with the 
ROS lesions.
Recently, it was shown that exposure of naive mESCs to fibro-
blast growth factor 2 (FGF-2) and activin A (ActA) for 48 h under 
similar conditions as those described above gives a homogeneous 
cell population whose transcriptome closely resembles that of the 
post-implantation epiblast26. Under these conditions, mC levels 
increased more rapidly, approaching somatic levels within a time 
frame closely reflecting that observed during embryonic develop-
ment (Supplementary Fig. 9a). Levels of hmC rose steadily 
throughout the 48-h time course. Whereas fC peaked at 36 h, hmU 
reached its maximum at 24 h (Supplementary Fig. 9b). qPCR data 
showed a robust induction of Dnmt3b that is 
most likely responsible for the increasing mC 
levels (Supplementary Fig. 9a). A transient 
peak of Tet1 expression at 24 h went in hand 
with rising hmU and fC levels, whereas Tet3 
expression started rising slowly from the same 
time point and may drive further accumulation 
of hmC and fC (Supplementary Fig. 9b). Tdg 
was progressively upregulated together with the 
onset of methylation activity, whereas Smug1 
showed little, if any, change (Supplementary 
Fig. 10). These data supported our view that 
hmU peaking is not caused by downregulation 
of the repair pathway.
Thus, the kinetic data showed a com-
plex interplay between methylation and two 
oxidation reactions during differentiation, 
which depends on the exact conditions. Most 
important is the fact that hmU showed a time-
 dependent occurrence similar to the other oxi-
dized bases hmC, fC and caC independently 
of the conditions investigated, confirming its 
formation during epigenetic reprogramming.
hmU attracts specific readers
To obtain initial insight into a potential biologi-
cal function of hmU in comparison to hmC, we 
screened for specific readers associating with 
hmU:A as well as with hmC:G and hmU:G 
using protein pulldown and relative quantifica-
tion by LC/MS/MS. In previous stable isotope 
labeling by amino acids in cell culture (SILAC)-
based proteomics studies with hmC, fC and 
caC containing oligonucleotides, we and oth-
ers observed a high number of specific protein 
readers, arguing that the new bases influence a 
variety of different processes28,29. For this hmU 
study, we further developed this approach for 
the detection of proteins that directly interact 
with the modified bases hmU (as well as hmC 
for comparison) to get a more direct insight into 
their function (Fig. 6a). For the study, we not 
only included into the biotinylated DNA duplexes (24mers) an hmU 
(hmC) base but also equipped the counter strand with a polyethylene 
glycol–based linker carrying a reactive N-hydroxysuccinimide 
(NHS) ester moiety and a reductively cleavable disulfide bond in 
the middle. This reactive linker cannot be inserted into the DNA 
strand using solid phase synthesis. In addition, the NHS ester does 
not survive hybridization conditions. We therefore attached the 
linker as its azide derivative, using Cu(I)-catalyzed click chem-
istry, to an alkyne-bearing base present in the DNA duplex30,31. 
These DNA duplexes were subsequently incubated with nuclear 
extracts from mESCs. The DNA-bound protein complexes were 
isolated using streptavidin-coated magnetic beads (Fig. 6a)32. 
DNA duplexes with the canonical base pairs A:T and C:G at the 
respective positions served as reference strands. The NHS linker has 
two functions in the experiment: First, it will covalently trap the 
reader proteins specifically at the ε-amino groups of lysines, which 
allows the identification of transiently binding proteins as well. 
Second, because the linker is cleavable, it will tag the trapped lysine 
residues, leaving a defined label on those proteins that bind in close 
proximity to the modified bases hmC and hmU. This allowed us to 
distinguish protein readers that bound close to hmC and hmU from 
proteins that are secondary members of the complexes. The cova-
lently trapped proteins were next tryptically digested and labeled 
with tandem mass tagging (TMT) isobaric tags to allow protein 
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identification and quantification by MS32,33. Only proteins that were 
enriched in both the forward and the reverse TMT experiment were 
considered to be specific hmU (hmC) readers (Fig. 6). All of the 
readers were subsequently divided into two groups. Proteins that 
were enriched relative to the control strands are termed specific 
readers (sRs). Of those, the proteins that were identified with a pep-
tide containing the tag are termed direct-specific readers (dsRs).
The scatter plot (Fig. 6b and Supplementary Fig. 11a) revealed 
over 250 sRs recognizing the hmU:A base pair (relative to T:A). 
Of those proteins, 99 were identified with tagged peptides. These 
proteins were therefore designated dsRs. A gene ontology analysis 
showed that 64 proteins of the 250 sRs are nucleotide bind-
ers, and 25 proteins are involved in chromatin organization 
(Supplementary Fig. 11b).
Among the dsRs we identified were the regulatory proteins Uhrf2, 
transcription factor HIVEP3 or the poly [ADP-ribose]  polymerase 14 
(Parp14), which showed that these proteins interacted directly with 
hmU. We also detected several H2A and H2B histone proteins among 
the dsRs and the sRs. Notably, in the group of the sRs, we observed 
also Dnmt3a and Dnmt3b, which are involved in gene expression 
regulation. Methyl CpG-binding protein 2 (MeCP2) was identified 
as well, but it showed only low enrichment. We also detected sev-
eral transcriptional regulators, such as bromodomain PHD finger 
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of dnA modification levels during early differentiation (0−40 h) of naive 
meScs in the absence of growth factors. box plot of relative modification 
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significant on a level <0.001.
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transcription factor (Bptf), transcription factor E2F6 and mediator of 
RNA polymerase II transcription subunit 12 (Med12). Moreover, we 
identified hmU-binding E3 ubiquitin-protein ligases such as Uhrf1, 
Trim37 and Huwe1 and finally the chromodomain helicase DNA-
binding proteins 1 and 9 (Chd1 and Chd9) among the hmU readers, 
which are chromatin remodeling factors and regulate polymerase I 
and II transcription. To exclude bias by sequence-specific binding, 
we repeated the experiment with hmU in a different sequence con-
text. Indeed, 78% of the identified protein readers are also observed 
in this control experiment, and included among them were all of 
the proteins discussed above, with the notable exception of Uhrf1, 
which was not observed in this experiment (Supplementary Data 
Set 1). The data show that hmU:A recruits specific proteins that are 
involved in chromatin biochemistry in a broad sense.
As a first validation of the MS-identified readers, we focused on 
Uhrf1 and Uhrf2. Uhrf1 is a known mC and hmC binder34, whereas 
we recently identified the homolog Uhrf2 as a specific binder of 
hmC29. The MS data for hmU obtained in this study showed an 
enrichment of Uhrf1 and Uhrf2. In addition, Uhrf2 was identified 
as a direct binder. To validate the MS findings, we overexpressed 
Uhrf1 or Uhrf2 together with Tet1cd in 
HEK-293T29 and measured the levels of mC, 
hmC, fC, caC and also hmU. Indeed, we 
observed increased levels of hmU, proving a 
functional relation between hmU levels and 
Uhrf1 and Uhrf2 (Supplementary Fig. 12). 
As Uhrf2 is known to interact with Dnmt3a 
and Dnmt3b35 and these two proteins are 
also identified as sRs of hmU, our initial data 
provide a consistent picture.
Analysis of the specific hmU readers 
showed that 49 of the identified proteins were 
also enriched with an hmC-modified strand. 
Among these proteins were, for instance, 
 bromodomain PHD finger transcription factor 
(Bptf), MeCP2 and 19 other nucleotide- binding 
proteins. The obtained list of specifically bind-
ing proteins is in good agreement with our 
recently published data set29, which further 
supports the validity of the covalent trapping 
method. Finally, we compared the results 
of the hmU:A pulldown with a pulldown of 
hmU:G, which would be the product of hmC 
deamination. We found 69 of 280 sRs in both 
experiments. We identified transcription regu-
lators as sRs as well in the hmU:G pulldown. 
However, we also found several DNA repair 
proteins, such as DNA repair protein comple-
menting XP-C cells homolog (XPC), DNA 
repair protein Rad50 and five helicases, among 
others (Supplementary Data Set 1).
DISCUSSIoN
This work aimed to analyze the origin of hmU 
in mESCs. Although hmU as well as fU are 
both well-characterized oxidation products of 
thymidine9,10, hmU in particular was recently 
discussed as an intermediate in active demeth-
ylation by deamination of hmC11,12. We used sta-
ble isotopologs of the main oxidation products 
hmC, fC, caC, hmU, fU and 8-oxo-G in com-
bination with quantitative MS to show that the 
levels of hmU are strongly elevated in stem 
cells in comparison to somatic tissue. Notably, 
we did not observe equally elevated levels of 
fU and 8-oxo-G, both of which are formed by 
the reaction of DNA with ROS. This analysis suggests that hmU in 
stem cells is not only formed by ROS. The quantitative data allowed 
us to estimate that in WT stem cells, about 70–80% of the found 
hmU is not formed by ROS but is derived from a different process. 
Isotope tracing studies with labeled [13CD3]L-Met and [13C,15N2] 
thymidine showed that the detected hmU originates exclusively from 
T. Previous studies already proposed a connection between Tet activ-
ity and hmU levels, but these studies did not address the origin of 
hmU, which led to the hypothesis that hmU could form by deamina-
tion of hmC11,22. To investigate the involvement of deamination11–14, 
we studied Tdg−/− stem cells reconstituted with a catalytically inac-
tive Tdg. In these cells, the putative deamination–repair complex12 
of Tdg and Aid could form, and we expected to see elevated hmU 
levels. Indeed, in this experiment, we were able to detect labeled 
hmU, showing that deamination of hmC does occur, but the levels 
were low. Most notably, special conditions were required to detect 
this deamination. In WT cells, all of the detected hmU is clearly 
derived from T oxidation. As such, the detected hmU is situated in 
a base pair with A (hmU:A). In conclusion, the majority of hmU in 
mESCs is produced independently of both ROS and deamination. 
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Using a combination of functional knockdown in mESCs, ecto-
pic expression of Tet1 catalytic domain in HEK-293T cells and 
in vitro studies with recombinant Tet protein, we showed that the 
Tet enzymes, known to oxidize mC to hmC, are also responsible 
for oxidation from T to hmU. A kinetic study in which the tempo-
ral changes of all of the oxidized pyrimidines were observed under 
two different differentiation kinetics showed finally that hmU is 
formed in processes that also generate hmC and fC. Together with 
the observed peak levels of hmU of about 14,000 bases per genome, 
this suggests that hmU could have an epigenetic function similar 
to hmC. It is conceivable that the Tet enzymes introduce a small 
amount of hmU during the hmC manufacturing process to trigger 
faster demethylation by induction of DNA repair. It is known that 
hmC is not a substrate for repair8,12, whereas hmU is efficiently rec-
ognized and repaired36, for example, by the repair glycosylase Smug1 
(refs. 37,38). Sporadic introduction of hmU could therefore allow 
recruitment of repair factors, for example, for long patch repair, as 
recently suggested39. Alternatively, hmU might influence transcrip-
tion factor binding, which is known to be a hallmark of epigenetic 
reprogramming40. To study the proteins that closely interact with 
hmU, a new pulldown experiment was devised in which we inserted 
a trapping linker into the oligonucleotide. This linker is able to react 
covalently with proteins that assemble on the DNA duplex close to 
the hmU base. Because the linker is reductively cleavable, it leaves 
a tag on the respective lysine residues, which is detected in subse-
quent MS-based proteomics measurements. Using this technology, 
we observed that hmU:A recruits transcription factors and proteins 
that are involved in chromatin biochemistry, including Uhrf1 and 
Uhrf2. This result is in line with the recent observation that oxida-
tive lesions in DNA can change the binding affinity of the transcrip-
tion factor CREB when they are present in the respective cognate 
sequence41. A further analysis in HEK-293T revealed that the hmU 
readers Uhrf1 and Uhrf2 are able to modulate the levels of all of 
the oxidized mC bases and of hmU. It is interesting to note that the 
observed level increases of hmC were small, whereas they were sub-
stantial for hmU and also for the further oxidized bases fC and caC. 
As Uhrf1 and Uhrf2 are proteins known to be involved in numer-
ous epigenetic processes, our data supported the hypothesis that 
Tet-induced oxidation of T to hmU may have an epigenetic func-
tion. Even in the case that hmU is formed just as a side product 
of Tet-induced hmC formation, it is now clear that the oxidation 
chemistry performed by the Tet enzymes has to go in hand with 
effective DNA repair. 
received 15 December 2013; accepted 17 april 2014; 
published online 18 May 2014
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Methods and any associated references are available in the online 
version of the paper.
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oNLINE METhoDS
General materials and methods. Chemicals were purchased from Sigma-
Aldrich, Fluka, ABCR or Acros Organics and used without further purifica-
tion. Acetonitrile of LC/MS grade was purchased from Carl Roth GmbH + Co., 
KG. Formic acid, p.a. for MS, was purchased from Fluka, and water was puri-
fied with a Milli-Q Plus system from Merck Millipore.
The MS standards 5-methyl-2′-deoxycytidine (mC), 5-trideuteromethyl-
2′-deoxycytidine ([D3]mC), 5-hydroxymethyl-2′-deoxycytidine (hmC), 
5-dideuterohydroxymethyl-2′-deoxy-(N1,N3–15N2)-cytidine ([15N2,D2]
hmC), 5-formyl-2′-deoxycytidine (fC), 5-formyl-2′-deoxy-(N1,N3–15N2)-
cytidine ([15N2]fC), 5-carboxy-2′-deoxycytidine (caC), 5-carboxy-2′-deoxy-
(N1,N3–15N2)-cytidine ([15N2]caC), 5-hydroxymethyl-2′-deoxyuridine (hmU), 
5-(dideuterohydroxymethyl)-2′-deoxyuridine ([D2]hmU), 5-formyl-2′-
deoxyuridine (fU) and 5-formyl-2′-deoxy-(N1,N3–15N2)-uridine ([15N2]fU) were 
synthesized according to earlier published work19,21,42. All of the synthesized 
compounds were characterized and purity confirmed by 1H-NMR, 13C-NMR 
and ESI-MS, and some were additionally validated by 15N-NMR. 8-hydroxy-2′-
deoxy-(15N5)-guanosine ([15N5]8-oxo-G) (99 atom% 15N) was purchased from 
Cambridge Isotope Laboratories; 8-hydroxy-2′-deoxyguanosine (8-oxo-G) was 
from BIOLOG; 2′-deoxyguanosine (G) and 2′-deoxycytidine (C) were from 
ChemGenes. (methyl-13C,D3)-L-Met (99 atom% D and 13C) was purchased from 
Sigma-Aldrich, and 2′-deoxy-(C2–13C, N1,N3–15N2)-thymidine (99 atom% 13C 
and 15N) from Hartmann Analytic. Aqueous stock solutions of these com-
pounds were stored at −20 °C and warmed up to RT before usage.
Oligonucleotide synthesis. Oligonucleotide synthesis was performed on an 
ABI 394 DNA/RNA synthesizer (Applied Biosystems) using standard DNA 
synthesis conditions (DMT off) and acetyl-protected dC. Phosphoramidites 
(including the 5-hydroxymethyl-dU-CE phosphoramidite and the 5′-biotin 
phosphoramidite) and polystyrene carriers were obtained from Glen Research. 
5-octadiynyl-dU (Z) phosphoramidite was synthesized according to litera-
ture and characterized by 1H-NMR, 13C-NMR, 31P-NMR and ESI-MS43. The 
crude oligonucleotide was cleaved from the resin and deprotected in 30% (v/v) 
ammonium hydroxide and 40% (v/v) methylamine (1:1) at 65 °C for 10 min 
and purified by preparative and analytical HPLC (Waters Breeze and Alliance, 
respectively). Separation was performed by applying a VP 250/10 Nucleosil 
100-7 C18 column (flow: 5 ml/min) from Macherey-Nagel with a gradient 
of buffer A (0.1 M NHEt3OAc in water) and buffer B (0.1 M NHEt3OAc in 
80% MeCN). DNA-containing fractions were characterized by MALDI-TOF 
(Bruker Autoflex II) and analytical HPLC, combined, and desalted by C18-
Sep-Pak cartridges (Waters). For analytical HPLC, separation was performed 
by applying a CC 250/4 Nucleosil 120-3 C18 column from Macherey-Nagel 
(flow: 0.5 ml/min) with the aforementioned buffer system.
For the protein pulldown studies, an hmU-containing oligonucleotide was 
hybridized with a DNA strand modified with a 5′-biotin and a 5-octadienyl- 
dU. The sequences of the DNA strands are summarized in Supplementary 
Table 3. To 10 nmol of the dsDNA, 0.5 μl of a 200 mM solution of the cross- 
linking azide-PEG3-S-S-NHS ester (C18H29N5O8S2, Jena Bioscience, 
Jena, Germany) in DMSO was added. In a separate tube, CuBr was dis-
solved in a TBTA solution (DMSO/tBuOH 3:1, 100 mM) resulting in a 1:1 
Cu(I):TBTA ratio. This solution was immediately added to the DNA/azide 
mixture. Furthermore, 45 μl of DMSO/tBuOH (3:1) were added, the mixture 
was shaken at 37 °C for 3 h, and the resulting product was purified by 
ethanol precipitation.
LC/MS analysis of DNA samples. Quantitative LC/UV-ESI-MS/MS analysis of 
digested DNA samples was performed using an Agilent 1290 UHPLC system 
equipped with a UV detector and an Agilent 6490 triple quadrupole mass 
spectrometer coupled with the stable isotope dilution technique. An improved 
method, based on earlier published work29,42,44,45, was developed, which allowed 
the concurrent analysis of all nucleosides in one single analytical run. The 
source-dependent parameters were as follows: gas temperature 50 °C, gas 
flow 15 l/min (N2), nebulizer 30 psi, sheath gas heater 275 °C, sheath gas flow 
11 l/min (N2), capillary voltage 2,500 V in the positive ion mode, capillary volt-
age −2,250 V in the negative ion mode and nozzle voltage 500 V. The fragmentor 
voltage was 380 V. Delta EMV was set to 500 (positive mode) and 800 (negative 
mode). Compound-dependent parameters are summarized in Supplementary 
Tables 4 and 5. Chromatography was performed by a Poroshell 120 SB-C8 
column (Agilent, 2.7 μm, 2.1 mm × 150 mm) at 30 °C using a gradient of water 
and MeCN, each containing 0.0085% (v/v) formic acid, at a flow rate of 
0.35 ml/min: 0 → 5 min; 0 → 3.5% (v/v) MeCN; 5 → 6.9 min; 3.5 → 5% MeCN; 
6.9 → 7.2 min; 5 → 80% MeCN; 7.2 → 10.5 min; 80% MeCN; 10.5 → 11.3 min; 
80 → 0% MeCN; 11.3 → 13 min; 0% MeCN. The effluent up to 1.5 min and after 
9 min was diverted to waste by a Valco valve. The autosampler was cooled to 
10 °C. The injection volume was amounted to 29 μl. Calibration curves, method 
validation and data processing are in Supplementary Note 2. A complete 
compilation of LC/MS quantifications results see Supplementary Note 3.
DNA digestion. 5–25 μg of genomic DNA in 25 μl H2O were digested as follows: 
An aqueous solution (7.5 μl) of 480 μM ZnSO4, containing 42 U nuclease S1 
(Aspergillus oryzae, Sigma-Aldrich), 5 U Antarctic phosphatase (New England 
BioLabs) and specific amounts of labeled internal standards (Supplementary 
Note 2) were added, and the mixture was incubated at 37 °C for 3 h. After 
addition of 7.5 μl of a 520 μM [Na]2-EDTA solution, containing 0.2 U snake 
venom phosphodiesterase I (Crotalus adamanteus, USB corporation), the sam-
ple was incubated for another 3 h at 37 °C and then stored at −20 °C. Prior to 
LC/MS/MS analysis, samples with up to 15 μg DNA, for which the quantifica-
tion of low amounts of caC was aspired, were filtered by using an AcroPrep 
Advance 96 filter plate 0.2 μm Supor (Pall Life Sciences). In contrast, samples 
with 15–25 μg DNA (isotope-tracing experiments) were filtered by using an 
AcroPrep Advance 96 filter plate 10K Omega (Pall Life Sciences).
Genomic DNA isolation. Tissues of female WT mice (C57-BL6/N) were 
dissected at postnatal day 90 and prepared as earlier described19,21. Genomic 
DNA was extracted using the Qiagen Blood and Cell Culture DNA Midi Kit 
except for mESC samples differentiated in the presence of growth factors 
(see below). Extraction was performed following the manufacturer’s instruc-
tions for genomic DNA isolation from cell culture samples or tissue samples, 
respectively. All buffers until loading of the sample on Genomic-tip 100/G 
were additionally supplemented with antioxidants 3,5-di-tert-butyl-4- 
hydroxytoluene. (BHT, 200 μM) and deferoxamine mesylate salt (desferal, 
200 μM) as well as the deaminase inhibitor tetrahydrouridine (THU, 200 μM), 
according to published methods, to reduce background oxidation or deamina-
tion18. Elution buffer QF was supplemented with 200 μM BHT. Following elu-
tion, all steps were performed on ice. DNA was then precipitated with NaOAc 
(0.3 M final) and 0.7 volumes iPrOH. DNA pellets from cultured cells were 
washed twice with ice-cold 70% EtOH and resuspended in H2O containing 
20 μM BHT using a Qiagen TissueLyser (30 Hz, 2 min). DNA pellets from 
mouse tissues were resuspended in PBS buffer and additionally extracted with 
phenol/CHCl3, precipitated, washed and resuspended as described above.
R1 mESC samples differentiated in the presence of growth factors or trans-
fected with Smug1 esiRNAs were lysed directly in the plates with RLT buffer 
(Qiagen) supplemented with BHT and desferal as described above. DNA was 
isolated using the Zymo Quick gDNA Midi Kit according to the manufacturer’s 
instruction, except that elution was repeated four times with 100 μl of elu-
tion buffer supplemented with BHT (200 μM). Eluted DNA was precipitated 
with 2 M ammonium acetate and two volumes of absolute ethanol and finally 
resuspended in H2O containing 20 μM BHT. The flow-through from the spin 
columns was used to isolate RNA (see real-time PCR analysis).
mESC cell culture. Feeder independent WT01 mESCs (C57BL/6 strain)46 were 
cultured in the presence of serum and LIF as previously described4. Tdg+/− and 
Tdg−/− mESCs were described previously47. Tdg−/− mESCs were complemented 
by random integration of either empty vector (hereafter referred to as Tdg−/− 
mESCs) or a minigene expressing catalytically inactive Tdg (N151A)47. Clonal 
mESC lines with targeted Tdg alleles, R1 cells (strain 129/Sv)48, J1 cell lines 
(strain 129S4/SvJae)49 and a mESC line derived from C57Bl/6/129 mixed 
background50 were routinely maintained on gelatinized plates in DMEM 
(PAA or Sigma) supplemented with 10% FBS, 1× MEM-nonessential amino 
acids (NEAA), 0.2 mM L-alanyl-L-glutamine, 100 U/ml penicillin, 100 μg/ml 
strepto mycin (all from PAA), 0.1 mM β-mercaptoethanol, 20 ng/ml 
(≥1 ×103 U/ml) mouse recombinant LIF (ORF Genetics), 1 μM PD 0325901 and 
3 μM CHIR 99021 (2i; both from Axon Medchem). In these conditions, the glo-
bal levels of genomic mC were very low (and, as a consequence, the levels of its 
oxidized derivatives were even lower; data not shown). Before DNA isolation, 
2i cultures were passaged twice (over 5 d) in DMEM supplemented with FBS 
and LIF as above but lacking 2i. With this strategy, primed mESC cultures were 
obtained with no sign of overt differentiation and modified genomic cytosines 
reached reproducibly higher and stable levels. For isotope tracing with heavy 
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thymidine in serum-primed mESCs 2i cultures of R1, cells were passaged 
twice (5 d) in the same serum-containing medium lacking 2i and simultane-
ously supplemented with 100 μM [13C,15N2]T. For isotope tracing with heavy 
methionine in serum-primed mESCs, 2i cultures of R1 cells and mESC lines 
with targeted Tdg alleles were passaged twice (over 5 d) without 2i in L-Met-
free DMEM (Life Technology) supplemented as above and with 0.2 mM of 
either [methyl-13C,D3]L-Met or natural L-Met. For mESC differentiation with-
out growth factors, R1 cells and the C57Bl/6/129 mixed background cell line 
were first plated at 1 × 105 cells/cm2 on gelatin-coated plates in N2B27 medium 
containing 1,000 U/ml LIF to favor attachment and initial survival51. After 12 h, 
the medium was replaced without addition of LIF (defined as time point 0 h). 
The medium was replaced once more at 24 h. For isotope tracing with [methyl-
13C,D3]L-Met during mESC differentiation, R1 cells were cultured for two pas-
sages in L-Met-free N2B27 medium supplemented with LIF, 2i and 0.2 mM 
of either [methyl-13C,D3]L-Met or natural L-Met. Differentiation of R1 cells 
in the presence of FGF-2 and ActA was as described26, with minor modifi-
cations. Briefly, mESCs were cultured in N2B27 medium containing 2i and 
1,000 U/ml LIF for several passages and then seeded at 2.2 × 105 cells/cm2 in N2B27 
medium containing 1% KnockOut Serum Replacement (Life Technologies), 
12 ng/ml FGF-2 (PeproTech) and 20 ng/ml ActA (ORF Genetics) on 
plates coated with a thin layer of Geltrex extracellular matrix preparation 
(Life Technologies). The medium was exchanged after 24 h.
Knockdown experiments in mESCs. shRNA expression vectors targeting 
Tet1 and Tet2 were generated by cloning synthetic oligonucleotides in pLKO.1 
(ref. 52). Recombinant lentiviruses were produced by cotransfecting pLKO.1 
shRNA expression vectors and packaging plasmids in HEK-293 cells. 48 h after 
transduction in the presence of 8 μg/ml polybrene, shRNA-expressing mESCs 
were selected with 4 μg/ml puromycin. Cell pools were continuously cultured 
in the presence of puromycin. shRNA target sequences were as follows: SCR 
(control), 5′-CCT AAG GTT AAG TCG CCC TCG-3′ (ref. 52); Tet1, 5′-TGT 
AGA CCA TCA CTG TTC GAC-3′ (see ref. 52), Tet2: 5′-TTC GGA GGA 
GAA GGG TCA TAA-3′. esiRNAs for Smug1 knockdown were generated as 
described53. The cDNA template for in vitro transcription was generated by 
PCR using following primers: forward, 5′- CGT AAT ACG ACT CAC TAT 
AGG GAG CCC GTG GGT G-3′, and reverse, 5′-CGT AAT ACG ACT CAC 
TAT AGG GGT TTC GTC CAC TGG G-3′. R1 mESCs were weaned from 
2i for two passages in FBS- and LIF-containing medium as described above. 
Upon plating the second passage, the cells were transfected in a p60 plate with 
6 μg of Smug1 esiRNAs (34.5 nM) and 20 μl of Lipofectamine RNAi MAX 
(Life Technologies) according to the manufacturer’s instructions and were 
lysed 72 h after transfection.
Culture and transfection procedures for HEK-293T cells. All transfections 
were performed using jetPRIME transfection reagent (PEQLAB Biotechnologie 
GmbH) according to the manufacturer’s instructions. HEK-293T cells were 
seeded 24 h before transfection at a density of 2.5 × 106 cells per 75 cm2 flask and 
incubated in 10 ml of medium. The transfection solution (500 μl of jetPRIME 
buffer, a specific amount of plasmid DNA (Supplementary Note 4) and 20 μl 
of jetPRIME reagent) was added to the medium, and the cells were incub-
ated for 48 h, with an additional medium exchange 24 h after transfection. 
When cotransfection of esiRNA was performed, a second transfection step 
(500 μl of jetPRIME buffer, 5 μg of esiRNA and 20 μl of jetPRIME reagent) was 
carried out 4 h after transfection of plasmid DNA. esiRNAs were purchased 
from Sigma (human TDG esiRNA EHU038971; human SMUG1 esiRNA 
EHU098861; human CDK5RAP1 esiRNAEHU079221). Supplementary 
Note 4 summarizes the overexpression and knockdown procedures.
Isotope tracing with [13C,15N2]thymidine or [13C,D3]L-Met in HEK-293T cells 
transfected with Tet1cd. 24 h before transfection, 2.5 × 106 cells were seeded 
in a 75-cm2 flask containing 10 ml either of (for [13C,15N2]thymidine) DMEM 
medium supplemented with 50 μM [13C,15N2]T or (for [13C,D3]L-Met) DMEM 
medium lacking L-Met, L-cystine and pyruvate, which was supplemented with 
10% dialyzed FBS, 2 mM [13C,D3]L-Met and 0.2 mM L-cystine. Transfection 
was performed as described above using labeled medium.
Real-time PCR analysis of mRNA expression. For analysis of Tet1 and Tet2 
knockdown in mESC total RNA was prepared with Trizol (Invitrogen), cDNA 
synthesis was performed with Quantitect reverse transcription kit from 
Qiagen, and real-time PCR was performed with the Power Sybr Green PCR 
master mix from Applied Biosystems on an Applied Biosystems 7500 Fast 
system. Knockdown efficiencies relative to control samples transfected with 
SCR esiRNAs were 79% and 70% for Tet1 and Tet2, respectively. The primers 
used to estimate them are listed in Supplementary Note 4. For analysis of Smug1 
knockdown in mESCs and EpiLC differentiation samples, total RNA was pre-
pared with RNeasy spin columns (Qiagen), followed by DNase treatment using 
TURBO DNA-free (Ambion, Life Technologies); cDNA synthesis was carried 
out using iScript cDNA Synthesis kit (Bio-Rad); real-time PCR was performed 
with SsoFast EvaGreen Supermix (Bio-Rad). Smug1 knockdown efficiency rel-
ative to control samples transfected with esiRNAs targeting GFP was estimated 
to be 60%. Quantification of Tet, Dnmt, Tdg and Smug1 transcripts during 
EpiLC differentiation and Smug1 knockdown samples was performed using 
the primers listed in Supplementary Note 4. Expression levels were quanti-
fied with respect to the housekeeping gene Gapdh and normalized to time 
point 0 h.
Tet in vitro assay. A plasmid was prepared from dam−/dcm− competent E. coli 
strain (New England BioLabs) and methylated with M.SssI (New England 
BioLabs). 1.5 μg of plasmid DNA were then treated with recombinant Tet1 
from the 5hmC TAB-Seq Kit (Wisegene) corresponding to ref. 54. After 3 h 
incubation at 37 °C and proteinase K treatment, the oxidized plasmids were 
purified with GeneJET PCR Purification Kit from Thermo Scientific and 
eluted in 25 μl water. Samples were then subjected to LC/MS/MS analysis as 
described42. The results are compiled in Supplementary Note 3.
Correlation and cluster analyses. Statistical data analysis was performed using 
IBM SPSS Statistics 19. Results of bivariate correlation analyses are summarized 
in Supplementary Note 5. Unsupervised clustering of species with respect to 
its correlation coefficients was applied by average linkage hierarchical cluster-
ing using a squared Euclidean distance measure.
Pulldown assay. For the pulldown assay, 250 μg (50 μl) of the crude nuclear 
protein extracts were filled up to 500 μl with 50 mM TEAB and 1 mM MgCl2. 
The binding conditions were 45 mM TEAB, 1.1 mM MgCl2, 2 mM HEPES, 
42 mM NaCl and 20 μM EDTA. Complete Protease Inhibitor Cocktail Tablets 
were used from Roche Diagnostics (Indianapolis, IN, USA). The DNA oligo-
mers with DNA-protein cross-linker were dissolved in neat DMSO, and 1 nmol 
was added to the protein lysate and incubated for 20 min at room temperature. 
Streptavidin-coated magnetic particles (Roche Diagnostics, Indianapolis, IN, 
USA) were washed three times with binding buffer (100 mM NaCl, 10 mM 
Tris, 1 mM EDTA, pH 7.4) before 200 μl of the bead slurry (equal to 2 mg 
beads) were added to the sample. Following 2 h incubation at room tempera-
ture under constant rotating, the beads were washed three times with 50 mM 
TEAB and 1 mM MgCl2. The beads were reconstituted in 50 mM TEAB and 
1 mM MgCl2. Disulfide bonds of the cross linker were cleaved and alkylated in 
the process of enzymatic digestion, and the magnetic particles were removed 
before adding trypsin (described below).
Protein sample preparation. Cell lysis of mouse embryonic stem cells was per-
formed as described in ref. 29. For each lysis, approximately 7.5 × 107 cells were 
used. Protein concentration was determined by Bradford assay. For each exper-
iment 250 μg (50 μl) of the crude nuclear protein extract were used. Protein 
samples for MS analysis were reduced by adding 100 mM TCEP and by incu-
bating on a shaker at 650 r.p.m. for 1 h at 60 °C and subsequently alkylated with 
200 mM iodoacetamide in the dark for 30 min at 25 °C. Protein samples were 
digested with 0.5 μg trypsin (Promega, Madison, MA, USA) for 16 h at 37 °C. 
The reaction was stopped using 1 mM phenylmethylsulphonylfluoride. After 
tryptic digestion, peptide labeling with the TMT2plex reagents (Thermo Fisher 
Scientific, Waltham, MA, USA) was performed according to the manufacturer’s 
instructions. TMT2plex reagents 126 and 127 were used to label the samples. 
When the sample (proteins enriched with hmU- or hmC-containing DNA 
strands) was labeled with TMT126, the control sample (proteins enriched with 
no modified DNA-bases) was labeled with the TMT127 reagent and vice versa. 
Subsequent to the labeling, both sample and control, were combined. This way, 
each experiment was performed twice as a so-called label swap experiment. 
Organic solvent was removed by vacuum centrifugation, and the sample was 
finally reconstituted in 1% (v/v) formic acid for MS analysis.
LC/MS analysis of protein samples. The samples were analyzed using an 
UltiMate 3000 nano liquid chromatography system (Dionex, Fisher Scientific, 
Waltham, MA, USA) coupled to an LTQ-Orbitrap XL (Thermo Fisher 
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proteins, the only proteins considered as ‘specific readers’ were enriched in 
both the forward and the reverse experiment.
Scientific, Waltham, MA, USA). Of each eluate, 15 μl were injected for the 
analysis. The samples were desalted and concentrated on a μ-precolumn 
cartridge (PepMap100, C18, 5 μM, 100 Å, size 300 μm i.d. x 5 mm) and fur-
ther processed on a custom-made analytical column (ReproSil-Pur, C18, 3 μM, 
120 Å, packed into a 75 μm i.d. x 150 mm and 8 μm picotip emitter). A 57-min 
multistep analytical separation was performed at a flow rate of 300 nl/min. 
In the first 50 min, a linear gradient was ramped up from 5% (v/v) solvent B 
(acetonitrile containing 0.1% formic acid and 5% DMSO) and 95% solvent A 
(water containing 0.1% formic acid and 5% DMSO) to 95% solvent B. This level 
was held for 5 min and then ramped down again to 5% solvent B within 2 min. 
Mass spectrometric analyses were performed starting with a full mass scan in 
the mass range between m/z 300 and m/z 1,650. This survey scan was followed 
by three MS/MS scans using the FTMS mass analyzer and high normalized 
collision energy of 70 in the HCD cell and three additional scans using the ion 
trap mass analyzer and a normalized collision energy of 35.
Protein identification and relative quantification method. The Thermo 
Proteome Discoverer 1.1 software (Thermo Fisher Scientific, Waltham, MA, 
USA) was used for protein identification and for relative quantification. The 
Sequest (Thermo Fisher Scientific, Waltham, MA, USA) search engine was 
used in combination with a Uniprot database (Mus musculus; date of download, 
04/2013). As a limit of detection, a ratio of threefold signal over the noise filter 
was applied. A maximum of two missed cleavage sites was allowed. The mass 
tolerances were 10 p.p.m. for the precursor mass and 0.5 Da for the fragment 
ion mass. Carbamidocysteine was set as static modification. Dynamic modi-
fications were: cation, Na (D, E); the residue of the DNA-protein crosslinker 
(+146.028 Da; K, Y); Oxidation (M) as well as TMT2plex (N-term. and K). 
Identified, nonredundant peptides, which were labeled with the TMT2 reagent, 
were used for relative quantification. The integration window tolerance was 
20 p.p.m., and the integration method was set to ‘most confident centroid’. The 
signals of the TMT2 reporter ions 126 and 127 were used to calculate ratios and 
monitor either preferred or nonpreferred binding of the identified proteins to the 
modified DNA bases in comparison to the control strand. From the identified 
42. Schiesser, S. et al. Deamination, oxidation, and C–C bond cleavage reactivity 
of 5-hydroxymethylcytosine, 5-formylcytosine, and 5-carboxycytosine. J. Am. 
Chem. Soc. 135, 14593–14599 (2013).
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postsynthetic functionalization of alkyne-modified DNA. Org. Lett. 8, 
3639–3642 (2006).
44. Cao, H. & Wang, Y. Collisionally activated dissociation of protonated 
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45. Wang, J. et al. Quantification of oxidative DNA lesions in tissues of 
Long-Evans Cinnamon rats by capillary high-performance liquid 
chromatography-tandem mass spectrometry coupled with stable isotope-
dilution method. Anal. Chem. 83, 2201–2209 (2011).
46. Chen, T., Ueda, Y., Dodge, J.E., Wang, Z. & Li, E. Establishment and 
maintenance of genomic methylation patterns in mouse embryonic stem cells 
by Dnmt3a and Dnmt3b. Mol. Cell. Biol. 23, 5594–5605 (2003).
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maintaining epigenetic stability. Nature 470, 419–423 (2011).
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Supplementary	Tables	
	
Supplementary	 Table	 1:	 Compound-dependent	 LC-MS/MS-parameters	 used	 for	 the	 analysis	 of	
genomic	DNA	fed	with	 fluorinated	nucleosides.	CE:	 collision	energy,	CAV:	collision	cell	accelerator	
voltage,	 EMV:	 electron	 multiplier	 voltage.	 The	 nucleosides	 were	 analyzed	 in	 the	 positive	
([M+H)]+	species)	as	well	as	the	negative	([M-H]-	species)	ion	selected	reaction	monitoring	mode	(SRM).		
compound	 Precursor	
ion	(m/z)	
MS1	
Resolution	
Product	
Ion	(m/z)	
MS2	
Resolution	
Dwell	
time	
[ms]	
CE	
(V)	
CAV	
(V)	
Polarity	
	 	 Time	segment	1.5-3.0	min	 	 	 	
F-dC	 246.09	 Wide	 112.06	 Wide	 70	 15	 3	 Positive	
[15N2]-F-dC	 248.08	 Wide	 114.04	 Wide	 70	 15	 3	 Positive	
[15N2]-cadC	 274.08	 Wide	 158.03	 Wide	 40	 5	 5	 Positive	
cadC	 272.09	 Wide	 156.04	 Wide	 40	 5	 5	 Positive	
F-hmdC	 276.10	 Wide	 142.06	 Wide	 50	 10	 3	 Positive	
[15N2]-F-hmdC	 278.09	 Wide	 144.06	 Wide	 50	 10	 3	 Positive	
[15N2,D2]-
hmdC	
262.12	 Wide	 146.07	 Wide	 25	 27	 1	 Positive	
hmdC	 258.11	 Wide	 142.06	 Wide	 25	 27	 1	 Positive	
[D3]-mdC	 245.13	 Wide	 129.09	 Wide	 50	 60	 1	 Positive	
mdC	 242.11	 Wide	 126.07	 Wide	 50	 60	 1	 Positive	
	 	 Time	segment	3.0-4.7	min	 	 	 	
F-hmdU	 275.07	 Wide	 255.06	 Wide	 80	 3	 7	 Negative	
F-dU	 245.06	 Wide	 225.06	 Wide	 80	 3	 5	 Negative	
[D3]-F-mdC	 263.12	 Wide	 129.09	 Wide	 80	 15	 3	 		Positive	
F-mdC	 260.10	 Wide	 126.07	 Wide	 80	 15	 3	 Positive	
F-cadC	 290.08	 Wide	 156.04	 Wide	 80	 5	 5	 Positive	
	 	 Time	segment	4.7-10	min	 	 	 	
F-fdC	 274.08	 Wide	 140.05	 Wide	 90	 15	 3	 Positive	
[15N2]-F-fdC	 276.08	 Wide	 142.04	 Wide	 90	 15	 3	 Positive	
F-fdU	 273.05	 Wide	 253.05	 Wide	 30	 3	 5	 Negative	
F-dT	 259.07	 Wide	 239.07	 Wide	 70	 3	 5	 Negative	
dT	 243.10	 Wide	 127.05	 Wide	 20	 5	 5	 Negative	
[15N2]-fdC	 258.09	 Wide	 142.04	 Wide	 30	 5	 5	 Positive	
fdC	 256.09	 Wide	 140.05	 Wide	 30	 5	 5	 Positive	
[15N2]-fdC	 142.04	 Wide	 98.04	 Wide	 20	 13	 7	 Positive	
fdC	 140.05	 Wide	 97.04	 Wide	 20	 13	 7	 Positive	
	
Supplementary	 Table	 2:	 Compound-dependent	 LC-MS/MS	 ranges	 of	 the	 corresponding	 linear	
equations.	
compound	 n	(ULOQ)	 n	(LLOQ)	 A/A*	(ULOQ)	 A/A*	(LLOQ)	
F-fdC	 25.1	fmol	 0.390	fmol	 0.2267	 0.003345	
F-dC	 800	fmol	 3.13	fmol	 4.074	 0.01512	
F-mdC	 49.9	fmol	 0.780	fmol	 0.04174	 0.0005833	
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Supplementary	 Table	 3:	 Compound-dependent	 LC-MS/MS-parameters	 used	 for	 the	 analysis	 of	
genomic	DNA	fed	with	1.	CE:	collision	energy,	CAV:	collision	cell	accelerator	voltage,	EMV:	electron	
multiplier	 voltage.	 The	 nucleosides	 were	 analyzed	 in	 the	 positive	 ([M+H)]+	 species)	 as	 well	 as	 the	
negative	([M-H]-	species)	ion	selected	reaction	monitoring	mode	(SRM).		
compound	 Precursor	
ion	(m/z)	
MS1	
Resolution	
Product	
Ion	(m/z)	
MS2	
Resolution	
Dwell	
time	
[ms]	
CE	
(V)	
CAV	
(V)	
Polarity	
	 	 Time	segment	1.5-3.3	min	 	 	 	
sh-cadC	 279.10	 Wide	 158.03	 Wide	 50	 5	 5	 Positive	
[15N2]-cadC	 274.08	 Wide	 158.03	 Wide	 20	 5	 5	 Positive	
cadC	 272.09	 Wide	 156.04	 Wide	 20	 5	 5	 Positive	
sh-hmdC	 265.12	 Wide	 144.06	 Wide	 60	 27	 1	 Positive	
[15N2,D2]-
hmdC	
262.12	 Wide	 146.07	 Wide	 20	 27	 1	 Positive	
hmdC	 258.11	 Wide	 142.06	 Wide	 20	 27	 1	 Positive	
sh-mdC	 249.12	 Wide	 128.06	 Wide	 60	 60	 1	 Positive	
[D3]-mdC	 245.13	 Wide	 129.09	 Wide	 20	 60	 1	 Positive	
mdC	 242.11	 Wide	 126.07	 Wide	 20	 60	 1	 Positive	
sh-dC	 235.11	 Wide	 114.04	 Wide	 60	 10	 2	 Positive	
dC	 228.10	 Wide	 112.05	 Wide	 15	 1	 1	 Positive	
[13C9,15N3]-dC	 240.10	 Unit	 119.10	 Unit	 70	 10	 2	 Positive	
	 	 Time	segment	3.3-4.15	min	 	 	 	
[D2]-hmdU	 259.09	 Wide	 216.08	 Wide	 80	 7	 5	 Negative	
hmdU	 257.08	 Wide	 214.07	 Wide	 80	 7	 5	 Negative	
sh-dU	 234.08	 Wide	 192.09	 Wide	 120	 5	 5	 Negative	
[15N2]-dU	 229.06	 Wide	 185.06	 Wide	 80	 5	 5	 Negative	
dU	 227.07	 Wide	 184.06	 Wide	 120	 5	 5	 Negative	
	 	 Time	segment	4.15-9	min	 	 	 	
[15N2]-8-oxo-
dG	
289.08	 Wide	 173.04	 Wide	 10	 9	 7	 Positive	
8-oxo-dG	 284.10	 Wide	 168.05	 Wide	 10	 9	 7	 Positive	
sh-fdC	 263.10	 Wide	 142.04	 Wide	 80	 5	 5	 Positive	
[15N2]-fdC	 258.09	 Wide	 142.04	 Wide	 80	 5	 5	 Positive	
fdC	 256.09	 Wide	 140.05	 Wide	 10	 5	 5	 Positive	
sh-fdU	 262.07	 Wide	 141.01	 Wide	 80	 15	 5	 Negative	
[15N2]-fdU	 257.06	 Wide	 141.01	 Wide	 80	 15	 5	 Negative	
fdU	 255.06	 Wide	 139.01	 Wide	 10	 15	 5	 Negative	
sh-dT	 250.11	 Wide	 129.04	 Wide	 20	 5	 5	 Positive	
dT	 243.10	 Wide	 127.05	 Wide	 10	 45	 3	 Positive	
	 	
Nature Chemical Biology: doi:10.1038/nchembio.2531
	 3	
Supplementary	 Table	 4:	 Compound-dependent	 LC-MS/MS-parameters	 used	 for	 the	 analysis	 of	
genomic	DNA	fed	with	7.	CE:	collision	energy,	CAV:	collision	cell	accelerator	voltage,	EMV:	electron	
multiplier	 voltage.	 The	 nucleosides	 were	 analyzed	 in	 the	 positive	 ([M+H)]+	 species)	 as	 well	 as	 the	
negative	([M-H]-	species)	ion	selected	reaction	monitoring	mode	(SRM).		
compound	 Precursor	
ion	(m/z)	
MS1	
Resolution	
Product	
Ion	(m/z)	
MS2	
Resolution	
Dwell	
time	
[ms]	
CE	
(V)	
CAV	
(V)	
Polarity	
	 	 Time	segment	1.5-3.3	min	 	 	 	
[13C9,15N3]-dC	 240.10	 Unit	 119.10	 Unit	 70	 30	 5	 Positive	
dC	 228.1	 Wide	 112.10	 Wide	 70	 1	 3	 Positive	
	 	 Time	segment	3.3-4.8	min	 	 	 	
dU	 227.07	 Wide	 184.06	 Wide	 80	 5	 5	 Negative	
[13C9,15N2]-dU	 238.09	 Wide	 193.10	 Wide	 80	 5	 5	 Negative	
	 	 Time	segment	4.8-12.0	min	 	 	 	
dT	 243.1	 Wide	 127.05	 Wide	 70	 40	 3	 Positive	
[13C9,15N2]-dT	 254.12	 Unit	 133.06	 Unit	 70	 3	 5	 Positive	
[	D3]-dT	 246.10	 Unit	 130.05	 Unit	 30	 3	 5	 Positive	
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Supplementary	Figures	
	
	
	
Supplementary	Figure	1:	Characteristic	MS	transition	of	[13C5][15N2]-dC	and	[13C9][15N3]-dC.	
Fingerprint	MS-fragmentation	pathways	and	detected	MS	signals	of	2	and	7	used	to	track	isotopically	
labelled	dC	and	its	derivatives	in	mESC	cultures.	
	
	
	
	
Supplementary	 Figure	 2:	 Quantitative	 data	 of	 isotopically	 labelled	 pyrimidine	 derivatives	 in	 the	
soluble	 nucleoside	 pool	 of	 mESCs	 after	 feeding	 [13C5][15N2]-fdC	 shows	 its	 incorporation	 and	 no	
formation	of	[13C5][15N2]-dC.	LC-MS/MS	analysis	of	the	soluble	nucleoside	pool	from	J1	mESCs	cultured	
in	the	presence	of	50	µM	1	under	priming	conditions	for	three	days.	Compound	1	is	incorporated	but	
no	 formation	 of	 2	 is	 detected	 in	 the	 soluble	 nucleoside	 pool.	 Mean	 values	 and	 s.d.	 of	 technical	
triplicates	from	a	single	culture	are	shown.	
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Supplementary	Figure	3:	Schematic	overview	of	the	possible	metabolic	conversions	of	fdC	and	dC.	
	
	
	
	
Supplementary	Figure	4:	Schematic	overview	of	the	feeding	experiment	with	(R)-2´-F-fdC	to	mESCs.	
Feeding	of	15	results	in	the	incorporation	of	(R)-2´-F-fdC	into	genomic	DNA	and	is	converted	in	vivo	to	
(R)-2´-F-dC	by	a	C-C	bond	cleavage	reaction.	
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Supplementary	 Figure	 5:	Quantitative	 data	 of	 fluorinated	 pyrimidine	 derivatives	 after	 treatment	
with	10	show	incorporation	of	10	and	3%	re-methylation.	
LC-MS/MS	analysis	of	genomic	DNA	from	J1	mES	cells	cultured	in	the	presence	of	1.0	µM	(R)-2’-F-dC	
under	priming	conditions	for	three	days.	DNA	samples	of	four	independent	cultures	were	measured,	
each	as	technical	triplicate.	Mean	values	with	s.d.	are	depicted.	
	
	
	
	
Supplementary	Figure	6:	Quantification	data	of	incorporated	(R)-2’-F-dC	after	feeding	of	10	at	two	
concentrations.	Levels	similar	to	those	resulting	from	feeding	of	(R)-2’-F-fdC	were	observed.		
Analysis	of	genomic	DNA	from	J1	mES	cells	cultured	for	three	days	under	priming	conditions	 in	the	
presence	of	5	and	10	nM	(R)-2’-F-dC.	Mean	values	and	s.d.	of	technical	triplicates	from	single	cultures	
are	shown.	
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Supplementary	 Figure	 7:	 Time	 dependent	 co-feeding	 with	 15	 and	 10	 show	 incorporation	 of	 10	
already	after	5	min,	15	after	15	min	and	11,	resulting	from	both	compounds,	after	20	min.	
LC-MS/MS	analysis	of	the	genomic	DNA	from	J1	mESCs	cultured	under	priming	conditions	and	after	
48	h	supplemented	with	both	(R)-2’-F-fdC	(350	µM)	and	(R)-2’-F-dC	(1.0	µM)	for	0,	5,	10,	15,	20	and	
30	min.	Mean	values	and	s.d.	of	technical	triplicates	from	single	cultures	are	shown.	
	
	
	
	
Supplementary	Figure	8:	Catalytically	active	DNA	methyltransferases	are	required	for	methylation	
of	(R)-2’-F-dC,	but	not	for	deformylation	of	(R)-2’-F-fdC	(related	to	Fig.	4d).	
LC-MS/MS	analysis	of	genomic	DNA	from	Dnmt	TKO	J1	mESCs	cultured	in	the	presence	of	(R)-2’-F-fdC	
under	 priming	 conditions.	 Shown	 are	 mean	 values	 and	 s.d.	 from	 two	 independent	 cultures,	 each	
measured	as	technical	triplicates.	
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Supplementary	Figure	9:	Tet	enzymes	are	not	required	for	deformylation	of	(R)-2’-F-fdC	(related	to	
Fig.	4e).	
LC-MS/MS	 analysis	 of	 genomic	 DNA	 from	 wt	 and	 Tet	 TKO	 mESCs	 cultured	 in	 the	 presence	 of	
(R)-2’-F-fdC	under	priming	 conditions.	 Left	panel:	 cell	 lines	described	 in	 (34).	Right	panel:	 cell	 lines	
reported	in	(33)	(same	cell	lines	as	for	experiment	shown	in	Figure	4e).	Shown	are	mean	values	and	
s.d.	from	two	independent	cell	culture	experiments,	each	measured	as	technical	triplicates.	
	
	
	
	
Supplementary	Figure	10:	Deformylation	of	(R)-2’-F-fdC	is	not	affected	by	treatment	with	ascorbic	
acid-2-phosphate.	
LC-MS/MS	analysis	 of	 genomic	DNA	 from	wt	mESCs	 cultured	 in	 the	presence	of	 (R)-2’-F-fdC	under	
priming	conditions	with	or	without	ascorbic	acid-2-phosphate.	The	cell	lines	used	in	this	experiment	
were	reported	in	(33)	and	are	the	same	as	used	for	experiment	shown	in	Figure	4e	and	Supplementary	
Figure	 9.	 Shown	 are	 mean	 values	 and	 s.d.	 from	 two	 independent	 cell	 culture	 experiments,	 each	
measured	as	technical	triplicates.	
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Supplementary	Figure	11:	Deformylation	of	(R)-2’-F-fdC	to	(R)-2’-F-dC	occur	also	in	non-pluripotent	
mouse	and	human	cell	lines	(related	to	Fig.	4f).	
LC-MS/MS	analysis	of	genomic	DNA	isolated	from	Neuro-2a,	HeLa	and	CHO-K1	cells	cultured	 in	the	
presence	of	(R)-2’-F-fdC.	Albeit	at	variable	levels,	incorporation	of	(R)-2’-F-fdC	into	the	genome	as	well	
as	its	conversion	to	(R)-2’-F-dC	are	detected	in	all	cell	lines.	Shown	are	mean	values	and	s.d.	from	three	
independent	cell	culture	experiments,	each	measured	as	technical	triplicates.	
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Supplementary	Figure	12:	Representative	external	calibration	curves	for	all	investigated	nucleosides.	
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Supplementary	 Figure	 13:	 Internal	 calibration	 curves	 for	 the	 exact	 quantification	 of	 (R)-2’-F-fdC,	
(R)-2’-F-dC	and	(R)-2’-F-mdC	with	the	corresponding	linear	equation	and	coefficient	of	determination.		
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Synthetic procedures 
 
General information 
Isotopically labelled 7 was bought from B.A.C.H. UG, 2'-deoxy-2'-(R)-fluorocytidine 10 was 
purchased from Carbosynth. Compounds 8 and 9 resulted from the feeding experiment of 7, 
compounds 11 - 14 resulted from the feeding of 10. 15 and 30 were synthesized as described 
in the literature.1,2 Identity of compounds used in this study were confirmed by standard 
spectroscopic methods such as NMR and MS. 
Synthesis of 2'-deoxy-5-formyl(1',2',3',4',5'-13C5, 15N2)cytidine (1) 
  
Scheme 1: Synthesis of 13C5-15N2-labelled fdC 1. 
  
Nature Chemical Biology: doi:10.1038/nchembio.2531
2'-O-acetyl-3',5'-di-O-benzoyl(1',2',3',4',5'-13C5, N1,N3- 15N2)-uridine (23) 
 
The 13C ribose fragment 21 and 15N2 urea 22 were synthesized according to the literature.3,4 Bis-
benzoyl and bis-acetyl protected 13C ribose 21 (2.00 g, 4.47 mmol, 1.0 eq), 15N2-Uracil (510 mg, 4.47 
mmol, 1.0 eq) and N,O-bis(trimethylsilyl)acetamide (3.28 mL, 13.4 mmol, 3.0 eq) were suspended in 
dry MeCN (25 mL) and heated to 60 °C whereas a clear solution developed after 30 minutes of 
stirring. Subsequently TMS triflate (2.83 mL, 15.7 mmol, 3.5 eq) was added at 60 °C and the mixture 
was stirred for an additional 30 minutes. After the reaction was cooled to room temperature, MeCN 
was evaporated in vacuo, the residue was taken up in sat. aqueous NaHCO3 (75 mL) and extracted 
with DCM (3 x 75 mL). The combined organic layers were dried over Na2SO4 and the solvents were 
removed by rotary evaporation. Purification of the crude material through column chromatography 
(20% EtOAc/iHex --> 50% EtOAc/iHex) yielded 1.75 g (3.49 mmol, 79%) of 23 as a white foam. 
1H-NMR (400 MHz, CDCl3, ppm): δ = 8.08 - 8.05 (m, 4H, Bz-H), 7.67- 7.57 (m, 2H, Bz-H), 7.51 - 7.46 
(m, 4H, Bz-H), 7.49 (td, 3J = 7.8 Hz, 1JN-H = 3.2 Hz, 1H, 5-H), 6.41 (d, 1JC-H = 169.1 Hz, 1H, 1'-H), 5.96 (d, 
1JC-H = 150.3 Hz, 1H, 3'-H), 5.74 (d, 1JC-H = 153.0 Hz, 2'-H), 5.57 5.74 (m, 1H, 6-H), 4.97 (d, 1JC-H = 154.6 
Hz, 1H, 4'-H), 4.82 (d, 1J13C-H = 150.1 Hz, 1H, 5'-H), 2.06 (s, 3H, Ac-CH3). 13C-NMR (101 MHz, CDCl3, 
ppm): δ = 169.7 (Ac-C=O), 166.0 (Bz-C=O), 165.3 (Bz-C=O), 162.4 (d, 1JC-N = 9.5 Hz, C-4),150.1 (t, 1JC-N = 
19.4 Hz, C-2), 139.2 (d, 1JC-N = 12.5 Hz, C-5), 133.9 (2 x CAr), 133.8 (2 x CAr), 129.8 (2 x CAr), 129.6 (2 x 
CAr), 128.8 (2 x CAr), 128.7 (2 x CAr), 103.5 (d, 1JC-N = 6.9 Hz, C-6) 87.2 (ddd, J = 44.4 Hz, 13.7 Hz, 3.7 Hz, 
1'-C), 80.4 (dd, J = 43.1 Hz, 38.3 Hz, 4'-C), 73.0 (dd, J = 44.3, 39.9, 2'-C), 70.9 (td, J = 39.9 Hz, 39.4 Hz, 
3.7 Hz, 3'-C), 63.7 (d, J = 43.1 Hz), 20.5 (Ac-CH3). 15N-NMR (41 MHz, CDCl3, ppm): δ = -224.4, -224.5. 
HRMS (ESI+): calc. for C2013C5H26N15N2O9+ [M+NH4]+: 519.1772, found: 519.1784. HRMS (ESI-): calc. for 
C2013C5H2115N2O9 [M-H]-: 500.1361, found: 500.1359. IR (ATR): ν (cm-1) = 1712 (s), 1688 (s), 1679 (s), 
1631 (w), 1601 (w), 1584 (w), 1450 (m), 1369 (m), 1315 (w), 1249 (s), 1220 (s), 1176 (m), 1107 (s), 
1067 (s), 1025 (s), 806 (m), 762 (w), 707 (s), 686 (m). 
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3’,5’-(1,1,3,3,-tetraisopropyldisiloxane-1,3-diyl)-(1',2',3',4',5'-13C5, N1,N3-15N2)-uridine (24) 
 
First, 23 (1.75 g, 3.49 mmol, 1.0 eq) was deprotected by stirring the compound in a solution of 
MeNH2 in ethanol (10 mL, 33%) overnight. The ethanolic solution was concentrated in vacuo and 
resuspended in water (25 mL). The aqueous phase was extracted with DCM (5 x 25 mL) until no UV 
absorption on a TLC plate was visible anymore. Subsequently, the water was removed by rotary 
evaporation and the deprotected nucleoside was dried on high vac. Then, pyridine (3.0 mL) was 
added and the light red, clear solution was cooled to 0 °C. 1,3-dichloro-1,1,3,3-
tetraisopropyldisiloxane (1.34 L, 4.19 mmol, 1.2 eq) was added dropwise and the mixture was then 
warmed to room temperature and stirred for 14 hours. MeOH (3.0 mL) was added and the volatiles 
were removed in vacuo. The crude product mixture was then charged with saturated solution of 
aqueous NH4Cl (50 mL), extracted twice with EtOAc (50 mL) and the organic layers dried over Na2SO4. 
After removal of the solvent in vacuo, pure product was isolated after column chromatography (30% 
EtOAc/iHex --> 40% EtOAc/iHex), which yielded 920 mg (1.86 mmol, 53%) of 24 as an off white foam. 
1H-NMR (599 MHz, CDCl3, ppm): δ = 9.23 (d, 2JN-H = 90.9 Hz, 1H, N-H), 7.72 (td, 3J = 8.1 Hz, 2JN-H = 2.2 
Hz, 1H, 5-H), 5.88 (d, 1JC-H = 174.6 Hz, 1H, 1'-H), 5.69 (ddd, 3J = 7.8 Hz, 3JN-H = 4.6 Hz, , 3JN-H = 2.8 Hz, 1H, 
6-H), 4.47 - 3.87 (m, 2'-H, 3'-H, 4'-H, 5'-H), 1.10 - 1.01 (m, 28H, Si(CH3)2, Si-CH). 13C-NMR (151 MHz, 
CDCl3, ppm): δ = 163.3 (d, 1JC-N = 9.5 Hz, C-4), 150.0 (t, 1JC-N = 18.4 Hz, 2-C), 139.9 (d, 1JC-N = 12.7 Hz, C-
5), 105.4 (d, 2JC-N = 34.7 Hz, C-6) , 90.9 (dd, 1JC-C = 42.6 Hz, 1JC-N = 11.0 Hz, 1'-C), 81.9 (t, J = 42.3 Hz, 2'-
C), 75.1 (t, 1JC-C  = 40.6, 3'-C), 68.9 (t, J = 39.9 Hz, 4'-C), 60.2 (d, J = 39.9 Hz), 17.4 - 16.8 (Si-C(CH3)), 
13.4 - 12.8 (4 x Si-C(CH3)). 15N-NMR (41 MHz, CDCl3, ppm): δ = -224.4, -224.5. HRMS (ESI+): calc. for 
C1613C5H3915N2O7Si2+ [M+H]+: 494.2399, found: 494.2412. HRMS (ESI-): calc. for C1613C5H3715N2O7Si2- 
[M-H]-: 492.2253, found: 492.2252. IR (ATR): ν (cm-1) = 2944 (m), 2867 (m), 1688 (s), 1679 (s), 1650 
(m), 1631 (w), 1462 (m), 1444 (m), 1383 (w), 1255 (m), 1198 (w), 1135 (m), 1096 (s), 1028 (s), 976 (s), 
919 (w), 884 (s), 852 (m), 807 (m), 761 (m), 694 (s). 
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3’,5’-(1,1,3,3,-tetraisopropyldisiloxane-1,3-diyl)-2’-O-phenoxythiocarbonyl-(1’,2’,3’,4’,5’-13C5, N1,N3-
15N2)-uridine (25) 
 
Compound 25 was synthesized according to the literature with slight modifications.5 24 (280 mg, 
0.57 mmol, 1.0 eq) was dissolved in MeCN (8 mL) and O-phenyl chlorothionoformate (120 L, 0.86 
mmol, 1.5 eq) and 4-(diemthylamino)pyridine (202 mg, 1.65 mmol, 2.9 eq) were added at room 
temperature. After the yellowish mixture, which showed a colourless precipitate after 30 minutes, 
was stirred for a total of six hours, the reaction was aborted through addition of MeOH (10 mL) and 
the volatiles were removed under reduced pressure. Subsequently, a saturated aqueous NaHCO3 
solution (25 mL) was given to the crude reaction mixture and extracted with DCM (3 x 25 mL). 
Combined organic layers were then dried over Na2SO4 and the solvent was removed in vacuo. 
Purification through column chromatography (25% EtOAc/iHex) yielded 262 mg (0.42 mmol, 74%) of 
pure product 25 as a colourless oil. 
1H-NMR (599 MHz, CDCl3, ppm): δ = 8.27 (d, 2JN-H = 91.1 Hz, 1H, N-H), 7.71 (dt, 3J = 8.1 Hz, 2JN-H = 2.2 
Hz, 1H, 5-H), 7.42 (t, 3J = 8.0 Hz, 2H, HAr), 7.30 (t, 3J = 7.6 Hz, 1H, HAr ), 7.12 (d, 3J = 8.3 Hz, 2H, HAr), 
6.15 (td, 1JC-H = 164.2 Hz, 3J = 5.5 Hz, 1H, 2'-H), 6.07 (d, 1JC-H = 174.8 Hz, 1H, 1'-H), 5.72 (ddd, 3J = 7.7 
Hz, 3JN-H = 4.9 Hz, , 3JN-H = 2.5 Hz, 1H, 6-H), 4.55 (ddt, 1JC-H = 142.4 Hz, 3J = 8.4 Hz, 4.0 Hz,1H, 4'-H), 4.45 
- 3.90 (m, 3H, 3'-H, 5'-H), 1.12 - 1.03 (m, 28H, Si(CH3)2, Si-CH). 13C-NMR (151 MHz, CDCl3, ppm): δ = 
193.7 ((O)2C=S), 162.5 (d, 1JC-N = 9.5 Hz, C-4), 153.4 (CAr) 149.3 (t, 1JC-N = 18.5 Hz, 2-C), 139.4 (d, 1JC-N = 
12.8 Hz, C-5), 129.6 (2 x CAr), 126.7 (CAr), 121.7 (2 x CAr), 102.3 (d, 2JC-N = 7.5 Hz, C-6), 88.6 (dd, 1JC-C = 
53.5 Hz, 1JC-N = 12.2 Hz, 1'-C), 83.7 (t, J = 41.9 Hz, 2'-C), 82.2 (t, 1JC-C  = 42.3, 3'-C), 68.1 (t, J = 41.0 Hz, 
4'-C), 59.4 (d, J = 43.1 Hz), 17.4 - 16.8 (Si-C(CH3)), 13.4 - 12.4 (4 x Si-C(CH3)). 15N-NMR (41 MHz, CDCl3, 
ppm): δ = -223.5, -223.6. HRMS (ESI+): calc. for C2313C5H4315N2O8SSi2+ [M+H]+: 630.2382, found: 
630.2393. IR (ATR): ν (cm-1) = 2944 (w), 2866 (w), 2359 (w), 1722 (w), 1709 (m), 1691 (m), 1679 (m), 
1649 (w), 1641 (w), 1631 (w), 1591 (w), 1462 (w), 1443 (w), 1382 (w), 1274 (m), 1202 (s), 1137 (w), 
1098 (s), 1030 (s), 925 (m), 883 (m), 853 (m), 808 (m), 766 (m), 689 (s). 
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3’,5’-(1,1,3,3,-tetraisopropyldisiloxane-1,3-diyl)-2’-deoxy-(1’,2’,3’,4’,5’-13C5, N1,N3-15N2)-uridine (26) 
 
The deoxygenation of 25 was carried out as described in the literature with slight modifications.5 
First, 25 (260 mg, 0.41 mmol, 1.0 eq), AIBN (14 mg, 0.08 mmol, 0.2 eq) and tributyltin hydride (165 
L, 0.62 mmol, 1.5 eq) were dissolved in toluene (8 mL). The mixture was freeze-pump-thaw 
degassed (3 x) and then heated to 75 °C for 90 minutes. The solvent was removed in vacuo and the 
residue was taken up in water (25 mL). The aqueous layer was then extracted with DCM (3 x 25 mL) 
and the combined organic layers were dried over Na2SO4. Flash-chromatography of the crude (25% 
EtOAc/iHex --> 30% EtOAc/iHex) yielded 26 as a white foam (180 mg, 0.38 mmol, 93%). 
1H-NMR (599 MHz, CDCl3, ppm): δ = 8.43 (d, 2JN-H = 91.1 Hz, 1H, N-H), 7.71 (dt, 3J = 8.1 Hz, 2JN-H = 2.2 
Hz, 1H, 5-H), 6.19 (dd, 1JC-H = 175 Hz, 3J = 6.5 Hz, 1H, 1'-H), 5.70 - 5.67 (m, 1H, 6-H), 4.57 (d, 1JC-H = 
142.1 Hz, 3'-H), 4.27 - 3.64 (m, 3H, 4'-H, 5'-H), 2.63 - 2.14 (m, 2H, 2'H), 1.10 - 1.01 (m, 28H, Si(CH3)2, 
Si-CH). 13C-NMR (151 MHz, CDCl3, ppm): δ = 162.9 (d, 1JC-N = 9.4 Hz, C-4), 149.8 (t, 1JC-N = 18.5 Hz, 2-C), 
139.6 (d, 1JC-N = 12.9 Hz, C-5), 101.6 (d, 2JC-N = 7.0 Hz, C-6), 85.1 (t, 1JC-C = 41.9 Hz, 4'-C), 84.3 (dd, 1JC-C = 
36.4 Hz, 1JC-N = 10.6 Hz, 1'-C), 67.0 (t, 1JC-C = 39.2 Hz, 3'-C), 60.0 (d, J = 37.0 Hz, 5'-C), 39.9 (t, 1JC-C  = 37 
Hz, 2'-C), 17.5 - 16.7 (Si-C(CH3)), 13.4 - 12.4 (4 x Si-C(CH3)). 15N-NMR (41 MHz, CDCl3, ppm): δ = -
224.1, -224.2. HRMS (ESI+): calc. for C1613C5H3915N2O6Si2+ [M+H]+: 478.2450, found: 478.2451. HRMS 
(ESI-): calc. for C1613C5H3715N2O6Si2- [M-H]-: 476.2304, found: 476.2306. IR (ATR): ν (cm-1) = 2944 (w), 
2866 (w), 1680 (s), 1446 (w), 1384 (w), 1246 (m), 1094 (m), 1065 (m), 1029 (s), 967 (m), 919 (w), 883 
(s), 853 (m), 806 (m), 761 (m), 693 (s). 
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3’,5’-(1,1,3,3,-tetraisopropyldisiloxane-1,3-diyl)-2’-deoxy-(1’,2’,3’,4’,5’-13C5, N1,N3-15N2)-cytidine (27) 
 
For the amination reaction, triazole (398 mg, 5.76 mmol, 9.0 eq) was dissolved in MeCN (12 mL) and 
cooled to 0°C. Then, POCl3 (120 L, 1.27 mmol, 2.0 eq) was added dropwise and the milky suspension 
was kept at 0 °C for ten minutes. Triethyl amine (753 L, 5.50 mmol, 8.6 eq) was subsequently given 
to the slurry and stirred for an additional 20 minutes. Finally, 26 (304 mg, 0.64 mmol, 1.0 eq) was 
added and the reaction was allowed to warm to room temperature overnight. After TLC showed 
complete consumption of the starting material, the crude was suspended in DCM (25 mL) and 
washed with brine (25 mL). The organic phase was dried over Na2SO4 and the volatiles were removed 
in vacuo. This residue was then diluted with dioxane (15 mL), charged with NH4OH (4 mL, 25%) and 
stirred at 40 °C for three hours. The mixture was subsequently neutralized with saturated aqueous 
NH4Cl (50 mL) and extracted with EtOAc (2 x 25 mL). Column chromatography (5% MeOH/DCM) 
yielded 147 mg (0.31 mmol, 48%) of 27 as a colourless glass. 
1H-NMR (800 MHz, CDCl3, ppm): δ = 7.90 (ddd, 3J = 7.3 Hz, 2JN-H = 2.7 Hz, 1.1 Hz, 1H, 5-H), 6.17 (d, 1JC-H 
= 174.7 Hz, 3J = 7.7 Hz, 1H, 1'-H), 5.64 (dd, 3J = 7.4 Hz, 2JN-H = 3.4 Hz, 6-H), 4.46 (d, 1JC-H = 137.8 Hz, 1H, 
3'-H), 4.25 (d, 1JC-H = 149.2 Hz, 1H, 4'-H), 4.10 (d, 1JC-H = 139.7 Hz, 1H, 5'-H), 3.86 (d, 1JC-H = 143.6 Hz, 1H, 
5'-H), 2.61 (d, 1JC-H = 134.2 Hz, 1H, 2'-H), 2.61 (d, 1JC-H = 134.2 Hz, 1H, 2'-H), 2.41 (d, 1JC-H = 143.2 Hz, 
1H, 2'-H), 1.10 - 0.98 (m, 28H, Si(CH3)2, Si-CH). 13C-NMR (201 MHz, CDCl3, ppm): δ = 164.6 (d, 1JC-N = 
6.2 Hz, C-4), 154.6 (t, 1JC-N = 12.2 Hz, 2-C), 140.3 (d, 1JC-N = 12.8 Hz, C-5), 92.0 (d, 2JC-N = 7.0 Hz, C-6), 
84.1 (d, 1JC-C = 40.4 Hz, 1'-C), 83.9 (t, 1JC-C = 42.8 Hz, 4'-C), 65.7 (t, 1JC-C = 36.9, 3'-C), 59.9 (d, J = 43.0 Hz, 
5'-C), 38.9 (t, 1JC-C = 36.9 Hz, 2'-C), 16.5 - 15.8 (Si-C(CH3)), 12.4 - 11.4 (4 x Si-C(CH3)). 15N-NMR (41 
MHz, CDCl3, ppm): δ = -217.7, -217.9. HRMS (ESI+): calc. for C1613C5H40N15N2O5Si2+ [M+H]+: 477.2609, 
found: 477.2610. HRMS (ESI-): calc. for C1613C5H38N15N2O5Si2- [M-H]-: 475.2464, found: 475.2464. IR 
(ATR): ν (cm-1) = 3337 (w), 2944 (w), 2867 (w), 1622 (m), 1465 (m), 1394 (w), 1267 (w), 1180 (w), 
1120 (m), 1095 (s), 1030 (s), 937 (w), 883 (s), 782 (m), 694 (s). 
  
Nature Chemical Biology: doi:10.1038/nchembio.2531
3’,5’-(1,1,3,3,-tetraisopropyldisiloxane-1,3-diyl)-5-iodo-2’-deoxy-(1’,2’,3’,4’,5’-13C5, N1,N3-15N2)-
cytidine (28) 
 
Ceric ammonium nitrate (320 mg, 0.58 mmol, 2.0 eq), iodine (147 mg, 0.58 mmol, 2.0 eq) and 27 
(139 mg, 0.29 mmol, 1.0 eq) were dissolved in MeCN (20 mL) and heated to 60 °C for two and a half 
hours. The dark brownish solution was then poured into a mixture of brine (25 mL) and saturated 
aqueous Na2S2O3 solution (5 mL). After extraction with DCM (3 x 25 mL), the organic phases were 
dried over Na2SO4 and then removed in vacuo. Purification via column chromatography (4% 
MeOH/DCM) yielded 28 as an off white powder (149 mg, 0.25 mmol, 86%). 
1H-NMR (599 MHz, CDCl3, ppm): δ = 8.07 (sd, 2JN-H = 2.4 Hz, 1H, 5-H), 5.98 (dd, 1JC-H = 175.8 Hz, 3J = 
6.8 Hz, 1H, 1'-H), 4.49 (d, 1JC-H = 126.2 Hz, 1H, 3'-H), 4.29 (d, 1JC-H = 146.0 Hz, 1H, 4'-H), 4.13 (d, 1JC-H = 
137.9 Hz, 1H, 5'-H), 3.86 (d, 1JC-H = 136.7 Hz, 1H, 5'-H), 2.63 (d, 1JC-H = 133.4 Hz, 1H, 2'-H), 2.44 (d, 1JC-H 
= 136.0 Hz, 1H, 2'-H), 1.11 - 0.99 (m, 28H, Si(CH3)2, Si-CH). 13C-NMR (151 MHz, CDCl3, ppm): δ = 163.7 
(d, 1JC-N = 5.2 Hz, C-4), 154.6 (t, 1JC-N = 10.5 Hz, 2-C), 146.5 (d, 1JC-N = 12.6 Hz, C-5), 85.7 - 84.9 (1'-C + 4'-
C), 66.5 (t, 1JC-C  = 39.2, 3'-C), 59.7 (d, J = 43.2 Hz, 5'-C), 55.3 (C-6), 39.9 (t, 1JC-C  = 37.0 Hz, 2'-C), 17.8 - 
16.9 (8 x Si-C(CH3)), 13.5 - 12.3 (4 x Si-C(CH3)). 15N-NMR (41 MHz, CDCl3, ppm): δ = -209.7, -209.9. 
HRMS (ESI+): calc. for C1613C5H39IN15N2O5Si2+ [M+H]+: 603.1576, found: 603.1581. HRMS (ESI-): calc. 
for C1613C5H37IN15N2O5Si2- [M-H]-: 601.1430, found: 601.1427. IR (ATR): ν (cm-1) = 3435 (w), 3328 (w), 
2944 (w), 2867 (w), 1631 (m), 1600 (m), 1570 (m), 1463 (m), 1386 (w), 1262 (w), 1235 (w), 1155 (w), 
1116 (w), 1094 (s), 1044 (m), 1023 (s), 696 (m), 937 (w), 919 (w), 884 (m), 871 (m), 852 (w), 787 (w), 
775 (m), 697 (m). 
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3’,5’-(1,1,3,3,-tetraisopropyldisiloxane-1,3-diyl)-5-formyl-2’-deoxy-(1’,2’,3’,4’,5’-13C5, N1,N3-15N2)-
cytidine (29) 
 
A high pressure autoclave glass vessel was charged with PPh3 (13 mg, 0.05 mmol, 0.6), 
Pd2(dba)3CHCl3 (8 mg, 0.01 mmol, 0.1 eq) and 28 (48 mg, 0.08 mmol, 1.0 eq) and suspended in 
toluene (5 mL). The vessel was flushed twice with CO and then set to a final CO pressure of 50 psi. 
The mixture was then heated to 65 °C and tributyltin hydride (27 L diluted with 300 L toluene) was 
added through a syringe pump with an addition speed of 20 L per hour. After the addition was 
finished, the volatiles were removed in vacuo and the yellowish crude mixture was purified by flash 
column chromatography (20% EtOAc/iHex --> 40% EtOAc/iHex --> 50% EtOAc/iHex), whereas 37 mg 
(0.073 mmol, 92%) of product 29 could be obtained as a light yellowish oil. 
1H-NMR (400 MHz, CDCl3, ppm): δ = 9.50 (s, 1H, CHO), 8.53 (sd, 2JN-H = 2.7 Hz, 1H, 5-H), 6.01 (dd, 1JC-H 
= 177.6 Hz, 3J = 6.7 Hz, 1H, 1'-H), 4.54 - 3.63 (m, 4H, 3'-H, 4'-H, 5'-H), 2.78 (d, 1JC-H = 135.1 Hz, 1H, 2'-
H), 2.44 (d, 1JC-H = 137.5 Hz, 1H, 2'-H), 1.10 - 0.96 (m, 28H, Si(CH3)2, Si-CH). 13C-NMR (151 MHz, CDCl3, 
ppm): δ = 187.5 (CHO), 162.9 (d, 1JC-N = 5.9 Hz, C-4), 153.3 (t, 1JC-N = 7.9 Hz, 2-C), 152.7 (d, 1JC-N = 14.3 
Hz, C-5), 104.8 (C-6), 86.1 - 84.9 (1'-C + 4'-C), 65.9 (t, 1JC-C  = 38.2, 3'-C), 59.4 (d, J = 42.9 Hz, 5'-C), 39.5 
(t, 1JC-C  = 36.9 Hz, 2'-C), 17.5 - 16.8 (8 x Si-C(CH3)), 13.5 - 12.4 (4 x Si-C(CH3)). 15N-NMR (41 MHz, 
CDCl3, ppm): δ = -206.6, -206.8. HRMS (ESI+): calc. for C1713C5H40N15N2O6Si2+
 
[M+H]+: 505.2559, found: 
505.2567. IR (ATR): ν (cm-1) = 3393 (w), 2944 (m), 2866 (m), 2361 (w), 1658 (s), 1498 (m), 1463 (m), 
1437 (m), 1412 (w), 1387 (w), 1308 (w), 1228 (m), 1183 (m), 1160 (m), 1118 (s), 1092 (s), 1064 (s), 
1030 (s), 970 (m), 939 (m), 919 (w), 883 (m), 778 (m), 749 (m), 720 (s), 693 (s).  
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5-formyl-2'-deoxy-(1',2',3',4',5'-13C5, N1,N3-15N2)-cytidine (1) 
 
29 (30 mg, 0.06 mmol, 1.0 eq) was dissolved in EtOAc (1 mL) and pyridine (24 L) and HF pyridine (16 
L, 0.6 mmol, 10 eq) were added. After the mixture was stirred for 12 hours at room temperature, a 
white precipitate formed. Excess of HF was quenched with TMSOMe (60 L) and the colourless slurry 
was stirred for an additional 30 minutes. Then, the mixture was centrifuged (6000 rpm à 10 mins.), 
the supernatant removed and the colourless powder washed with EtOAc (5 mL) for three 
consecutive times. HPLC purification (0% --> 25% MeCN in 30 minutes) yielded 1 (7 mg, 0.026 mmol, 
45%) as a colourless solid.  
1H-NMR (400 MHz, D2O, ppm): δ = 9.50 (s, 1H, CHO), 8.84 (sd, 2JN-H = 2.9 Hz, 1H, 5-H), 6.15 (dt, 1JC-H = 
175.4 Hz, 3J = 5.8 Hz, 1H, 1'-H), 4.61 (d, 1JC-H = 151.9 Hz, 1H, 3'-H), 4.30 - 3.93 (m, 2H, 4'-H + 5'-H), 3.76 
- 3.53 (m, 1H, 5'-H), 2.74 (d, 1JC-H = 136.0 Hz, 1H, 2'-H), 2.53 (d, 1JC-H = 134.5 Hz, 1H, 2'-H). 13C-NMR 
(151 MHz, D2O, ppm): δ = 190.5 (CHO), 161.7 (d, 1JC-N = 7.4 Hz, C-4), 154.7 (d, 1JC-N = 14.2 Hz, C-5), 
154.0 (t, 1JC-N = 11.3 Hz, 2-C), 105.4 (C-6), 87.8 - 86.5 (1'-C + 4'-C), 69.3 (t, 1JC-C  = 36.5, 3'-C), 60.5 (d, J = 
41.5 Hz, 5'-C), 40.0 (t, 1JC-C  = 36.0 Hz, 2'-C). 15N-NMR (41 MHz, D2O, ppm): δ = -209.9, -210.2. HRMS 
(ESI+): calc. for C513C5H13N15N2NaO5
 + [M+Na]+: 285.0856, found: 285.0857. 
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Synthesis of isotopically labelled 2'-(R)-fluorocytidine derivatives 
  
Scheme 2: Synthesis of 15N2-labelled 2'-(R)-F-fdC 20, 2'-(R)-F-hmdC 37 and [D3]-2'-(R)-F-mdC 18. 
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3',5'-di-O-acetyl-2'-deoxy-2'-(R)-fluoro-3-nitrouridine (31) 
 
NH4NO3 (1.45 g, 18.1 mmol, 2.0 eq) was cautiously powdered with a mortar and pestle and 
subsequently suspended in DCM (50 mL). The resulting mixture was cooled to 0 °C and trifluoroacetic 
anhydride (5.10 g, 36.2 mmol, 4.0 eq) was added dropwise. After 30 minutes of warming up to room 
temperature, a brownish slurry developed which was stirred for another two hours until almost all of 
the remaining NH4NO3 was dissolved (note that complete dissolution of NH4NO3 could not be 
observed even after extended stirring). The resulting brownish-yellow solution was then again cooled 
to 0 °C and 30 (3.00 g, 9.06 mmol, 1.0 eq) was added in small portions. The reaction mixture was 
stirred for additional three hours at 0 °C and was quenched through the addition of PBS-Buffer (100 
mL, pH = 7.4). The aqueous layer was extracted with DCM (3 x 75 mL), combined organic layers were 
dried over Na2SO4 and the solvent was removed in vacuo. The crude residue was purified by column 
chromatography (1% MeOH/DCM to 2.5% MeOH/DCM) and 31 (3.60 g, 9.59 mmol, quant.) was 
yielded as a colourless powder. 
1H-NMR (599 MHz, CDCl3, ppm): δ = 7.47 (d, 3J = 8.3 Hz, 1H, 6-H), 5.89 (d, 3J = 8.3 Hz, 1H, 5-H), 5.81 
(dd, 3JH-F = 17.2 Hz, 3J = 1.4 Hz, 1H, 1'-H), 5.41 (ddd, 2JH-F = 51.6 Hz, 3J = 4.8 Hz, 3J = 1.4 Hz, 1H, 2'-H), 
5.13 (ddd, 3JH-F = 18.0 Hz, 3J = 4.8 Hz, 3J = 3.5 Hz, 1H, 3'-H), 4.47 - 4.43 (m, 2H, 5'-H + 4'-H), 4.33 - 4.30 
(m, 1H, 5'H), 2.16 (s, 3H, C3'-O-(C=O)-CH3), 2.10 (s, 3H, C5'-O-(C=O)-CH3). 13C-NMR (151 MHz, CDCl3, 
ppm): δ = 170.2 (C5'-O-(C=O)-CH3), 169.9 (C3'-O-(C=O)-CH3), 154.9 (C-4), 145.1 (C-2), 140.1 (C-6), 
102.0 (C-5), 92.0 (d, 2JC-F = 37.3 Hz, C-1'), 90.8 (d, 1JC-F = 193.1 Hz, C-2'), 79.3 (C-4'), 69.3 (d, 2JC-F = 
16.0 Hz, C-3'), 61.8 (C-5'), 20.8 (C5'-O-(C=O)-CH3), 20.5 (C3'-O-(C=O)-CH3). 19F-NMR (377 MHz, CDCl3, 
ppm): δ = −199.4 (dt, 2JF-H = 51.8 Hz, 3JF-H = 18.4 Hz). HRMS (ESI+): calc. for C13H18FN4O9+
 
[M+NH4]+: 
393.1052, found: 393.1048. IR (ATR): ν (cm-1) = 3096 (w), 1737 (s), 1693 (s), 1644 (s), 1617 (m), 1558 
(w), 1540 (w), 1506 (w), 1456 (w), 1436 (m), 1377 (m), 1289 (m), 1252 (m), 1224 (s), 1119 (m), 1100 
(s), 1055 (s), 990 (m), 960 (m), 901 (m), 884 (m), 852 (w), 828 (m), 804 (m), 748 (m), 738 (m), 705 (w), 
677 (w). Melting Range: 132 °C - 134 °C. 
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3',5'-di-O-acetyl-2'-deoxy-2'-(R)-fluoro-(N3-15N)-uridine (32)
 
 
First, 15NH4Cl (400 mg, 7.34 mmol, 1.2 eq) was dissolved in H2O (15 mL) and KOH (412 mg, 7.34 
mmol, 1.2 eq) and NEt3 (1.50 mL, 10.0 mmol, 1.6 eq) were added. 31 (2.30 g, 6.13 mmol, 1.0 eq) was 
dissolved in MeCN (15 mL) and also given to the clear solution, which was then vigorously stirred at 
room temperature overnight. Subsequently, MeCN was removed in vacuo and the resulting aqueous 
phase was neutralized through the addition of sat. NH4Cl (100 mL). The aqueous layers were 
extracted with DCM (3 x 100 mL), organic layers were collected and dried over Na2SO4. The volatiles 
were removed under reduced pressure and the crude mixture was purified by column 
chromatography (DCM --> 2% MeOH/DCM). 32 (818 mg, 2.47 mmol, 40%) was yielded as a white 
foam. 
1H-NMR (800 MHz, DMSO-d6, ppm): δ = 7.71 (d, 3J = 8.1 Hz, 1H, 6-H), 5.87 (dd, 3JH-F = 22.4 Hz, 3J = 2.0 
Hz, 1H, 1'-H), 5.69 - 5.68 (m, 1H, 5-H), 5.33 (ddd, 2JH-F = 52.5 Hz, 3J = 5.3 Hz, 3J = 2.0 Hz, 1H, 2'-H), 5.26 
(ddd, 3JH-F = 25.2 Hz, 3J = 5.3 Hz, 3J = 2.8 Hz, 1H, 3'-H), 4.34 (dd, 2J = 12.4 Hz, 3J = 3.0 Hz, 1H, 5'-H), 4.27 
(m, 1H, 4'-H), 4.16 (dd, 2J = 12.3 Hz, 3J = 5.8 Hz, 1H, 5'-H), 2.11 (s, 3H, C3'-O-(C=O)-CH3), 2.04 (s, 3H, 
C5'-O-(C=O)-CH3). 13C-NMR (202 MHz, DMSO-d6, ppm): δ = 170.2 (C5'-O-(C=O)-CH3), 169.5 (C3'-O-
(C=O)-CH3), 163.2 (sd, 1JC-N = 8.7 Hz, C-4), 150.1 (sd, 1JC-N = 17.6 Hz, C-2), 142.9 (C-6), 102.1 (C-5), 90.8 
(d, 1JC-F = 186.3 Hz, C-2'), 90.5 (d, 2JC-F = 37.0 Hz, C-1'), 77.9 (C-4'), 69.8 (d, 2JC-F = 14.3 Hz, C-3'), 62.7 (C-
5'), 20.5 (C5'-O-(C=O)-CH3), 20.3 (C3'-O-(C=O)-CH3). 19F-NMR (377 MHz, DMSO-d6, ppm): δ = -198.0 
(ddd, 2JH-F = 52.5 Hz, 3JH-F = 22.3, 3JH-F = 17.2). 15N-NMR (41 MHz, DMSO-d6, ppm): δ = -222.0. HRMS 
(ESI+): calc. for C13H19FN215NO7+ [M+NH4]+: 349.1172, found: 349.1174. HRMS (ESI-): calc. for 
C13H14FN15NO7- [M-H]-: 330.0761, found: 330.0763. IR (ATR): ν (cm-1) = 3092 (w), 3002 (w), 2929 (w), 
2878 (w), 2817 (w), 1737 (s), 1716 (s), 1672 (s), 1464 (w), 1449 (w), 1429 (w), 1417 (m), 1380 (m), 
1365 (m), 1335 (w), 1299 (w), 1266 (m), 1236 (s), 1120 (w),  1095 (m), 1073 (s), 1048 (s), 995 (m), 968 
(m), 900 (s), 875 (m), 865 (m), 825 (s), 763 (m), 751 (m), 732 (w), 699 (w), 684 (w). Melting Range: 
169 °C - 173 °C.  
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3',5'-bis-O-(tert-butyl(dimethyl)silyl)-2'-deoxy-2'-(R)-fluoro-(N3-15N)-uridine (33) 
 
For the deprotection of 32 (800 mg, 2.42 mmol, 1.0 eq), the compound was dissolved in methanolic 
ammonia (7N, 5 mL) and stirred at room temperature overnight. The volatiles were then removed in 
vacuo and the mixture was dried on high vac. The resulting crude yellow oil was dissolved in pyridine 
(10 mL), imidazole (741 mg, 10.9 mmol, 4.5 eq) and TBSCl (1.09 g, 7.26 mmol, 3.0 eq) were added 
and the mixture was stirred at room temperature for 16 hours. After pyridine was removed by rotary 
evaporation, the residue was suspended in sat. NaHCO3 (100 mL) and extracted with DCM (3 x 75 mL) 
and the combined organic layers were dried over Na2SO4. The obtained oily compound was then 
coevaporated with toluene (3 x 25 mL), whereas 1.11 g (2.33 mmol, 96%) of 33 were yielded as a 
colourless waxy solid. 
1H-NMR (599 MHz, CDCl3, ppm): δ = 7.92 (d, 3J = 8.2 Hz, 1H, 6-H), 6.06 (dd, 3JH-F = 15.3 Hz, 3J = 2.0 Hz, 
1H, 1'-H), 5.69 (dd, 3J = 8.2 Hz, 3JH-N = 2.6 Hz, 1H, 5-H), 4.77 (ddd, 2JH-F = 52.3 Hz, 3J = 4.3 Hz, 3J = 2.0 Hz, 
1H, 2'-H), 4.29 (ddd, 3JH-F = 18.9 Hz, 3J = 7.2 Hz, 3J = 4.2 Hz, 1H, 3'-H), 4.08 (dd, 3J = 7.2 Hz, 3J = 1.6 Hz, 
1H, 4'-H), 4.05 (dd, 2J = 11.7 Hz, 3J = 2.1 Hz, 1H, 5'-H), 3.78 (dd, 2J = 11.7 Hz, 3J = 1.8 Hz, 1H, 5'-H), 0.93 
- 0.90 (m, 18H, Si(CH3)2(tBu)), 0.12 - 0.10 (m, 12H, Si(CH3)2(tBu)). 13C-NMR (151 MHz, CDCl3, ppm): δ = 
163.1 (d, 1JC-N = 8.7 Hz, 4-C), 150.0 (sd, 1JC-N = 17.8 Hz, 2-C), 139.9 (C-6), 102.5 (C-5), 93.2 (d, 1JC-F = 
193.3 Hz, C-2'), 87.9 (d, 2JC-F = 33.8 Hz, C-1'), 83.9 (C-4'), 68.7 (d, 2JC-F = 16.2 Hz, C-3'), 60.9 (C-5'), 26.1 
(Si(C(CH3)3)), 25.7 (Si(C(CH3)3)), 18.5 (Si(C(CH3)3)), 18.2 (Si(C(CH3)3)), -4.5 (Si(CH3)2tBu), -4.9 
(Si(CH3)2tBu), -5.3 (Si(CH3)2tBu), -5.4 (Si(CH3)2tBu). 19F-NMR (377 MHz, CDCl3, ppm): δ = -202.5 (ddd, 
2JH-F = 52.4 Hz, 3JH-F = 19.0, 3JH-F = 15.3). 15N-NMR (41 MHz, CDCl3, ppm): δ = -224.4. HRMS (ESI+): calc. 
for C21H40FN15NO5Si2+ [M]+: 476.2425, found: 476.2429. HRMS (ESI-): calc. for C21H38FN15NO5Si2- [M-H]-
: 474.2279, found: 474.2291. IR (ATR): ν (cm-1) = 3381 (w), 3254 (w), 2953 (w), 2927 (m), 2856 (m), 
1749 (w), 1713 (s), 1707 (s), 1692 (s), 1681 (s), 1629 (w), 1471 (w), 1452 (m), 1398 (w), 1388 (w), 
1362 (w), 1321 (w), 1362 (m), 1321 (w), 1276 (m), 1251 (m), 1230 (w), 1157 (m), 1120 (s), 1094 (m), 
1072 (m), 1052 (m), 993 (m), 978 (m), 938 (w), 899 (w), 880 (m), 863 (m), 828 (s), 811 (m), 802 (s), 
778 (s), 757 (s), 748 (m), 711 (m), 704 (m), 663 (m). 
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3',5'-bis-O-[tert-butyl(dimethyl)silyl]-2'-deoxy-2'-(R)-fluoro-(N3,N4-15N2)-cytidine (34) 
 
In a round bottom flask, 1,2,4-triazole (1.04 g, 15.1 mmol, 9.9 eq) was dissolved in MeCN (30 mL), 
cooled to 0 °C and stirred for ten minutes. To the resulting turbid solution, NEt3 (2.00 mL, 14.4 mmol, 
9.4 eq) was added dropwise and the mixture was stirred at 0 °C for another 20 minutes. 
Subsequently, a solution of 33 (730 mg, 1.53 mmol, 1.0 eq) in MeCN (10 mL) was given to the 
reaction and heated to 60 °C for 14 hours. After the starting material was consumed (as judged by 
TLC analysis), the mixture was quenched through addition of saturated NaHCO3 (100 mL) and the 
resulting aqueous layer was extracted with DCM (3 x 100 mL). Combined organic layers were dried 
over Na2SO4 and the solvents were removed under reduced pressure. The resulting crude triazole 
derivative of 26 was then resuspended in dioxane (3.0 mL) and an aqueous solution of 15NH3 (3N, 3.0 
mL) was added. After the reaction was stirred at room temperature for 24 hours, starting material 
was still visible on the TLC. Thus, the heat was slightly increased to 30 °C and stirred for another 16 
hours. The reaction was stopped through addition of saturated aqueous solution of NH4Cl (50 mL), 
extracted with DCM (3 x 50 mL) and the combined organic layers were backwashed with brine (100 
mL) and subsequently dried over Na2SO4. Purification through column chromatography (DCM --> 2% 
MeOH/DCM --> 3% MeOH/DCM --> 4% MeOH/DCM) yielded 34 (430 mg, 0.90 mmol, 59%) as a 
colourless foam. 
1H-NMR (800 MHz, CDCl3, ppm): δ = 8.07 (d, 3J = 7.5 Hz, 1H, 6-H), 6.03 (dd, 3JH-F = 15.9 Hz, 3J = 0.9 Hz, 
1H, 1'-H), 5.80 (d, 3J = 7.5 Hz, 1H, 5-H), 4.79 (dd, 2JH-F = 52.2 Hz, 3J = 3.9 Hz, 1H, 2'-H), 4.23 (ddd, 3JH-F = 
22.6 Hz, 3J = 8.6 Hz, 3J = 3.9 Hz, 1H, 3'-H), 4.12 - 4.07 (m, 2H, 4'-H + 5'-H), 3.79 (dd, 2J = 11.9 Hz, 3J = 1.8 
Hz, 1H, 5'-H), 0.94 (s, 9 H, Si(CH3)2(tBu)), 0.89 (s, 9 H, Si(CH3)2(tBu)), 0.13 (s, 3H, Si(CH3)2(tBu)), 0.12 (s, 
3H, Si(CH3)2(tBu)), 0.10 (s, 3H, Si(CH3)2(tBu)), 0.08 (s, 3H, Si(CH3)2(tBu)). 13C-NMR (201 MHz, CDCl3, 
ppm): δ = 165.0 (dd, 1JC-N = 21.8 Hz, 1JC-N = 8.54 Hz 4-C), 154.9 (sd, 1JC-N = 9.2 Hz, 2-C), 141.5 (C-6), 94.5 
(C-5), 93.4 (d, 1JC-F = 192.3 Hz, C-2'), 88.9 (d, 2JC-F = 33.4 Hz, C-1'), 83.1 (C-4'), 68.0 (d, 2JC-F = 17.3 Hz, C-
3'), 60.4 (C-5'), 26.1 (Si(C(CH3)3)), 25.8 (Si(C(CH3)3)), 18.6 (Si(C(CH3)3)), 18.2 (Si(C(CH3)3)), -4.5 
(Si(CH3)2tBu), -4.9 (Si(CH3)2tBu), -5.3 (Si(CH3)2tBu), -5.4 (Si(CH3)2tBu). 19F-NMR (376 MHz, CDCl3, ppm): 
δ = -201.3 (ddd, 2JH-F = 51.8 Hz, 3JH-F = 20.8, 3JH-F = 15.6). 15N-NMR (41 MHz, CDCl3, ppm): δ = -288.1, -
288.3. HRMS (ESI+): calc. for C21H41FN15N2O4Si2 + [M]+: 476.2555, found: 476.2558. HRMS (ESI-): calc. 
for C21H39FN15N2O4Si2- [M-H]-: 474.2409, found: 474.2411. IR (ATR): ν (cm-1) = 3170 (bw), 2954 (w), 
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2929 (w), 2857 (w), 1717 (w), 1645 (m), 1519 (w), 1506 (m), 1394 (w), 1362 (w), 1278 (w), 1253 (m), 
1157 (m), 1157 (w), 1120 (m), 1071 (m), 991 (w), 881 (m), 860 (m), 835 (s), 812 (m), 777 (s), 670 (m), 
592 (m). 
 
3',5'-bis-O-(tert-butyl(dimethyl)silyl)-5-iodo-2'-deoxy-2'-(R)-fluoro-(N3,N4-15N2)-cytidine (35) 
 
In a round bottom flask, 34 (30 mg, 0.06 mmol, 1.0 eq) was dissolved in MeCN (5 mL) and ceric 
ammonium nitrate (71 mg, 0.13 mmol, 2.2 eq) and iodine (32 mg, 0.13 mmol, 2.2 eq) were added. 
The dark brownish mixture was then stirred at 60 °C for a total time of three hours and after the 
reaction was cooled to room temperature, MeCN was removed in vacuo. Addition of DCM (20 mL) 
lead to the precipitation of cerium salts, which were filtered off and the DCM was finally removed 
under reduced pressure. Column chromathography (5% MeOH/DCM) of the crude mixture yielded 35 
(37 mg, 60 μmol, quant.) as an orange oil. 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.99 (s, 1H, 6-H), 5.98 (dd, 3JH-F = 16.0 Hz, 3J = 1.8 Hz, 1H, 1'-H), 
4.81 (ddd, 2JH-F = 52.3 Hz, 3J = 4.4 Hz, 3J = 1.8 Hz, 1H, 2'-H), 4.19 (ddd, 3JH-F = 18.9 Hz, 3J = 7.6 Hz, 3J = 4.4 
Hz, 1H, 3'-H), 4.09 - 4.01 (m, 2H, 4'-H + 5'-H), 3.78 (dd, 2J = 11.9 Hz, 3J = 2.1 Hz, 1H, 5'-H), 0.95 (s, 9 H, 
C3'/C5'-O-Si(CH3)2(tBu)), 0.89 (s, 9 H, Si(CH3)2(tBu)), 0.16 (s, 3H, Si(CH3)2(tBu)), 0.15 (s, 3H, 
Si(CH3)2(tBu)), 0.10 (s, 3H, Si(CH3)2(tBu)), 0.08 (s, 3H, Si(CH3)2(tBu)). 13C-NMR (101 MHz, CDCl3, ppm): δ 
= 164.0 (dd, 1JC-N = 23.0 Hz, 1JC-N = 6.0 Hz, 4-C), 154.5 (sd, 1JC-N = 8.9 Hz, 2-C), 146.4 (C-6), 57.0 (C-5), 
93.1 (d, 1JC-F = 193.3 Hz, C-2'), 89.2 (d, 2JC-F = 33.0 Hz, C-1'), 83.9 (C-4'), 68.8 (d, 2JC-F = 16.5 Hz, C-3'), 
61.1 (C-5'), 57.4 (C-5), 26.5 (Si(C(CH3)3)), 25.8 (Si(C(CH3)3)), 18.9 (Si(C(CH3)3)), 18.2 (Si(C(CH3)3)), -4.4 
(Si(CH3)2tBu), -4.7 (Si(CH3)2tBu), -4.8 (Si(CH3)2tBu), -4.9 (Si(CH3)2tBu). 19F-NMR (376 MHz, CDCl3, ppm): 
δ = -201.7 (ddd, 2JH-F = 52.3 Hz, 3JH-F = 19.0, 3JH-F = 16.8). 15N-NMR (41 MHz, CDCl3, ppm): δ = -280.4, -
280.5. HRMS (ESI+): calc. for C21H40FIN15N2O4Si2+ [M]+: 602.1521, found: 602.1530. HRMS (ESI-): calc. 
for C21H38FIN15N2O4Si2+- [M-H]-: 600.1376, found: 600.1378. IR (ATR): ν (cm-1) = 3305 (w), 2955 (w), 
2916 (s), 2850 (s), 1730 (s), 1635 (m), 1470 (s), 1418 (w), 1382 (w), 1361 (w), 1276 (m), 1253 (m), 
1220 (m), 1178 (s), 1123 (m), 1105 (m), 1062 (m), 1047 (m), 992 (m), 942 (w), 889 (m), 864 (m), 836 
(s), 777 (s), 740 (m), 719 (m), 670 (m), 643 (m), 622 (m), 593 (m). 
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3',5'-bis-O-(tert-butyl(dimethyl)silyl)5-formyl-2'-deoxy-2'-(R)-fluoro-(N3,N4-15N2)-cytidine (36) 
 
The reaction vessel of a high pressure CO-autoclave was charged with 35 (220 mg, 0.37 mmol, 1.0 
eq), PPh3 (58 mg, 0.2 mmol, 0.6 eq), Pd2(dba)3CHCl3 (38 mg, 0.04 mmol 0.1 eq) and toluene (5.5 mL). 
The mixture was purged with CO twice and finally set under a pressurized atmosphere of CO (50 psi). 
After heating to 65 °C, tributyltin hydride (120 μL, 0.44 mmol, 1.2 eq) was added to the reaction 
through a syringe pump (17 μL/h). After the addition was finished, the mixture was cooled to room 
temperature and the volatiles were removed under reduced pressure. The crude was subjected to 
purification by column chromatography (20% EtOAc/ iHex --> 50% EtOAc/ iHex) and 36 (158 mg, 0.31 
mmol, 85%) was obtained as a yellow foam. 
1H-NMR (599 MHz, CDCl3, ppm): δ = 9.50 (s, 1H, CHO), 8.53 (s, 1H, 6-H), 8.26 (dd, 1JH-N = 92.9 Hz, 1J = 
6.0 Hz, 1H, 15NH2), 7.29 (d, 1JH-N = 92.9 Hz, 1H, 15NH2), 6.02 (dd, 3JH-F = 16.3 Hz, 3J = 2.0 Hz, 1H, 1'-H), 
4.92 (dd, 2JH-F = 51.9 Hz, 3J = 4.1 Hz, 1H, 2'-H), 4.23 - 4.14 (m, 3H, 3'-H, 4'-H, 5'-H), 3.83 (dd, 2J = 12.2 
Hz, 3J = 2.1 Hz, 1H, 5'-H), 0.94 (s, 9 H, Si(CH3)2(tBu)), 0.89 (s, 9 H, Si(CH3)2(tBu)), 0.14 (s, 3H, 
Si(CH3)2(tBu)), 0.11 (s, 3H, Si(CH3)2(tBu)), 0.10 (s, 3H, Si(CH3)2(tBu)), 0.08 (s, 3H, Si(CH3)2(tBu)). 13C-NMR 
(151 MHz, CDCl3, ppm): δ = 187.3 (CHO), 162.9 (dd, 1JC-N = 20.9 Hz, 1JC-N = 5.1 Hz, C-4), 153.2 (C-6), 
153.0 (C-2), 105.7 (C-5), 93.0 (d, 1JC-F = 192.9 Hz, C-2'), 89.8 (d, 2JC-F = 34.4 Hz, C-1'), 83.8 (C-4'), 68.2 (d, 
2JC-F = 16.5 Hz, C-3'), 60.7 (C-5'), 26.2 (Si(C(CH3)3)), 25.7 (Si(C(CH3)3)), 18.8 (Si(C(CH3)3)), 18.2 
(Si(C(CH3)3)), -4.3 (Si(CH3)2tBu), -4.8 (Si(CH3)2(C(CH3)3)), -4.8 (Si(CH3)2tBu), -5.2 (Si(CH3)2tBu). 19F-NMR 
(377 MHz, CDCl3, ppm): δ = -200.9 (ddd, 2JH-F = 51.7 Hz, 3JH-F = 19.9, 3JH-F = 15.7). 15N-NMR (41 MHz, 
CDCl3, ppm): δ = -175.2, -286.0. HRMS (ESI+): calc. for C22H41FN15N2O5Si2+ [M]+: 504.2504, found: 
504.2513. HRMS (ESI-): calc. for C22H39FN15N2O5Si2- [M-H]-: 502.2358, found: 502.2357. IR (ATR): ν 
(cm-1) = 3383 (bw), 2954 (w), 2929 (w), 2857 (w), 1663 (s), 1636 (m), 1506 (m), 1472 (w), 1418 (w), 
1361 (w), 1252 (m), 1237 (m), 1167 (w), 1120 (m), 1070  (s), 993 (m), 979 (w), 835 (s), 813 (m), 777 
(s), 699 (w), 667 (m), 598 (m), 575 (w). 
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5-formyl-2'-deoxy-2'-(R)-fluoro-(N3,N4-15N2)-cytidine (20) 
 
For the TBS deprotection, 36 (100 mg, 0.20 mmol, 1.0 eq) was dissolved in a mixture of EtOAc (2.8 
mL) and pyridine (0.8 mL). HF pyridine (52 μL, 2.00 mmol, 10 eq) was added, the reaction was stirred 
for 16 hours at room temperature and a colourless precipitate formed. To quench the reaction, 
methoxytrimethyl silane (200 μL) was given to the mixture and stirred for another two hours at room 
temperature, whereas more of the colourless precipitate formed. The product was isolated through 
repeated washing with EtOAc after centrifuging (6000 rpm, three times in total) of the suspension. 
20 (32 mg, 0.12 mmol, 58%) were yielded as a slightly yellowish powder, which was finally purified 
twice by semipreparative HPLC (Waters Nucleodur C18 ec, 0% MeCN/H2O --> 13% MeCN/H2O in 30 
minutes, 5.0 mL/min) for cell-feeding purposes. 
1H-NMR (800 MHz, D2O, ppm): δ = 9.54 (s, 1H, CHO), 8.90 (s, 1H, 6-H), 6.10 (d, 3JH-F = 17.7 Hz, 1H, 1'-
H), 5.22 (dd, 2JH-F = 52.3 Hz, 3J = 4.3 Hz, 1H, 2'-H), 4.39 (ddd, 3JH-F = 24.2 Hz, 3J = 9.3 Hz, 3J = 4.3 Hz, 1H, 
3'-H) 4.37 (dt, 3J = 9.3 Hz, 3J = 3.0 Hz, 1H, 4'-H), 4.15 (dd, 2J = 13.1 Hz, 3J = 2.4 Hz, 1H, 5'-H), 3.94 (dd, 2J 
= 13.1 Hz, 3J = 3.5 Hz, 1H, 5'-H). 13C-NMR (201 MHz, D2O, ppm): δ = 190.3 (CHO), 162.8 (dd, 1JC-N = 
21.8 Hz, 1JC-N = 6.5 Hz, C-4), 155.0 (C-6), 154.9 (C-2), 105.9 (C-5), 93.7 (d, 1JC-F = 186.0 Hz, C-2'), 89.9 (d, 
2JC-F = 34.9 Hz, C-1'), 82.5 (C-4'), 67.2 (d, 2JC-F = 16.7 Hz, C-3'), 59.1 (C-5'). 19F-NMR (376 MHz, D2O, 
ppm): δ = -201.6 (ddd, 2JH-F = 52.3 Hz, 3JH-F = 24.0, 3JH-F = 17.7). 15N-NMR (41 MHz, D2O, ppm): δ = -
199.9, -200.4. HRMS (ESI+): calc. for C10H13FN15N2O5+ [M+H]+: 276.0774, found: 276.0778. HRMS (ESI-
): calc. for C10H11FN15N2O5- [M-H]-: 274.0629, found: 274.0629. 
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5-hydroxymethyl-2'-deoxy-2'-(R)-fluoro-(N3,N4-15N2)-cytidine (37) 
 
First, 20 (1.00 mg, 3.60 μmol, 1.0 eq) was dissolved in MeOH (1.0 mL), CeCl3 7 H2O (4.10 mg, 10.9 
μmol, 3.0 eq) and NaBH4 (0.20 mg, 3.60 μmol, 1.0 eq) were added subsequently, whereas an 
evolution of gas could be observed. After stirring at room temperature for one hour, complete 
conversion to the desired product could be observed (as judged by LC-MS). Then, a saturated 
aqueous solution of NH4Cl (1.0 mL) was given to the crude and the solvent was removed by 
lyophillization. Purification of 37 was achieved through semipreparative HPLC (Waters Nucleodur C18 
ec, 0% MeCN/H2O --> 10% MeCN/H2O in 45 minutes, 5.0 mL/min) and yielded 0.80 mg (2.80 μmol, 
80%) of pure 37 as a white powder. 
1H-NMR (800 MHz, D2O, ppm): δ = 7.85 (s, 1H, 6-H), 5.92 (dd, 3JH-F = 19.4 Hz, 3J = 1.1 Hz, 1H, 1'-H), 
5.07 (dd, 2JH-F = 52.9 Hz, 3J = 4.5 Hz, 1H, 2'-H), 4.35 (s, 2H, CH2OH), 4.28 (ddd, 3JH-F = 22.0 Hz, 3J = 8.9 
Hz, 3J = 4.5 Hz, 1H, 3'-H) 4.07 (dt, 3J = 8.9 Hz, 3J = 3.3 Hz, 1H, 4'-H), 3.97 (dd, 2J = 13.0 Hz, 3J = 2.4 Hz, 
1H, 5'-H), 3.78 (dd, 2J = 13.0 Hz, 3J = 4.0 Hz, 1H, 5'-H). 13C-NMR (201 MHz, D2O, ppm): δ = 165.2 (dd, 
1JC-N = 21.2 Hz, 1JC-N = 6.7 Hz, C-4), 156.9 (C-2), 140.9 (C-6), 106.5 (C-5), 93.7 (d, 1JC-F = 184.4 Hz, C-2'), 
89.8 (d, 2JC-F = 35.0 Hz, C-1'), 82.1 (C-4'), 67.7 (d, 2JC-F = 16.1 Hz, C-3'), 59.6 (C-5'), 57.7 (CH2OH). 19F-
NMR (376 MHz, D2O, ppm): δ = -200.5 (ddd, 2JH-F = 52.9 Hz, 3JH-F = 22.0, 3JH-F = 19.4). 15N-NMR (41 
MHz, D2O, ppm): δ = -201.9, -202.0. HRMS (ESI+): calc. for C10H15FN15N2O5+ [M+H]+: 278.0931, found: 
278.0933. HRMS (ESI-): calc. for C10H13FN15N2O5- [M-H]-: 276.0785, found: 276.0787. 
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2'-deoxy-2'-(R)-fluoro-(N3,N4-15N2)-cytidine (19) 
 
34 (117 mg, 0.25 mmol, 1.0 eq) was dissolved in EtOAc (3.5 mL) and pyridine (98 L). Subsequently 
HF pyridine (70% solution, 123 L, 4.92 mmol, 20 eq) was added and the mixture stirred at room 
temperature for 22 hours. TMSOMe (4.9 mL) was then added and after another hour of stirring at 
room temperature, the solvents were removed in vacuo. The residue was dissolved in H2O and then 
purified by HPLC which yielded 44 mg (0.18 mmol, 72%) of 19 as a colourless solid. 
1H-NMR (800 MHz, D2O, ppm): δ = 7.81 (d, 3J = 7.6 Hz, 1H, 6-H), 6.02 (d, 3J = 7.7 Hz, 1H, 5-H), 5.97 (d, 
3JH-F = 19.8 Hz, 1H, 1'-H), 5.15 (ddd, 2JH-F = 52.9 Hz, 3J = 4.9 Hz, 3J = 1.1 Hz, 1H, 2'-H), 4.34 (ddd, 3JH-F = 
22.5 Hz, 3J = 9.0 Hz, 3J = 4.6 Hz, 1H, 3'-H), 4.16-4.08 (m, 1H, 4'-H), 4.01 (dd, 2J = 13.0 Hz, 3J = 2.4 Hz, 
1H, 5'-H), 3.83 (dd, 2J = 13.0 Hz, 3J = 4.4 Hz, 1H, 5'-H). 13C-NMR (201 MHz, D2O, ppm): δ = 162.6 (C4), 
149.9 (C2), 140.6 (C6), 96.0 (C5), 93.2 (d, 1JC-F = 193.8 Hz, C2'), 89.9 (d, 2JC-F = 35.7 Hz, C1'), 82.2 (C4'), 
67.8 (d, 2JC-F = 15.5 Hz, C3'), 59.9 (C5'). 19F-NMR (376 MHz, D2O, ppm): δ = −200.3 (dt, 2JF-H = 53.1 Hz, 
3JF-H = 19.0 Hz). HRMS (ESI−): calc. for C11H15FN15N2O6- [M+OAc]-: 306.0891, found: 306.0894. 
 
3',5'-bis-O-(tert-butyl(dimethyl)silyl)- 5-iodo-2'-deoxy-2'-(R)-fluoro -uridine (38) 
 
TBS-protected 3',5'-bis-O-[tert-butyl(dimethyl)silyl]-2'-deoxy-2'-fluoro-uridine (0.50 g, 1.05 mmol, 
1.0 eq) was dissolved in MeCN (100 mL) and CAN (2.30 g, 2.10 mmol, 2.0 eq) and I2 (1.07 g, 2.10 
mmol, 2.0 eq) were added to the mixture. The dark red brownish solution was heated to 65 °C for 1.5 
hours and subsequently poured into saturated NaHCO3 and a saturated solution of Na2S2O3 was 
added until the solution became colourless. The aqueous phases were exrtracted with EtOAc (2x50 
mL) and the combined organic fractions dried over Na2SO4. Column chromatography (20% 
EtOAc/iHex) yielded the iodinated compound as a brownish foam (469 mg, 0.78 mmol, 74%). 
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1H-NMR (400 MHz, CDCl3, ppm): δ = 9.34 (s, 1H, NH),  7.98 (s, 1H, 6-H), 6.08 (dd, 3JH-F = 14.3 Hz, 3J = 
3.8 Hz, 1H, 1'-H), 4.82 (dt, 2JH-F = 52.5 Hz, 3J = 4.2 Hz, 1H, 2'-H), 4.27 (dt, 3JH-F = 12.9 Hz, 3J = 4.9 Hz, 1H, 
3'-H), 4.08 - 4.06 (m, 1H, 4'-H), 3.98 (dd, 2J = 11.9 Hz, 3J = 1.8 Hz, 1H, 5'-H), 3.76 (dd, 2J = 11.9 Hz, 3J = 
2.1 Hz, 1H, 5'-H), 0.95 (s, 9 H, C3'/C5'-O-Si(CH3)2(tBu)), 0.90 (s, 9 H, Si(CH3)2(tBu)), 0.16 (s, 3H, 
Si(CH3)2(tBu)), 0.15 (s, 3H, Si(CH3)2(tBu)), 0.10 (s, 3H, Si(CH3)2(tBu)), 0.08 (s, 3H, Si(CH3)2(tBu)). 13C-NMR 
(101 MHz, CDCl3, ppm): δ = 160.0 (4-C), 149.9 (2-C), 144.0 (C-6), 92.4 (d, 1JC-F = 195.3 Hz, C-2'), 87.4 
(d, 2JC-F = 33.7 Hz, C-1'), 85.1 (C-4'), 69.6 (d, 2JC-F = 15.6 Hz, C-3'), 69.2 (C-5'), 61.7 (C-5), 26.3 
(Si(C(CH3)3)), 25.7 (Si(C(CH3)3)), 18.7 (Si(C(CH3)3)), 18.2 (Si(C(CH3)3)), -4.6 (Si(CH3)2tBu), -5.0 
(Si(CH3)2tBu), -5.1 (Si(CH3)2tBu), -5.1 (Si(CH3)2tBu). HRMS (ESI+): calc. for C21H39FIN2O5Si2+ [M+H]+: 
601.1421, found:601.1432. 
 
3',5'-bis-O-[tert-butyl(dimethyl)silyl]- 5-(D3) -methyl 2'-deoxy-2'-(R)-fluoro-uridine (39) 
 
38 (100 mg, 0.167 mmol, 1.0 eq) was dissolved in THF (4 mL) and Ni(dppp)Cl2 (45 mg, 0.083 mmol, 
0.5 eq) was added. The mixture was cooled to 0 °C and CD3MgI (0.55 mL, 1M solution in ether, 
3.3 eq) was added slowly. The clear red solution was slowly warmed to rt and stirred for one hour 
and subsequently quenched with sat. NH4Cl (10 mL). The aqueous phase was extracted twice with 
EtOAc (15 mL), combined organic fractions dried over Na2SO4 and volatiles removed in vacuo. The 
crude mixture was finally purified thorugh column chromatography (20% EtOAc/iHex) to yield 30 mg 
(0.061 mmol, 37%) of 39.  
1H-NMR (400 MHz, CDCl3, ppm): δ = 8.82 (s, 1H, NH), 7.38 (s, 1H, 6-H), 6.07 (dd, 3JH-F = 15.5 Hz, 3J = 
3.6 Hz, 1H, 1'-H), 4.83 (dt, 2JH-F = 52.9 Hz, 3J = 4.2 Hz, 1H, 2'-H), 4.29 (dt, 3JH-F = 13.4 Hz, 3J = 5.1 Hz, 1H, 
3'-H), 4.08 - 4.00 (m, 1H, 4'-H), 3.97 (dd, 2J = 11.8 Hz, 3J = 2.0 Hz, 1H, 5'-H), 3.76 (dd, 2J = 11.8 Hz, 3J = 
2.8 Hz, 1H, 5'-H), 0.93 (s, 9 H, C3'/C5'-O-Si(CH3)2(tBu)), 0.91 (s, 9 H, Si(CH3)2(tBu)), 0.12 - 0.18 (m, 12H, 
Si(CH3)2(tBu)). 13C-NMR (101 MHz, CDCl3, ppm): δ = 163.7 (4-C), 150.2 (2-C), 135.5 (C-6), 111.6 (5-C), 
92.3 (d, 1JC-F = 194.2 Hz, C-2'), 87.4 (d, 2JC-F = 33.5 Hz, C-1'), 84.5 (C-4'), 69.5 (d, 2JC-F = 15.8 Hz, C-3'), 
61.7 (C-5'), 26.0 (Si(C(CH3)3)), 25.7 (Si(C(CH3)3)), 18.5 (Si(C(CH3)3)), 18.2 (Si(C(CH3)3)), -4.7 (Si(CH3)2tBu), 
-5.1 (Si(CH3)2tBu), -5.3 (Si(CH3)2tBu), -5.3 (Si(CH3)2tBu). HRMS (ESI+): calc. for C22H39D3FN2O5Si2+ [M+H]+: 
492.2799, found: 492.2805. 
Nature Chemical Biology: doi:10.1038/nchembio.2531
 5-(D3)-methyl-2'-deoxy-2'-(R)-fluoro-5 -cytidine (18) 
 
39 (30 mg, 0.06 mmol, 1.0 eq) was dissolved in pyridine (1.0 mL) and 1,2,4-triazole (34 mg, 
0.49 mmol, 8.0 eq) and POCl3 (12 L, 0.12 mmol, 1.2 eq) were added at rt. The mixture was stirred 
for two hours and then poured into sat. NH4Cl (10 mL). The resulting aqueous phase was quickly 
extracted with EtOAc (10 mL), dried over Na2SO4 and the solvents removed in vacuo. The residue was 
redissolved in dioxane (3.0 mL) and NH4OH (25%, 1.0 mL) was added. After stirring at rt overnight, 
volatiles were removed in vacuo and the crude taken up in EtOAc (0.5 mL). Subsequently, 
HF pyridine (70% solution, 8 L, 0.32 mmol, 5.4 eq) and pyridine (12 L) were added stirred at room 
temperature overnight. HF pyridine was quenched through addition of TMSOMe (100 L) and the 
residue was finally purified by HPLC (0 --> 10% MeCN/H2O in 45 mins) to give 18 as a white powder. 
 
1H-NMR (400 MHz, D2O, ppm): δ = 7.54 (s, 1H, 6-H), 5.87 (dd, 3JH-F = 19.8 Hz, 3J = 1.2 Hz, 1H, 1'-H), 
5.00 (dd, 2JH-F = 53.0 Hz, 3J = 4.6 Hz, 1H, 2'-H), 4.23 (ddd, 3JH-F = 22.3 Hz, 3J = 8.9 Hz, 3J = 4.6 Hz, 1H, 3'-
H), 4.04-3.97 (m, 1H, 4'-H), 3.91 (dd, 2J = 13.0 Hz, 3J = 2.4 Hz, 1H, 5'-H), 3.72 (dd, 2J = 13.0 Hz, 3J = 4.3 
Hz, 1H, 5'-H). 13C-NMR (101 MHz, D2O, ppm): δ = 166.2 (C4), 157.0 (C2), 139.1 (C6), 104.4 (C5), 93.7 
(d, 1JC-F = 184.5 Hz, C2'), 89.7 (d, 2JC-F = 35.1 Hz, C1'), 82.1 (C4'), 67.8 (d, 2JC-F = 16.6 Hz, C3'), 59.8 (C5').  
HRMS (ESI+): calc. for C10H12D3FN2O4+ [M+H]+: 263.1229, found:263.1230. 
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1. Chemical Synthesis 
Unless  noted  otherwise,  all  reactions  were  performed  using  oven  dried  glassware  under  an 
atmosphere of nitrogen. Molsieve‐dried solvents were used from Sigma Aldrich and chemicals were 
bought  from  Sigma  Aldrich,  TCI,  Carbolution  and  Carbosynth.  Isotopically  labeled  trimethylamino 
glycine was obtained from Eurisotop. For extraction and chromatography purposes, technical grade 
solvents were distilled prior to their usage. Reaction controls were performed using TLC‐Plates from 
Merck (Merck 60 F254), flash column chromatography purifications were performed on Merck Geduran 
Si  60  (40‐63 PM).  Visualization  of  the  TLC  plates was  achieved  through  UV‐absorption  or  through 
staining  with  Hanessian's  stain.  NMR  spectra  were  recorded  in  deuterated  solvents  on  Varian 
VXR400S, Varian Inova 400, Bruker AMX 600, Bruker Ascend 400 and Bruker Avance III HD. HR‐ESI‐MS 
spectra were obtained from a Thermo Finnigan LTQ FT‐ICR. IR‐measurements were performed on a 
Perkin Elmer Spectrum BX FT‐IR spectrometer with a diamond‐ATR (Attenuated Total Reflection) unit. 
HPLC purifications were performed on a Waters Breeze system (2487 dual array detector, 1525 binary 
HPLC pump) using a Nucleosil VP 250/10 C18 column from Macherey Nagel. HPLC‐grade MeCN was 
purchased from VWR. For HPLC purifications of compounds 1a/b, 9a/b and 10a/b a buffer system of 
0.25 mM ammonium  formate  in H2O, pH = 4.3  (referred  to as buffer A)  and 0.25 mM ammonium 
formate in 80% MeCN/H2O (referred to as buffer B) was used. 
 
Synthesis of Hydroxylamine 1 and internal standards 9a/b and 10a/b 
(N‐Tritylaminooxy)acetic acid (6) 
 
(N‐Tritylaminooxy)acetic acid was synthesized according to Kojima et al.1 
 
N‐(prop‐2‐ene‐1‐yl)‐2‐((tritylamino)oxy)acetamide (7) 
 
N‐trityl protected aminooxyacetic acid 6 (2.50 g, 7.50 mmol, 1.0 eq) was suspended in DCM (40 mL) 
and was subsequently charged with TBTU (2.89 g, 9.00 mmol, 1.2 eq), DIPEA (1.60 mL, 9.00 mmol, 
1.2 eq) and propargylamine (1.40 mL, 22.6 mmol, 3.0 eq). The suspension was stirred at rt, whereupon 
S2 
 
after 15 hours a clear yellowish solution was formed. The mixture was diluted with EtOAc (300 mL), 
the organic phase was washed with NH4Cl (300 mL) and NaHCO3 (300 mL) and then dried over Na2SO4. 
Volatiles  were  finally  removed  in  vacuo  and  the  crude  mixture  was  purified  via  column 
chromatography (10% EtOAc ‐‐> 40% EtOAc/iHex). 7 (2.57g, 6.93 mmol, 92%) was yielded as a colorless 
solid. 
 
1H‐NMR (300 MHz, CDCl3): G/ppm = 7.37−7.22 (m, 15H, (C6H5)3C), 6.59 (s, 1H, (C6H5)3C‐NH‐O), 5.81 (bs, 
1H, O=C‐NH), 4.25 (s, 2H, O‐CH2C=O), 3.85 (dd, 3J = 5.5 Hz, 4J = 2.6 Hz, 2H, HN‐CH2), 2.15 (t, 4J = 2.6 Hz, 
1H, C≡C‐H). 13C‐NMR (75 MHz, CDCl3): G/ppm = 169.1 (C=O), 143.9 (3C, 3 ×O‐NH‐C‐C), 129.0 (6C, CAr‐
H), 128.2 (6C, CAr‐H), 127.4 (3C, Ctert‐H), 79.3 (C≡C‐H), 74.6 (C(C6H5)3), 73.4 (O‐CH2), 71.7 (C≡C‐ H), 28.8 
(NH‐CH2). HRMS (ESI+): calc. for C24H22N2NaO2 [M+Na]+: 393.1573; found: 393.1571. IR (ATR): ߥ෤ (cm‐1) 
= 3288 (w), 3222 (w), 3056 (w), 2913 (w), 2359 (w), 2339 (w), 1635 (m), 1542 (m), 1489 (m), 1065 (m), 
996 (m), 763 (m), 747 (m), 707 (s), 697 (s), 685 (s), 627 (s). Melting Range: 157 ‐ 158 °C.  
 
2‐((4‐Azidophenyl)amino‐N,N,N‐trimethyl‐2‐oxoethaneaminium chloride (4a) 
 
Betaine 3a (0.30 g, 2.56 mmol, 1.0 eq) was first dried on high vac at 180 °C for 20 minutes. After cooling 
to rt,  the colorless solid was suspended  in DMF (25 mL). 4‐Azidoanilin hydrochloride 2  (0.54g, 3.17 
mmol, 1.2 eq), TBTU (0.99 g, 3.07 mmol, 1.2 eq) and DIPEA (1.10 mL, 6.32 mmol, 2.4 eq) were added 
whereupon a yellow brownish solution formed gradually. After stirring for one hour at rt all solids were 
dissolved and the reaction was further stirred at rt over night. DMF was then removed in vacuo and 
the crude mixture was purified by column chromatography (DCM/MeOH/H2O/7N NH3 in methanol = 
90:10:0.6:0.6)  and  4a was  yielded  as  the  corresponding  phenyl  triazolate  salt.  The  salt  was  then 
redissolved in H2O (50 mL) and was acidified to pH = 1. The aqueous phase was extracted with Et2O 
until TLC analysis of  the organic phase  fractions showed no UV absorption. The aqueous  layer was 
subsequently neutralized with conc. NH3 and  the chloride salt of 4a  (0.62 g, 2.30 mmol, 90%) was 
yielded as a brownish powder. 
 
1H‐NMR (300 MHz, dmso d6): G/ppm = 11.22 (s, 1H, NH), 7.69 (d, 3J = 8.9 Hz, 2H, CH=C‐NH), 7.12 (d, 3J 
= 8.4 Hz, 2H, CH=C‐N3), 4.42 (s, 2H, CH2), 3.30 (s, 9H, N(CH3)3). 13C‐NMR (101 MHz, dmso d6): G/ppm = 
162.0 (C=O), 135.0 (NH‐C=CH), 134.9 (N3‐C=CH), 121.2 (2C, NH‐C=CH), 119.5 (2C, N3‐C=CH), 64.3 (CH2), 
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53.4 (3C, N(CH3)3). HRMS (ESI+): calc. for C11H16N5O+ [M+]: 234.1349; found: 234.1348. IR (ATR): ߥ෤ (cm‐
1) = 3348 (w), 2983 (w), 2118 (s), 2083 (m), 1692 (s), 1676 (m), 1615 (m), 1549 (m), 1508 (s), 1287 (s), 
1256 (m), 1050 (s), 1038 (s), 922 (s), 833 (s). Melting Range: 144 ‐ 146 °C.  
 
N,N,N‐trimethyl‐2‐oxo‐2‐((4‐(4‐((2‐((tritylamino)oxy)acetamido)methyl)‐1H‐1,2,3‐triazole1‐yl)phe‐
nyl)amino)ethanaminium chloride/bromide (8a) 
 
First, a mixture of DCM and H2O (à 5 mL) was freeze‐pump‐thaw degassed (3x) and then azide 4a (0.18 
g, 0.65 mmol, 1.0 eq), alkyne 7 (0.24 g, 0.65 mmol, 1.0 eq) and CuBrxSMe2 (40 mg, 0.20 mmol, 0.3 eq) 
were added. The suspension was stirred vigorously over night at rt whereupon a colorless emulsion 
formed.  The  mixture  was  then  concentrated  under  reduced  pressure  and  purified  by  column 
chromatography using a short plug of silica (DCM/MeOH/H2O/7N NH3 in methanol = 80:20:0.6:0.6). 8a 
was yielded as a slightly yellow brownish solid (0.32 g, 0.50 mmol, 77%). 
 
1H‐NMR (300 MHz, dmso d6): G/ppm = 11.67 (s, 1H, NH‐C6H4), 8.55 (s, 1H, CH2‐C=CH‐N), 8.34 (s, 1H, 
Ph3C‐NH), 8.32 (t, 3J = 5.8 Hz, 1H, O=C‐NH‐CH2), 7.91–7.84 (m, 4H, C6H4), 7.34–7.19 (m, 15H, C(C6H5)3), 
4.53 (s, 2H, (CH2‐N(CH3)3), 4.45 (d, 3J = 5.8, 2H, NH‐CH2), 3.85 (s, 2H, N‐O‐CH2), 3.33 (s, 9H, N(CH3)3). 
13C‐NMR  (101 MHz,  dmso  d6):  G/ppm  =  169.7  (O=C‐NH‐CH2),  162.4  (O=C‐CH2‐N),  146.0  (CH2‐C=C), 
144.1  (3C,  O‐NH‐C‐C),  138.1  (N‐C=CH‐CH),  132.6  (N‐C=CH‐CH),  128.9  (6C, CAr‐H),  127.6  (6C, CAr‐H), 
126.7 (3C, C‐H), 121.0 (CH2‐C=CH‐N), 120.5 (4C, N‐C=CH‐CH=C‐N), 73.7 (C(C6H6)3), 73.2 (O‐CH2), 64.4 
(CH2‐N(CH3)3), 53.4 (N(CH3)3), 33.8 (NH‐CH2). HRMS (ESI+): calc. for C35H38N7O3+ [M+]: 604.3031; found: 
604.3026. IR (ATR): ߥ෤ (cm‐1) = 3387 (w), 3054 (w), 2923 (w), 1685 (m), 1613 (m), 1558 (m), 1519 (s), 
1490 (m), 1446 (m), 1413 (m), 1312 (m), 1265 (m), 1224 (m), 1192 (m), 1085 (m), 1045 (m), 1002 (m), 
990 (m), 948 (m), 922 (m), 876 (m), 838 (m), 757 (s), 698 (s), 627 (s). Melting Range: 142 ‐ 152 °C.  
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2‐((4‐(4‐((2‐(Aminooxy)acetoamido)methyl)‐1H‐1,2,3‐triazole‐1‐yl)phenyl‐amino)‐N,N,N‐trimethyl‐
2‐oxoethanaminium formate (1a) 
 
Trityl protected compound 8a (0.24g, 0.38 mmol) was dissolved in DCM (6 mL) and then 6M HCl (6 mL) 
was added. The mixture was rigorously stirred at rt for one hour until a phase separation was visible. 
The aqueous phase was then extracted with DCM (5 x 5mL) until TLC analysis of the organic phase 
fractions showed no UV absorption. The pH was adjusted to 9‐10 using 2M NH3 and the aqueous phase 
was removed in vacuo. 75 mg of 1a were then further purified by preparative HPLC (0% ‐‐> 20% buffer 
B) and yielded 23 mg (0.05 mmol, 26%) of 1a as the colorless formate salt. 
 
1H‐NMR (400 MHz, D2O): G/ppm = 8.40 (s, 1H, CH2‐C=CH‐N), 8.21 (s, 1H, HCOO), 7.58 (d, 3J = 9.2 Hz, 
2H, CH‐CH=C‐N3), 7.52 (d, 3J = 9.2 Hz, 2H, CH‐CH=C‐NH), 4.53 (s, 2H, N‐O‐CH2), 4.27 (s, 2H, NH‐CH2), 
4.22 (s, 2H, CH2‐N(CH3)3), 3.36 (s, 9H, N(CH3)3). 13C‐NMR (101 MHz, D2O): G/ppm = 169.7 (O=C‐NH‐
CH2), 162.4 (O=C‐CH2‐N), 146.0 (CH2‐C=C), 144.1 (3C, O‐NH‐C‐C), 138.1 (N‐C=CH‐CH), 132.6 (N‐C=CH‐
CH), 128.9 (6C, CAr‐H), 127.6 (6C, CAr‐H), 126.7 (3C, C‐H), 121.0 (CH2‐C=CH‐N), 120.5 (4C, N‐C=CH‐CH=C‐
N), 73.7 (C(C6H6)3), 73.2 (O‐CH2), 64.4 (CH2‐N(CH3)3), 53.4 (N(CH3)3), 33.8 (NH‐CH2). HRMS (ESI+): calc. 
for C16H24N7O3+ [M+]: 362.1935; found: 362.1935. IR (ATR): ߥ෤ (cm‐1) = 3130 (m), 3037 (s), 2807 (m), 2649 
(m), 2363 (w), 1684 (s), 1610 (m), 1556 (s), 1517 (s), 1487 (m), 1475 (m), 1442 (m), 1403 (s), 1312 (m), 
1262 (m), 1193 (m), 1128 (w), 1083 (w), 1048 (m), 991 (m), 967 (w), 921 (s), 837 (s). 
 
N,N,N‐Trimethyl‐2‐oxo‐2‐((4‐(4‐((2‐((((3S,4R)‐3,4,5‐trihydroxypentyliden)amino)oxy)acet‐amido)‐
methyl)‐1H‐1,2,3‐triazol‐1‐yl)phenyl)amino)ethanaminium formate (9a) 
 
1a (50.0 mg, 0.12 mmol, 1‐0 eq) and 2'‐desoxyribose (182 mg, 1.36 mmol, 11.8 eq) were dissolved in 
H2O (2.7 mL) and incubated over night at 30 °C and 1400 rpm in a Eppendorf Comfort thermomixer. 
The mixture was filtered over a 0.2 Pm syringefilter and was subsequently purified by HPLC twice (0 → 
15%  buffer  B).  Pure  product  9a  (9.1  mg,  17  Pmol,  15%) was  obtained  as  a  colorless  foam.  The 
compound was present as a mixture of E/Z isomers in aqueous solution that were not assigned. 
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1H‐NMR (600 MHz, D2O): G/ppm = 8.46 (s, 1H, HCOO), 8.34 (s, 1H, CH2‐C=CH‐N), 7.79 (d, J=9.0 Hz, 2H, 
CH‐CH=C‐N3), 7.74 ‐ 7.71 (m, 8H, CH‐CH=C‐NH, C1 ́‐HA), 7.08 (t, 3J = 5.4 Hz, 1H, C1 ́‐HB), 4.67 (s, 2H, N‐
O‐CH2B), 4.63 (s, 2H, NH‐CH2), 4.62 (s, 2H, N‐O‐ CH2A), 4.35 (s, 2H, CH2‐N(CH3)3), 3.92–3.87 (m, 1H, C3 ́‐
HB), 3.85 ‐ 3.80 (m, 1H, C3 ́‐HA), 3.78–3.69 (m, 1H, C5 ́‐H), 3.66–3.53 (m, 2H, C5 ́‐H, C4 ́‐H), 3.42 (s, 9H, 
N(CH3)3), 2.79–2.69 (m, 2H, C2 ́‐HB), 2.58 ‐ 2.54 (m, 1H, C2 ́‐HA), 2.41 ‐ 2.35 (m, 1H, C2 ́‐HA). 13C‐NMR 
(150 MHz, D2O): G/ppm = 172.4 (O=C‐NH‐CH2), 170.9 (HCOO), 162.7 (O=C‐CH2‐N), 153.5 (C1 ́A), 153.1 
(C1 ́B),  145.1  (CH2‐C=C),  136.8  (N‐ C=CH‐CH),  133.5  (N‐C=CH‐CH),  122.5  (2C, CH=C‐NH),  122.3  (CH2‐
C=CH‐N), 121.9 (2C, CH=C‐N3), 74.2 (C4 ́), 74.0 (C4 ́), 71.7 (N‐O‐CH2B), 71.5 (N‐O‐CH2A), 69.0 (C3 ́A), 68.8 
(C3 ́B), 65.1 (CH2‐N(CH3)3), 62.3 (C5 ́), 54.3 (N(CH3)3), 34.1 (NH‐CH2), 32.4 (C2 ́A), 29.2 (C2 ́B). HRMS (ESI+): 
calc. for C21H32N7O6+ [M]+: 478.2409; found: 478.2404. 
 
(S,E)‐3‐(2,2‐Dimethyl‐1,3‐dioxolan‐4‐yl)acrylaldehyde (12) 
 
Methyl (2E)‐3‐[(4S)‐2,2‐dimethyl‐1,3‐dioxolan‐4‐yl]prop‐2‐enoate 11 (0.20 g, 1.08 mmol, 1.0 eq) was 
dissolved in DCM (2.0 mL) and cooled to –78 °C. DIBAL‐H (2.20 mL, 2M in toluene, 2.1 eq) was added 
and the yellowish mixture was slowly warmed to rt. After 90 minutes, DCM (5.0 mL) and H2O (4.0 mL) 
and NaOH (2M, 2.0 mL) were added. After stirring for an additional hour at rt, the organic phase was 
separated from the aqueous and dried over Na2SO4. Volatiles were removed under reduced pressure 
and the allylic alcohol was isolated in quantitative yield and used without further purification.  
1H‐NMR (400 MHz, CDCl3): G/ppm = 5.88 (dt, 3J = 15.4 Hz, 4J = 5.0 Hz, 1H, 5′‐H) 5.65 (dd, 3J = 15.6 Hz, 4J 
= 7.6 Hz, 1H, 5′‐H), 4.47 (q, 3J = 7.3 Hz, 1H, 4′‐H), 4.08 (d, 3J = 5.1 Hz, 2H, 1′‐H), 4.30 (dd, 3J = 8.2 Hz, 4J = 
6.1 Hz, 1H, 3′‐H), 3.53 (t, 3J = 7.9 Hz, 1H, 2′‐H), 2.34 (br s, 1H, CH2‐OH), 1.36 (s, 3H, O‐C(CH3)(CH3)‐O), 
1.32 (s, 3H, O‐C(CH3)(CH3)‐O). 
The allylic alcohol was dissolved in DCM (2.0 mL), cooled to 0 °C and was charged with Dess‐Martin‐
periodinan (0.45 g, 1.08 mmol, 1.0 eq). The milky suspension was slowly warmed to rt and stirred over 
night. After the addition of saturated Na2SO4 (10 mL) and a solution of Na2S2O3 (171 mg, dissolved in 
10 mL H2O), the mixture was extracted with DCM (3 x 15 mL) and dried over Na2SO4. Organic solvents 
were  removed  in  vacuo  and  the  crude  mixture  was  purified  via  column  chromatography  (2.5% 
MeOH/DCM). Aldehyde 12 (80 mg, 0.51 mmol, 47%) was isolated as a colorless oil. 
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1H‐NMR (400 MHz, CD2Cl2): G/ppm = 9.50 (d, 3J = 7.6 Hz, 1H, 1′‐CHO), 6.70 (dd, 3J = 15.6 Hz, 4J = 5.3 Hz, 
1H, 3′‐H), 6.23 (dt, 3J = 15.6 Hz, 4J = 5.8 Hz, 1H, 2′‐H), 4.73 (q, 3J = 6.8 Hz, 1H, 4′‐H), 4.18 (dd, 3J = 8.4Hz, 
4J = 6.8Hz, 1H, 5′‐H), 3.67 (dd, 3J = 8.4Hz, 4J = 6.8Hz, 1H, 5′‐H), 1.39 (s, 3H, O‐C(CH3)(CH3)‐O), 1.35 O‐
C(CH3)(CH3)‐O).  13C‐NMR (101 MHz, CD2Cl2): G/ppm = 193.0  (‐CHO), 153.4  (3′‐C), 132.1  (2′‐C), 110.3 
(Cquart),  74.9  (4′‐C),  68.7  (5′‐C),  26.2  (O‐C(CH3)(CH3)‐O),  25.4  (O‐C(CH3)(CH3)‐O). HRMS  (EI):  calc.  for 
C8H11O3x [M ‐ H] x: 155.0708; found: 155.0707. 
 
2‐((4‐(4‐((2‐((((1E,2E)‐3‐((S)‐2,2‐Dimethyl‐1,3‐dioxolane‐4‐yl)allylidene)‐amino)oxy)acetamido)me‐
thyl)‐1H  ‐1,2,3‐triazole‐1‐yl)phenyl)amino)‐N  ,N  ,N  ‐trimethyl‐2‐oxoethane‐1‐  aminium  formate 
(10a)  
 
Aldehyde 12 (20 mg, 0.13 mmol, 9.0 eq) and hydroxylamine 1a were dissolved in a 1:1 mixture of H2O 
and CHCl3 (à 2.5 mL) and stirred at rt. The course of the reaction was monitored by HPLC (0 ‐‐> 30% 
buffer B) whereas  it was determined  that after one hour  the reaction was complete. The aqueous 
phase was then washed with DCM (3 x 10 mL) and concentrated in vacuo. 13a (5.10 mg, 9.50 Pmol, 
68%) was yielded as a brownish viscous oil that was used without further purification. 
1H‐NMR (400 MHz, D2O): G/ppm = 8.31 (s, 1H, HCOO), 8.12 (s, 1H, CH2‐C=CH‐N), 7.84 (d, 1H, 1′‐H), 7.59 
− 7.53 (m, 4H, CH‐CH=C‐N3, CH‐CH=C‐NH), 6.20 − 6.03 (m, 2H, 2′ + 3′‐H’s), 4.54 − 4.52 (m, 1H, 4′‐H), 
4.50 (s, 2H, N‐O‐CH2), 4.47 (s, 2H, NH‐CH2), 4.20 (s, 2H, CH2‐N(CH3)3), 4.02 − 3.98 (m, 1H, 5′‐H), 3.45 − 
3.50 (m, 1H, 5′‐H), 3.27 (s, 9H, CH2‐N(CH3)3), 1.26 (s, 3H, O‐C(CH3)(CH3)‐O), 1.24 (s, 3H, O‐C(CH3)(CH3)‐
O). HRMS (ESI+): calc. for C24H34N7O5+ [M+]: 500.2616; found: 500.2617. 
For the deprotection of the acetonide, 13a (4.00 mg, 7.50 Pmol, 1.0 eq) was dissolved in MeOH and 
PTSA x H2O (1.40 mg, 7.50 Pmol, 1.0 eq) was added. The mixture was incubated in a Eppendorf comfort 
thermomixer (1300 rpm, 25 °C) over night and the solvent was removed in vacuo by lyophylization. 
The crude product was finally purified by semi preparative HPLC (0 ‐‐> 35% buffer B in 45 minutes) and 
pure 10a was yielded as a colorless foam.  
1H‐NMR (400 MHz, D2O): G/ppm = 8.53 (s, 1H, HCOO), 8.30 (s, 1H, CH2‐C=CH‐N), 8.01 (s, d, 3J = 8.9 Hz, 
1H, 1′‐H), 7.78 − 7.70 (m, 4H, CH‐CH=C‐N3, CH‐CH=C‐NH), 6.31 − 6.32 (m, 2H, 2′ + 3′‐H’s), 4.63 (s, 2H, N‐
O‐CH2), 4.62 (s, 2H, NH‐CH2), 4.35 − 4.32 (m, 3H, CH2‐N(CH3)3 + 4′‐H), 3.61 (dd, 1J = 11.7 Hz, 3J = 4.4, 1H, 
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5′‐H), 3.51 (dd, 1J = 11.7 Hz, 3J = 6.5, 1H, 5′‐H), 3.22 (s, 9H, CH2‐N(CH3)3). 13C‐NMR (101 MHz, D2O): 
G/ppm = 172.3 (O=C‐NH‐CH2), 170.9 (HCOO), 162.7 (O=C‐CH2‐N), 153.7 (1′‐C), 144.5 (CH2‐C=C), 142.8 
(3′‐C), 136.9 (N‐C=CH‐CH), 133.6 (N‐C=CH‐CH), 123.0 (2′‐C), 122.5 (2C, CH=C‐NH), 122.3 (CH2‐C=CH‐N), 
122.0 (2C, CH=C‐N3), 72.0 (N‐O‐CH2) 71.6 (4′‐C), 64.4 (5′‐C), 65.1 (CH2‐N(CH3)3), 54.3 (N(CH3)3), 34.1 (NH‐
CH2). HRMS (ESI+): calc. for C21H30N7O5+ [M]+: 460.2303; found: 460.2305. 
 
2‐((4‐Azidophenyl)amino‐N,N,N‐tri(methyl‐d3)‐2‐oxoethaneaminium chloride (4b) 
 
4b was synthesized analogously to 4a except that [d11]‐betaine (98% deuterium, Euriso‐Top GmbH) 
was used to  introduce isotopic  labels. Deuterium labels from the methylene group were not stable 
under  the  reaction  conditions  and  a  complete  D/H  exchange  was  observed.  Thus,  a  [d9]‐labeled 
product was obtained. 
1H‐NMR (600 MHz, D2O): G/ppm = 7.39 (d, 3J=8.6, 2H, CH‐CH=C‐NH), 7.04 (d, 3J=8.5, 2H, CH‐CH=C‐N3), 
4.18 (s, 2H, CH2). 13C‐NMR (150 MHz, D2O, ppm): G/ppm = 162.7 (C=O), 137.5 (NH‐C=CH), 132.5 (N3‐
C=CH), 123.5 (2C, NH‐C=CH), 119.6 (2C, N3‐C=CH), 65.0 (CH2). HRMS (ESI+): calc. for C11H7D9N5O+ [M]+: 
243.1914; found: 243.1916. 
 
2‐((4‐(4‐((2‐(Aminooxy)acetoamido)methyl)‐1H‐1,2,3‐triazole‐1‐yl)phenyl‐amino)‐N,N,N‐tri(methyl‐ 
d3)‐2‐oxoethanaminium formate (1b) 
 
Isotopologue 1b was synthesized according to 1a with the slight modification that the trityl protected 
intermediate 8b was not isolated and deprotected without further purification. 
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N,N,N‐Tri(methyl‐d3)‐2‐oxo‐2‐((4‐(4‐((2‐((((3S,4R)‐3,4,5‐trihydroxypentyliden)amino)oxy)acet‐
amido)‐methyl)‐1H‐1,2,3‐triazol‐1‐yl)phenyl)amino)ethanaminium formate (9b) 
 
Internal standard 9b was synthesized analogously to 9a, whereupon a mixture of (E)/(Z)‐isomers was 
obtained (depicted as A and B). 
1H‐NMR (600 MHz, D2O): G/ppm = 8.46 (s, 2H, HCOO), 8.35 (s, 1H, CH2‐C=CH‐N), 7.81 (d, 3J = 7.5 Hz, 
2H, CH‐CH=C‐N3), 7.75 ‐ 7.73 (m, 8H, CH‐CH=C‐NH, C1 ́‐HA), 7.08 (t, 3J = 5.4 Hz, 0.1H, C1 ́‐HB), 4.67 (s, 
2H, N‐O‐CH2B), 4.64 (s, 2H, NH‐CH2), 4.62 (s, 2H, N‐O‐CH2A), 4.34 (s, 2H, CH2‐N(CH3)3), 3.93–3.87 (m, 1H, 
C3 ́‐HB), 3.86–3.79 (m, 1H, C3 ́‐HA), 3.78–3.69 (m, 1H, 1x C5 ́‐H2), 3.67–3.53 (m, 2H, 1x C5 ́‐H2, C4 ́‐H), 
2.80–2.68 (m, 2H, C2 ́‐H2B), 2.59 ‐ 2.54 (m, 1H, C2 ́‐HA), 2.43–2.34 (m, 1H, C2 ́‐HA). 13C‐NMR (150 MHz, 
D2O, ppm): G/ppm = 172.4 (O=C‐NH‐CH2), 170.9 (HCOO), 162.8 (O=C‐CH2‐N), 153.5 (C1 ́A), 153.1 (C1 ́B), 
145.1 (CH2‐C=C), 136.8 (N‐C=CH‐CH), 133.6 (N‐C=CH‐CH), 122.6 (2C, CH=C‐NH), 122.4 (CH2‐C=CH‐N), 
122.0 (2C, CH=C‐N3), 74.2 (C4 ́), 74.0 (C4 ́), 71.7 (N‐O‐CH2B), 71.5 (N‐O‐CH2A), 69.0 (C3 ́A), 68.8 (C3 ́B), 
64.9 (CH2‐N(CD3)3), 62.3 (C5 ́), 53.3 (N(CD3)3), 34.1 (NH‐CH2), 32.4 (C2 ́A), 29.2 (C2 ́B). HRMS (ESI+): calc. 
for C21H23D9N7O6+ [M]+: 487.2973; found: 487.2967. 
 
2‐((4‐(4‐((2‐((((1E,2E)‐3‐((S)‐2,2‐Dimethyl‐1,3‐dioxolane‐4‐yl)allylidene)‐amino)oxy)acetamido)me‐
thyl)‐1H ‐1,2,3‐triazole‐1‐yl)phenyl)amino)‐N ,N ,N ‐tri(methyl‐d3)‐2‐oxoethane‐1‐ aminium formate 
(10b)  
 
10b was synthesized according to 10a. 
1H‐NMR (800 MHz, D2O): G/ppm = 8.47 (s, 1H, HCOO), 8.32 (s, 2H, CH2‐C=CH‐N), 8.02 (d, 3J = 9.4 Hz, 1H, 
1′‐H), 7.80 − 7.71 (m, 4H, CH‐CH=C‐N3, CH‐CH=C‐NH), 6.34 − 6.26 (m, 2H, 2′ + 3′‐H’s), 4.65 (s, 2H, N‐O‐
CH2), 4.63 (s, 2H, NH‐CH2), 4.35 ‐ 4.32 (m, 3H, CH2‐N(CH3)3 + 4′‐H), 3.63 (dd, 1J = 11.7 Hz, 3J = 4.4, 1H, 5′‐
H), 3.53 (dd, 1J = 11.7 Hz, 3J = 6.5, 1H, 5′‐H). 13C‐NMR (150 MHz, D2O): G/ppm = 172.3 (O=C‐NH‐CH2), 
170.9 (HCOO), 162.8 (O=C‐CH2‐N), 153.7 (1′‐C), 145.2 (CH2‐C=C), 142.8 (3′‐C), 136.9 (N‐C=CH‐CH), 133.6 
(N‐C=CH‐CH), 123.0 (2′‐C), 122.5 (2C, CH=C‐NH), 122.3 (CH2‐C=CH‐N), 122.0 (2C, CH=C‐N3), 72.1 (N‐O‐
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CH2) 71.6 (4′‐C), 64.4 (5′‐C), 65.1 (CH2‐N(CH3)3), 53.3 (N(CD3)3), 34.1 (NH‐CH2). HRMS (ESI+): calc. for 
C21H21D9N7O5+ [M]+: 469.2868; found: 469.2874. 
 
2. Cell Culture and Transfection Procedures 
DMEM  high  glucose  containing  10%  FBS  (PAN  Biotech),  2 mM  L‐glutamine,  100 U/mL  penicillin, 
100 μg/mL streptomycin, 1x MEM Non‐essential Amino Acid Solution and 0.1 mM β‐mercaptoethanol 
(Sigma Aldrich) was used as basal medium for mESC cultures. The mESC lines were maintained in naïve 
state on gelatin coated plates by supplementing basal medium with 1000 U/mL LIF  (ORF Genetics), 
3.0 µM GSK3 inhibitor CHIR99021 and 1.0 µM Mek inhibitor PD0325901 (2i; Selleckchem). Metabolic 
labelling experiments with isotope‐labeled nucleosides were performed by plating mESCs in priming 
conditions consisting of basal mESC medium supplemented with 1000 U/mL LIF. Labeled nucleosides 
(B.A.C.H. UG) were added to the culture medium at the following concentrations: dG* [13C1015N5] at a 
concentration of 100 µM for three days, followed by treatment with 200 µM labeled dG* for two days; 
dC* [13C915N3] and dT* [13C1015N2] was used at a concentration of 100 µM for five days. J1 wild type 
mESCs were obtained from the 129S4/SvJae strain and Dnmt TKO J1 mESCs were described in Li et al. 
and Tsumura et al.2‐3 The Tdg wild type and the Tdg KO cell lines were reported in Cortazar et al.4 
 
HEK293T cells were cultured in RPMI‐1640 medium containing 10% FBS, 2 mM L‐glutamine, 100 U/ml 
penicillin, 100 μg/ml streptomycin. ENC1 neural stem cells were cultured as previously described.5 
 
2.1 Ape1 Inhibition  
a) For treatment with the Ape1 inhibitor CRT0044876 (Sigma‐Aldrich), mESCs were cultured for three 
days in priming conditions, passaged and re‐plated in priming medium containing 100 µM CRT0044876 
for 48 or 60 h. After 24 h fresh medium containing the inhibitor was added and DMSO was used as 
vehicle control. b) Wild type and Dnmt TKO mESCs were cultured for three days in priming medium 
containing 100 µM dC*, passaged and re‐plated under priming conditions with the addition of 100 µM 
CRT0044876 (Sigma‐Aldrich) and 100 µM dC* for 48 h. After 24 h fresh medium containing the inhibitor 
and 100 µM dC* was added. DMSO was used as vehicle control. 
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Figure S1: AP‐sites after inhibition of Ape1. (A) A/A* ratios of labeled AP‐sites in wild type and Dnmt TKO mESCs were over 
the LOD but below the LLOQ. (B) Quantification of unlabeled AP‐sites of the dC* feeding experiment show an increase by 
treatment with the inhibitor CRT0044876. 
2.2 Ape1 Knockdown 
mESCs were cultured under priming conditions for three days, passaged and transfected with Apex1 
Mission®esiRNA (purchased from Sigma‐Aldrich) at 50 nM using Lipofectamine 2000 according to the 
manufacturer. The medium was changed after 24 h and cells were harvested 48 h post transfection. 
For qPCR analysis a second independent knockdown experiment was performed. 
 
2.3 Cell lysis and DNA isolation 
Isolation of genomic DNA was achieved using the QIAamp DNA Mini Kit from Qiagen. All mESC samples 
were washed with PBS (Sigma) and directly lysed in the plates by adding G2 buffer containing 400 µM 
of  2,6‐di‐tert‐butyl‐4‐methylphenol  (BHT)  and desferoxamine mesylate  (DM). DNA was  sheered by 
bead milling in a microfuge tube using one 5 mm diameter stainless steel bead per tube and MM400 
bead mill  (Retsch)  at  30  Hz  for  one minute  and  subsequent  centrifugation  at  15000  rpm  for  ten 
minutes.  Depending  on  the  amount  of  genomic  DNA  to  isolate,  the  cell  lysate  was  treated  with 
proteinase K (25 PL for genomic tips 20G or 100 PL for genomic tips 100G) and RNase A (2.0 PL/20G, 
10 PL/100G) at 50 °C for one hour. After 30 minutes, additional RNase A (2.0 PL or 10 PL, respectively) 
was added to the mixture. Genomic tip columns were then equilibrated with QBT loading buffer (1.0 
mL/20G or 4.0 mL/100G) and then the lysate, which was vortexed for one minute, was applied on the 
columns. After the entire liquid had entered the column, washing steps were carried out with QC buffer 
(2.0 mL/20G or 2x7.5 mL/100G) and the genomic DNA was finally eluted with QF buffer (2.0 mL/20G 
or  5.0  mL/100G)  supplemented  with  400 µM  BHT.  Precipitation  was  then  achieved  through  the 
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addition of i‐PrOH (1.4 mL/20G or 3.5 mL/100G, 70% Vol) and the resulting genomic DNA pellet was 
centrifuged (15 minutes, 6000 g, 4 °C). The supernatant was discarded, washing steps were carried out 
using 70% EtOH (5.0 mL, 15 minutes, 6000 g, 4 °C). Finally, the pure DNA pellet was resuspended in 1.0 
mL 70% EtOH and centrifuged (10 minutes, 15000 rpm, 4 °C). Next, the supernatant was removed and 
the pellet was  re‐dissolved  in ddH2O  (50  ‐  100 PL) with 20 µM BHT.  The  concentration was  finally 
determined with a NanoDrop (ND 1000, Peqlab). 
 
2.4 Artificial Generation of AP‐Sites 
Salmon sperm DNA (à 5.0 ug, Sigma Aldrich) was heated in a 10 mM sodium citrate buffer (pH = 5.0) 
for three and ten minutes at 70 °C, respectively. The mixture was subsequently neutralized to pH = 7.5 
using 0.2 mM NaOH and then derivatized and quantified as described before. The data shows that 
harsh conditions need to be applied in order to generate AP‐sites artificially. 
 
 
Figure S2: Artificial generation of AP‐sites under harsh conditions. 
 
2.5 Re‐Isolation of wtJ1 mESC DNA 
Reisolation of genomic DNA was performed by adding 30 Pg of DNA to 3200 PL of G2 buffer. The DNA 
containing lysis buffer was applied to a pre‐equilibrated 20G column and DNA isolation was performed 
as described (see cell lysis and DNA isolation). This experiment shows that the isolation procedure does 
not introduce Eelimination product artificially. 
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Figure S3: A/A* ratios of AP‐ and EE‐sites normalized by dG. The DNA of wild type mESCs shows similar values of the BER 
intermediates before and after reisolation. 
2.6 Quantification of AP‐ and EE‐Sites in Different Cell Lines 
 
Figure S4: Quantification of AP‐ and EE‐intermediates in wild type mESCs, ENC1 neural stem cells and somatic HEK293T cells 
shows similar values for the BER intermediates in all three cell lines. The quantification results of one biological replicate is 
depicted. 
2.7 RNA Isolation and Real‐Time Quantitative Polymerase Chain Reaction (qPCR) 
At 48 h post‐transfection, total RNA was isolated with the peqGOLD Total RNA Kit (PeqLab) according 
to the manufacturer’s instructions. Prior to the qPCR, 1 µg of RNA was transcribed to 1 µg of cDNA 
using  the  iScript  cDNA  Synthesis  Kit  (Bio‐Rad)  according  to  the  manufacturer.  The  final  cDNA 
concentration was 50 ng/µL. To 10 µL of iTaq Universal SYBR Green Supermix (Bio‐Rad) 2 µL of cDNA 
were  added  per  reaction.  For  each  primer  pair,  the  forward  and  the  reverse  primer  were mixed 
together in equal amounts and diluted with nuclease‐free ddH2O to a final concentration of 1.25 µM. 
12 µL of cDNA/iTaq mastermix and 8 µL of primer mix were added per well. Each sample was measured 
in triplicates on a MasterCycler RealPlex (Eppendorf) with the following PCR conditions: Step 1 95 °C 
(2:00 minutes), Step 2 95 °C (0:15 minutes), Step 3 55 °C (0:15 minutes), Step 4 72 °C (0:20 minutes); 
Step 2 – 4 were repeated 40 times. 
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Ape1 forward primer: 5’‐GGTCAGCTCCGTCAGACAAA‐3’ 
Ape1 reverse primer: 5’‐TCGGAAGGCTTCATCCCAAC‐3’ 
Alpha‐tubulin forward primer: 5’‐TGTGGATTCTGTGGAAGGCG‐3’ 
Alpha‐tubulin reverse primer: 5’‐AGCACACATTGCCACATACAAA‐3’ 
 
 
Figure  S5:  Relative mRNA  expression  levels  show  an  estimated  knockdown  efficiency  of  about  50%  using  Ape1  (Apex1) 
esiRNA. As housekeeping reference gene alpha‐tubulin was used. 
 
3. Quantification of Abasic Sites 
3.1 Derivatization of Genomic DNA with 1a 
Derivatization of abasic sites (5.0 Pg for unlabeled gDNA, 20 Pg for labeled gDNA) with 1 was carried 
out in a total volume of 20 PL, whereas the solution was buffered with HEPES (20 mM, pH = 7.5) and 
Na2EDTA  (0.1  mM).  A  stock  of  1a  in  H2O  (23.8  mM)  was  added  to  the  buffered  solution  (final 
concentration of 1a = 1.5 mM) and the reaction was started by vortexing the mixture for 5 seconds. 
The gDNA was incubated for 40 minutes at 37 °C/1400 rpm in an Eppendorf Comfort thermomixer. The 
reaction was stopped via addition of 1‐naphthylaldehyde (66.7 PL, 2M in i‐PrOH) to quench excess of 
1a and incubated again for 10 minutes at 37 °C/1400 rpm. Derivatized DNA was then precipitated via 
addition of NaOAc (3.3 PL, 3M), vortexing and incubation at 37 °C/1400 rpm for another 5 minutes. 
After absolute i‐PrOH (66.7 PL) was added, the tubes were inverted several times and then centrifuged 
(60 minutes, 10 °C, 15000 rpm). The supernatant was removed and washing steps were carried out 
(1x75% i‐PrOH, 10 °C, 15000 rpm ,30 minutes; 2x75% cold EtOH, 4 °C, 15000 rpm, 30 minutes), whereas 
after each washing step the supernatant was carefully removed. The resulting DNA pellet was finally 
re‐dissolved in 35 PL of ddH2O and then enzymatically digested to the nucleoside level. 
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3.2 Enzymatic Digestion of Derivatized Genomic DNA 
For enzymatic digestion, genomic DNA (5.0 µg for unlabeled gDNA or 20 µg for labeled gDNA in 35 µL 
H2O) was incubated in an aqueous solution containing 480 µM ZnSO4, 5 U Antarctic phosphatase (New 
England BioLabs) and 42 U nuclease S1 (Aspergillius oryzae, Sigma‐Aldrich) at 37 °C for 3 h. The solution 
also  contained  specific  amounts  of  labeled  internal  standards  for  accurate  quantification  of  DNA‐
modifications  and  the  derivatized  abasic  sites.  In  the  second  digestion  round,  0.2 U  snake  venom 
phosphodiesterase I (Crotalus adamanteus, USB corporation) in 7.5 μl of a 520 μM [Na]2‐EDTA solution 
was added and the mixture was incubated for further 3h or overnight at 37 °C (when digesting 20 ug 
of gDNA). After digestion, the samples were stored at −20 °C and filtered using an AcroPrep Advance 
96 filter plate 0.2 μm (0.20 μm Supor, Pall Life Sciences) prior to LC‐MS/MS analysis (39 µL injection 
volume at 4 °C).  
3.3 LC‐ESI‐MS/MS Analysis of DNA Samples 
For the LC‐MS/MS studies a triple quadrupole mass spectrometer (Agilent 6490) and an Agilent 1290 
UHPLC system with UV detector were used. Based on earlier published work6‐10, a new method was 
developed  that was  coupled  to  the  isotope dilution  technique,  allowing  an  exact  quantification of 
derivatized abasic sites, all canonical nucleosides and cytosine modifications in one single analytical 
run. The chromatographical separation was performed on a Poroshell 120 SB‐C8 column (Agilent, 2.7 
μm, 2.1 mm × 150 mm). Elution buffers were H2O and MeCN, each containing 0.0085% (v/v) formic 
acid, at a flow rate of 0.35 ml/min at 30 °C. The gradient was: 0 → 5 min; 0 → 3.5% (v/v) MeCN; 5 → 
6.9 min; 3.5 → 5% MeCN; 6.9 → 13.2 min; 5 → 80% MeCN; 13.2 → 14.8 min; 80% MeCN; 14.8 → 15.3 
min; 80 → 0% MeCN; 15.3 → 17 min; 0% MeCN. The eluent up to 1.5 min and after 12.2 min was 
diverted to waste by a Valco valve. 
The  source‐dependent  parameters were  as  follow:  gas  temperature  80  °C,  gas  flow 15  l/min  (N2), 
nebulizer 30 psi,  sheath gas heater 275  °C,  sheath gas  flow 11  l/min  (N2),  capillary voltage 2500 V 
(positive mode) and −2250 V (negative ion mode), nozzle voltage 500 V, fragmentor voltage 380 V, 
Δ EMV 500 (positive mode) and 800 (negative mode). Compound‐dependent parameters which gave 
highest intensities during method development are summarized in Supplementary Table 1. 
   
S15 
 
Supplementary Table 1. Compound‐dependent LC‐MS/MS‐parameters used for the analysis of genomic DNA. CE: collision 
energy, CAV: collision cell accelerator voltage, EMV: electron multiplier voltage. The nucleosides were analyzed in the positive 
([M+H)]+ species) as well as the negative ([M‐H]‐ species) ion selected reaction monitoring mode (SRM). 
 
compound 
Precursor 
ion (m/z) 
MS1 
Resolution 
Product 
ion (m/z) 
MS2  
Resolution 
Dwell 
time 
[ms] 
CE 
(V) 
CAV 
(V) 
Polarity 
Time segment 1.5–3.8 minutes 
[15N2]5cadC  274.08  wide  158.03  wide  170  5  5  Positive 
5cadC  272.09  wide  156.04  wide  170  5  5  Positive 
[15N2,D2]5hmdC  262.12  enhanced  146.07  enhanced  40  27  1  Positive 
5hmdC  258.11  enhanced  142.06  enhanced  40  27  1  Positive 
[D3]5mdC  245.13  enhanced  129.09  enhanced  30  60  1  Positive 
5mdC  242.11  enhanced  126.07  enhanced  30  60  1  Positive 
dC  228.12  enhanced  112.05  enhanced  25  5  5  Positive 
[13C9,15N3]dC  240.12  enhanced  119.06  enhanced  25  5  5  Positive 
Time segment 3.8–5.8 minutes 
[D2]5hmdU  259.09  wide  216.08  wide  48  7  5  Negative
5hmdU  257.08  wide  214.07  wide  48  7  5  Negative
[15N2]5fdU  257.06  wide  213.05  wide  48  6  5  Negative
5fdU  255.06  wide  212.06  wide  48  6  5  Negative
Time segment 5.8–8.1 minutes 
[15N5]8oxodG  289.08  wide  173.04  wide  90  9  7  Positive 
8oxodG  284.10  wide  168.05  wide  90  9  7  Positive 
dG  268.10  wide  152.06  wide  75  45  3  Positive 
[13C10,15N5] dG  283.12  wide  162.06  wide  75  45  3  Positive 
[15N2]5fdC  258.09  wide  142.04  wide  50  5  5  Positive 
5fdC  256.09  wide  140.05  wide  50  5  5  Positive 
dT  243.1  enhanced  127.05  enhanced  35  40  3  Positive 
[13C10,15N2]dT  255.12  wide  130.07  wide  50  8  5  Positive 
Time segment 8.1–12.2 minutes 
1‐Naphthyl‐Oxim  500.24  wide  472.23  wide  5  19  5  Positive 
9b_1  487.30  wide  459.29  wide  38  19  5  Positive 
9b_2  487.30  wide  201.18  wide  38  40  5  Positive 
[13C5]9a _1  483.26  wide  455.25  wide  38  19  5  Positive 
[13C5]9a _2  483.26  wide   192.13  wide  38  40  5  Positive 
9a_1  478.24  wide  450.23  wide  38  19  5  Positive 
9a_2  478.24  wide  192.13  wide  38  40  5  Positive 
10b_1  469.29  wide  441.28  wide  38  19  3  Positive 
10b_2  469.29  wide  201.18  wide  38  33  3  Positive 
[13C5]10a _1  465.23  wide  437.22  wide  38  19  3  Positive 
[13C5]10a_2  465.23  wide  192.13  wide  38  34  3  Positive 
10a _1  460.23  wide  432.22  wide  38  19  3  Positive 
10a_2  460.23  wide  192.13  wide  38  34  3  Positive 
1b  371.25  wide  343.24  wide  5  19  5  Positive 
1a  362.19  wide  334.19  wide  5  19  5  Positive 
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For  the  chromatographical  separation  of  enzymatically  hydrolysed  synthetic  DNA  containing  the 
adduct 9a, a slightly different gradient was used: 0 → 5 min; 0 → 3.5% (v/v) MeCN; 5 → 6.9 min; 3.5 
→ 5% MeCN; 6.9 → 12.2 min; 5 → 80% MeCN; 12.2 → 13.8 min; 80% MeCN; 13.8 → 14.3 min; 80 → 
0% MeCN; 14.3 → 16 min; 0% MeCN. 
The  source‐dependent  parameters  were  the  same  as  for  genomic  DNA measurements  except  for 
Δ EMV which was set to 300 V. The time segments were 0 ‐ 1.5 minutes; 15.5 ‐ 4 minutes; 4 ‐ 8 minutes 
and 8 ‐ 12.2 minutes. Fragmentation parameters for 9a/b and 1a/b are summarized in Supplementary 
Table 2. 
Supplementary Table 2. Compound‐dependent LC‐MS/MS‐parameters for 9a/b and 1a/b used for the analysis of a synthetic 
DNA oligo containing 9a. CE: collision energy, CAV: collision cell accelerator voltage, EMV: electron multiplier voltage. The 
nucleosides were analyzed in the positive ([M+H)] + species) as well as the negative ([M‐H] ‐ species) ion selected reaction 
monitoring mode (SRM).  
Time segment 8 –12.2 minutes 
9b_1  487.30  wide  459.29  wide  38  13  2  Positive 
9b_2  487.30  wide  201.18  wide  38  25  2  Positive 
9a_1  478.24  wide  450.23  wide  38  13  2  Positive 
9a_2  478.24  wide  192.13  wide  38  25  2  Positive 
1b  371.25  wide  343.24  wide  5  10  1  Positive 
1a  362.19  wide  334.19  wide  5  10  1  Positive 
 
3.4 Method Development 
Method validation and data processing were performed as described  in earlier published work.7  In 
order  to  obtain  calibration  curves,  each  standard  (5–8  standard  concentrations)  was  analysed  as 
technical triplicates and linear regression was applied using Origin® 6.0 (Microcal™). Therefore, the 
ratio  of  the  area  under  the  curve  (A/A*)  of  the  unlabeled  derivatized  abasic  sites  9a  or  10a, 
respectively,  to  the  internal  standard  (*) was plotted against  the ratio of  the amount of substance 
(n/n*) of the unlabeled derivatized abasic site 9a and 10a, respectively, to the internal standard (*) 
(Figure  S3).  Calibration  functions  were  calculated  without  weighing.  Acceptable  precision  (<  20% 
relative  s.d.)  and accuracy  (80–124%) was achieved.  The precision was obtained when A/A*  ratios 
measured  in  technical  triplicates  for  each  calibration  standard  had  standard  deviations  <20%.  The 
accuracy  was  the  ratio  of  the  used  to  the  calculated  amount  of  substance  in  percent  for  each 
concentration. To prove the accuracy, we used the respective calibration function for calculation of 
the substance amount n from A/A* ration for each calibration standard. 
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Figure S6: Calibration curves for (A) AP‐ (9) and (B) EE ‐site (10). 
 
The lower limit of detection was defined as the detected amount that is three times higher compared 
to  the  blank  response  (LOD).  The  lower  limit  of  quantification  (LLOQ)  was  defined  as  the  lowest 
concentration fulfilling the requirements of accuracy and precision and achieving an amount higher 
than LOD. A compilation of LLOQs and LODs is shown in Supplementary Table 3. 
 
Supplementary Table 3. Compilation of absolute  lower  limits of quantification  [fmol]  (LLOQ and  relative LLOQs  [per dN] 
depending on the amount of digested DNA. The relative LLOQs were calculated by generating ratios of the absolute LLOQ 
[fmol] to the total amounts of nucleosides (N; [fmol]) in the respective amount of DNA [μg]. The total amounts of nucleosides 
were obtained by using the average molar mass of 308.91 g mol‐1 for the monomeric DNA entity by taking the G‐content 
(21% G) in mESC into account. 
 
 
 
Absolute LOD 
[fmol] 
Absolute 
LLOQ 
[fmol] 
Relative 
LLOQ 
[per dN] 
Relative 
LLOQ 
[per dN] 
DNA 
amount 
  5 µg  20 µg 
9a  0.11 1.02 6.3E‐08 1.57E‐8 
10a  0.11 1.01 6.3E‐08 1.56E‐8 
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3.5 Preparation of a Synthetic 13‐mer with Defined Abasic Site 
Oligonucleotides (5'‐GTA ATG UGC TAG G‐3' and 3'‐CAT TAG ACG ATC C‐5', à 15 nmol, Metabion) were 
incubated in UDG‐buffer (150 PL, 20 mM Tris‐HCl, pH = 8.0, 1 mM DTT, 1.0 mM EDTA, New England 
Biolabs) at 95 °C for 5 minutes and then slowly cooled to rt. UDG (5.0 PL, 25 units, New England Biolabs) 
was added, carefully mixed and the mixture was incubated for 2 hours at 37 °C. The oligonucleotide 
was  then  isolated  by  chloroform/phenol  extraction  as  described  in  the  following  paragraph.  A 
CHCl3/phenol solution (200 PL, Roti Phenol) was added, vortexed for 30 seconds and centrifuged for 3 
minutes at rt and 13400 rpm. The aqueous phase was carefully removed and CHCl3/phenol treatment 
was repeated twice. After addition of NaOAc (20 PL, 3M), the oligonucleotide was precipitated with i‐
PrOH (600 PL). The resulting DNA pellet was centrifuged at rt for 30 minutes (15000 rpm), washed with 
cold EtOH (300 PL) and centrifuged at 4 °C and 15000 rpm for another 30 minutes. The washing step 
was repeated once more, the supernatant removed and the pellet was dried on air for five minutes 
before the oligonucleotide was re‐dissolved in ddH2O (150 PL). The identity was finally confirmed by 
MALDI‐TOF analysis. 
3.6 Reaction Kinetics on a Synthetic Oligo with a Defined Abasic Site 
In a total reaction volume of 20 PL, the oligonucleotide (300 pmol) was buffered with a solution of 
HEPES (20 mM, pH = 7.5), Na2EDTA (0.1 mM) and 1a (1.26 PL of 23.8 mM stock). The reaction (37 °C, 
800 rpm, Eppendorf comfort thermomixer) was started by vortexing the mixture for 5 seconds and 
after specific time points (t = 15 s, 30 s, 45 s, 90 s, 120 s, 150 s, 180 s, 4 min, 6 min, 8 min, 15 min, 20 
min) stopped via addition of acetone (200 PL). Excess acetone was removed on a speed vac (RVC‐2‐33 
IR, Christ) and was filtered on a AcroPrep Advance 96 filter plate (0.20 Pm Supor, Pall Life Sciences). 75 
pmol of DNA were subsequently injected into a Dionex micro HPLC system and reaction products were 
separated using a Zorbax SB‐C18 column (0.55 x 250 mm, 5.0 Pm pore size) with a flow rate of 350 
PL/min. The analysis was run at a column temperature of 60 °C and a gradient of 0% ‐> 20% buffer B 
in 45 minutes (whereas buffer A = 10 mM TEAB, pH = 7.5 in H2O and buffer B = 10 mM TEAB, pH = 7.5 
in 80% MeCN/H2O). Integration of the obtained UV signals (Figure S4) finally showed that the reaction 
of 1a with abasic sites on an ODN is complete after 20 minutes and that no other fragments were 
generated under physiological conditions. 
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Figure S7: Reaction kinetics on oligo with defined abasic site. (A) Obtained UV‐signals of ODN with abasic site and reverse 
strand before (black lines) and after derivatization with 1a. (B) Normalized UV signals of ODN + 1 after specific time points.  
3.7 In vitro Assay of a Synthetic Oligonucleotide with hOGG1 
An  8oxoG  containing  synthetic  13mer  5´‐GTAATG8oxoGGCTAGG‐3´  and  its  counter  strand  5´‐
CCTAGCCCATTAC‐3´ were hybridized. hOGG1 activity was determined by treating 96 pmol of a single 
8oxodG containing ds oligo  in 1x buffer 2  (New England BioLabs), 100 Pg/mL nuclease  free bovine 
serum albumin (BSA) and 4.8 U hOGG1 (New England BioLabs). The reaction was incubated for 20 h at 
37°C and stopped by heat  inactivation at 65°C for 5 minutes. The ds oligo was recovered using the 
Oligo  Clean  &  Concentrator  Kit  (Zymo  Research)  according  to  the  manufacturer.  The  assay  was 
performed in triplicates and diluted for exact quantification.  
 
Figure S8: Reaction of an 8oxodG containing oligonucleotide with hOGG1. (A) Reaction of hOGG1 creating a defined AP‐ 
and EE‐site inside a DNA duplex. (B) Quantification of the generated AP‐ and EE‐sites after treatment of the oligonucleotide 
with 1a. 
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3.8 Efficiency of Enzymatic Digestion 
In order to verify that the derivatized abasic site adducts can be completely enzymatically excised from 
the DNA, an aliquot of the fully reacted AP‐site of the ODN (see section before) was diluted 1/4000 
and the amount of AP‐site 9a was quantified as described in the sections before. In this sample an 
amount of 133 pmol of 9a was found (for the undiluted sample). The content of dG in this oligo was 
quantified to be 895 pmol and in total dG was present 7 times in the ODN. Hence, if all the derivatized 
abasic sites were efficiently hydrolyzed, an amount of 128 pmol of 9a was expected which is in good 
agreement with the 133 pmol that were quantified. 
3.9 Reaction Kinetics on Abasic Sites in Genomic DNA 
Reactions  were  carried  out  by  derivatizing  5  Pg  of  gDNA  with  1a  using  the  same  conditions  as 
mentioned above  (Derivatization of genomic DNA with 1a). The  reaction was stopped  through  the 
addition of 1‐naphthylaldehyde (66.7 PL, 2M in  i‐PrOH) at specific time points (t = 1 min, 2.5 min, 5 
min, 10 min, 20 min, 30 min, 60 min). Reaction aliquots were finally digested to the nucleoside level 
and quantified whereas  it was  shown  that after one minute of  reaction  time, all  abasic  sites were 
derivatized and a prolonged incubation up to 60 minutes showed that no abasic sites are generated 
artificially under these conditions (Figure S5A). Since the reaction with genomic DNA was very fast, 
shorter time points were also investigated (t = 0 s, 10 s, 15 s, 30 s, 45 s, 1 min, 2 min, 5 min, 10 min, 15 
min) and again, after one minute incubation time, all abasic‐ and EE‐ sites were derivatized (Figure S5B 
and C). 
 
Figure S9: Derivatization of gDNA with 1 shows a fast derivatization reaction and does not artificially generate abasic sites. 
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General Methods  
Chemicals were purchased from Sigma-Aldrich, Fluka, Alfa Aesar, ChemGenes or Acros and 
used without further purification. Solutions were concentrated in vacuo on a Heidolph rotary 
evaporator. The solvents were of reagent grade and purified by distillation. Dry solvents were 
bought from Sigma-Aldrich. Acetonitrile for HPLC-purification was purchased from VWR. 
Water was purified by a Milli-Q Plus system from Merck Millipore. Chromatographic 
purification of products was accomplished using flash column chromatography on Merck 
Geduran Si 60 (40-63 μM) silica gel (normal phase). Thin layer chromatography (TLC) was 
performed on Merck 60 (silica gel F254) plates. 1H and 13C -NMR spectra were recorded in 
deuterated solvents on Bruker ARX 300, Varian VXR400S, Varian Inova 400, Bruker AMX 600 
and Bruker Avance 800 spectrometers and calibrated to the residual solvent peak. Multiplicities 
are abbreviated as follows: s = singlet, d = doublet, t = triplet, q = quartet, hept = septet, m = 
multiplet, br. = broad. For assignment of the structures, additional 2D NMR spectra (COSY, 
HSQC, HMBC) were measured. High resolution electronspray ionization mass spectra 
(HRMS-ESI) were recorded on a Thermo Finnigan LTQ-FT (ESI-FTICR).  
 
Synthesis of 2’-deoxy-4-methyl-cytidine 
The final compounds were purified by reverse phase HPL chromatography (Macherey-Nagel, 
Nucleosil 100-7 C18, 10 × 250 mm, linear gradient from 0% to 10% acetonitrile in water in 45 
min for 2’-deoxy-4-methyl-cytidine or 0% to 15% acetonitrile in water in 45 min for 2’-deoxy-
6-methyladenosine). 
 
Scheme S1: Synthesis of 2’-deoxy-4-methyl-cytidine. TBS-Cl, imidazole, pyridine, 0 °C to r.t., 
o/n, quant b) 1. NaH, THF, r.t., 45 min, 2. TPS-Cl, r.t., 15 h, 3. MeNH2, r.t., 5 min, 86% c) HF 
in pyridine, EtOAc, r.t., o/n, quant. 
Synthesis of 2’-deoxy-4-methyl-cytidine  
O3’,O5’-TBS-2’-deoxyuridine  
2'-Deoxyuridine (3.00 g, 13,1 mmol, 1.0 eq) was dissolved in pyridine (50 mL) and cooled to 
0 °C. Imidazole (4.00 g, 59.0 mmol, 4.5 eq) and TBS-Cl (5.90 g, 39.3 mmol, 3.0 eq) were then 
added. The mixture was allowed to warm to rt overnight and volatiles were subsequently 
removed in vacuo. The gummy residue was taken up in DCM (100 mL) and washed with sat. 
NH4Cl (3x 100 mL). The organic phase was dried over Na2SO4 , the organic solvent removed 
under reduced pressure and the resulting oil was finally coevaporated with toluene (3x) to yield 
a white powder in quantitative yield (5.98 g, 13.1 mmol) that was used without further 
purification. 
O3’,O5’-TBS-4-methyl-2’-deoxycytidine 
O3’,O5’-TBS-2’-deoxyuridine (1.00 g, 2.19 mmol, 1.0) was dissolved in THF (50 mL) and 
cooled to 0 °C. NaH (60% in mineral oil, 434 mg, 10.95 mmol, 5.0 eq) was added in one portion 
and the grey suspension was kept at 0 °C for 45 minutes. Subsequently, TPS-Cl (1.33 g, 4.38 
mmol, 2.0 eq) was added and the mixture was warmed to rt and stirred for 15 hours. After all 
the starting material was consumed (as judged by TLC), ice cold sat. NH4Cl (200 mL) was 
added cautiosly and the aqueous layer was extracted with EtOAc (2x 100 mL). After drying the 
organic phase over Na2SO4, volatiles were removed in vacuo and the residue was charged with 
MeNH2 (50 mL, 33% in EtOH). After stirring at rt for 5 minutes, the reaction was aborted 
through addition of NH4Cl (200 mL) and the aqueous phase was again extracted with EtOAc 
(2x 50 mL). After drying over Na2SO4 and removal of EtOAc in vacuo, the compound was 
purified by column chromatography (DCM --> 2.5% MeOH --> 4% MeOH) and the product 
was yielded as a colourless foam (887 mg, 1.80 mmol, 86%). 
1H-NMR (599 MHz, CDCl3, ppm): δ = 7.87 (d, J = 7.8 Hz, 1H, 6-H), 6.29 (dd, J = 7.8 Hz, 
6.3 Hz, 1H, 1'-H), 5.55 (d, J = 7.8 Hz, 1H, 5-H), 4.35 (q, J = 5.5 Hz, 1H, 3'-H), 3.90 (dd, J = 
11.4 Hz, 2.6 Hz, 1H, 5'-H), 3.86 (m, 1H, 4'-H), 3.75 (dd, J = 11.1 Hz, 2.3 Hz, 1H, 5'-H), 3.0 
(ds, J = 4.9 Hz, 3H, CH3-NH), 2.44 - 2.36 (m, 1H, 2'-H), 2.07 (ddd, J = 13.5, 6.4, 4.9 Hz, 1H, 
2'-H),0.96 - 0.82 (m, 18H, TBS-C(CH3)3), 0.14 - 0.01 (m, 12H, TBS-CH3). 
13C-NMR (151 MHz, CDCl3, ppm): δ = 164.2 (C4), 156.2 (C2), 139.5 (C6), 94.4 (C5), 87.1 
(C4'), 85.7 (C3'), 70.1 (C1'), 61.9 (C5'), 42.1 (C2'), 28.0 (CH3), 25.9 - 25.7 (TBS-C(CH3)3), 
18.3 - 18.0 (TBS-C(CH3)3), -4.6 - -5.6 (TBS-CH3). 
HR-MS (ESI+): m/z calculated for [C22H44N3O4Si2+] ([M+H]+): 470.2865, found: 470.2864.  
2’-deoxy-4-methyl-cytidine 
In a falcon tube, the TBS-protected nucleoside (300 mg, 0.64 mmol, 1.0 eq) was dissolved in 
EtOAc (5 mL). The mixture was then charged with HFxpyridine (70%, 374 PL, 14.4 mmol, 
22.5 eq) and stirred at rt overnight. Then TMSxOMe (3.46 mL, 25.6 mmol, 40 eq) was added 
whereas a colorless precipitate was formed. The white solid was isolated through repeated 
centrifugation of the mixture (2x 10 minutes, 6000 rpm) and subsequent washing with EtOAc 
(2x 5 mL). The supernatant was discarded and the compound (154 mg, 0.64 mmol, quant.) was 
yielded as a white powder, that was further purified by HPLC. 
1H NMR (400 MHz, D2O) δ 7.68 (d, J = 7.6 Hz, 1H, C6-H), 6.29 (t, J = 6.7 Hz, 1H, C1’-H), 
5.98 (d, J = 7.6 Hz, 1H, C5-H), 4.45 (dt, J = 6.5, 3.9 Hz, 1H, C3’-H), 4.05 (dt, J = 5.1, 3.7 Hz, 
1H, C4’-H), 3.84 (dd, J = 12.4, 3.7 Hz, 1H, C5’-H), 3.76 (dd, J = 12.4, 5.2 Hz, 1H, C5’-H), 
2.89 (s, 3H, CH3), 2.41 (ddd, J = 14.1, 6.4, 4.0 Hz, 1H, C2’-H), 2.29 (dt, J = 13.9, 6.8 Hz, 1H, 
C2’-H) ppm. 
13C NMR (101 MHz, D2O) δ 164.5 (C4), 157.8 (C2), 139.3 (C6), 97.3 (C5), 86.4 (C4’), 85.8 
(C1’), 70.6 (C3’), 61.3 (C5’), 39.1 (C2’), 27.1 (CH3) ppm. 
HR-MS (ESI+): m/z calculated for [C10H16N3O4]+ ([M+H]+): 242.1136, found: 242.1137. 
 
Synthesis of 2’-deoxy-4-methyl-[N1,N3-15N2]-cytidine 
 
Scheme S2: Synthesis of 2’-deoxy-4-methyl-[N1,N3-15N2]-cytidine. a) TBS-Cl, imidazole, 
pyridine, r.t., 72 h, 64% b) 1. NaH, THF, r.t., 45 min, 2. TPS-Cl, r.t., 17 h, 3. MeNH2, r.t., 
10 min,  49% c) HF in pyridine, EtOAc, r.t., 17 h, 64%. 
 
O3’,O5’-TBS-2’-deoxy-[N1,N3-15N2]-uridine  
2‘-Deoxy-[15N,15N]-uridine (51 mg, 0.22 mmol, 1.0 eq), TBS-chloride (109 mg, 0.726 mmol, 
3.3 eq) and imidazole (99 mg, 1.4 mmol, 6.6 eq) were dissolved in 1 mL pyridine and stirred at 
r.t. for 72 h. The solvent was removed in vacuo, the residue was dissolved in DCM and washed 
with sat. NaHCO3 (aq). O3’,O5’-TBS-2’-deoxy-[N1,N3-15N2]-uridine (59 mg, 0.13 mmol, 64%) 
was obtained as a white solid. 
HR-MS (ESI+): m/z calculated for [C21H4115N2O5Si2]+ ([M+H]+): 459.2489, found: 459.2493. 
 
O3’,O5’-TBS-2’-deoxy-[N1,N3-15N2]-cytidine 
O3’,O5’-TBS-2’-deoxy-[N1,N3-15N2]-uridine (59 mg, 0.13 mmol, 1.0 eq) was dissolved in THF 
(2 mL) and cooled to 0 °C. Sodium hydride (16 mg, 0.65 mmol, 5.0 eq) was added and the 
mixture was stirred at r.t. for 45 minutes. Then TPS-chloride (79 mg, 0.26 mmol, 2.0 eq) was 
added and the mixture was stirred at r.t. for another 17 h. The reaction was quenched with 
saturated NH4Cl(aq), extracted with EtOAc and washed three times with saturated NH4Cl(aq). 
The organic phase was dried with Na2SO4 and the solvent was removed in vacuo. The residue 
was dissolved in MeNH2 (5 mL, 33% in EtOH) and stirred at r.t. for 10 minutes. The solvent 
was removed in vacuo and the residue was purified via column chromatography (DCM/MeOH 
0.5% to 1%, SiO2). O3’,O5’-TBS-2’-deoxy-4-methyl-[N1,N3-15N2]-cytidine (30 mg, 
0.064 mmol, 49%) was obtained as a white solid. Unreacted O3’,O5’-TBS-2’-deoxy-[N1,N3-
15N2]-uridine could be recovered via column chromatography. 
HR-MS (ESI+): m/z calculated for [C22H44N15N2O4Si2]+ ([M+H]+): 472.2806, found: 472.2804. 
 
2’-deoxy-4-methyl-[N1,N3-15N2]-cytidine 
O3’,O5’-TBS-2’-deoxy-4-methyl-[N1,N3-15N2]-cytidine (30 mg, 0.064 mmol, 1.0 eq) was 
dissolved in EtOAc (3 mL), HF in pyridine (40 µL, 1.4 mmol, 22.5 eq) was added and the 
reaction mixture was stirred at r.t. for 17 h. The mixture was cooled to 0 °C, quenched with 
TMS-OMe and stirred at r.t. for 4 h. The precipitation was centrifuged and the supernatant was 
removed and the solid was washed three times with EtOAc. The solvent was removed in vacuo 
and 2’-deoxy-4-methyl-[N1,N3-15N2]-cytidine (10 mg, 0.041 mmol, 64%) was obtained as a 
white solid. 
1H NMR (599 MHz, D2O) δ 7.68 (d, J = 7.4 Hz, 1H, C6-H), 6.29 (d, J = 7.7 Hz, 1H, C1’-H), 
5.99 (dd, J = 7.8, 3.9 Hz, 1H, C5-H), 4.45 (h, J = 4.1, 3.5 Hz, 1H, C3’-H), 4.05 (m, 1H, C4’-H), 
3.84 (m, 1H, C5’-H), 3.77 (m, 1H, C5’-H), 2.90 (d, J = 3.3 Hz, 3H, CH3), 2.41 (m, 1H, C2’-H), 
2.31 (q, J = 7.3 Hz, 1H, C2’-H) ppm. 
13C NMR (101 MHz, D2O) δ 164.4 (d, J = 9.7 Hz, C4), 157.8 (C2), 139.2 (d, J = 13.2 Hz, C6), 
97.3 (C5), 86.4 (C4’), 85.7 (d, J = 11.7 Hz, C1’), 70.6 (C3’) , 61.3 (C5’) , 39.0 (C2’), 27.0 (d, 
J = 2.0 Hz, CH3) ppm. 
HR-MS (ESI+): m/z calculated for [C10H16N15N2O4]+ ([M+H]+): 244.1076, found: 244.1078. 
Synthesis of 2’-deoxy-6-methyladenosine 
 
Scheme S3: Synthesis of 2’-deoxy-6-methyladenosine and 2’-deoxy-6-[D3]-methyladenosine. 
a) Methyl-p-toluenesulfonate, DMF, r.t., 20 h (R=CH3); CD3I, N,N-dimethylacetamide 28 °C, 
20 h (R=CD3), b) 2 M NaOH, 28 °C, 1 h, 13% (R=CH3), 14% (R=CD3). 
2’-Deoxy-6-methyladenosine was synthesized as published in [1]. 
Methyl-p-toluenesulfonate (600 mg, 3.22 mmol, 4.0 eq) was dissolved in 1 mL 
N,N-dimethylformamide and 2’-Deoxyadenosine (200 mg, 0.796 mmol, 1.0 eq) was added. 
The solution was stirred at r.t. for 20 h. Celite was added and the solution was filtered. Acetone 
(30 mL) was added to the filtrate and the mixture was stirred for 1 h. The precipitation was 
filtered, washed with acetone and dried on high vacuum. The white solid was dissolved in 5 mL 
2 M NaOH and stirred at 28 °C for 1 h. The solution was neutralized with 10% aqueous 
p-toluenesulfonic acid and the solvent was removed in vacuo. The residue was purified via 
column chromatography (DCM/MeOH 10:1 → 9:1, SiO2) and 2’-deoxy-6-methyladenosine 
(27 mg, 0.10 mmol, 13%) was obtained as a white solid.  
1H NMR (800 MHz, DMSO-d6) δ 8.32 (s, 1H, C8-H), 8.22 (s, 1H, C2-H), 7.77 (s, 1H, NH), 
6.35 (dd, J = 7.9, 6.2 Hz, 1H, C1’-H), 5.30 (d, J = 4.0 Hz, 1H, C3’-OH), 5.24 (t, J = 5.9 Hz, 
1H, C5’-OH), 4.41 (dq, J = 6.3, 3.1 Hz, 1H, C3’-H), 3.88 (q, J = 3.8 Hz, 1H, C4’-H), 3.62 (dq, 
J = 13.2, 4.4 Hz, 1H, C5’-H), 3.52 (ddt, J = 10.8, 7.7, 4.0 Hz, 1H, C5’-H), 2.95 (s, 3H, CH3), 
2.72 (ddd, J = 13.4, 7.7, 5.6 Hz, 1H, C2’-H), 2.26 (ddd, J = 13.2, 6.2, 2.8 Hz, 1H, C2’-H) ppm. 
13C NMR (201 MHz, DMSO-d6) δ 155.0 (C6), 152.4 (C2), 147.9 (C4), 139.3 (C8), 119.8 (C5), 
88.0 (C4’), 84.0 (C1’), 71.0 (C3’), 61.9 (C5’), 39.4 (C2’), 27.0 (CH3) ppm. 
HR-MS (ESI+): m/z calculated for [C11H16N5O3]+ ([M+H]+): 266.1248, found: 266.1248. 
Synthesis of 2’-deoxy-6-[D3]-methyladenosine 
2’-Deoxyadenosine (200 mg, 0.796 mmol, 1.0 eq) was dissolved in 1 mL 
N,N-dimethylacetamide and CD3I (0.15 mL, 2.4 mmol, 3.0 eq) was added. The yellow solution 
was stirred at 28 °C for 20 h. Acetone was added and the precipitation was filtered, washed 
with acetone and dried on high vacuum. The white solid was dissolved in 5 mL 2 M NaOH and 
stirred at 28 °C for 1 h. The solution was neutralized with 10% aqueous p-toluenesulfonic acid 
and the solvent was removed in vacuo. The residue was purified via column chromatography 
(DCM/MeOH 10:1 → 9:1, SiO2) and 2’-deoxy-6-[D3]-methyladenosine (29 mg, 0.11 mmol, 
14%) was obtained as a white solid.  
1H NMR (400 MHz, DMSO-d6) δ 8.32 (s, 1H, C8-H), 8.22 (s, 1H, C2-H), 7.74 (s, 1H, NH), 
6.35 (dd, J = 7.9, 6.1 Hz, 1H, C1’-H), 5.30 (d, J = 4.0 Hz, 1H, C3’-OH), 5.24 (s, 1H, C5’-OH), 
4.41 (dq, J = 6.0, 2.9 Hz, 1H, C3’-H), 3.88 (td, J = 4.2, 2.5 Hz, 1H, C4’-H), 3.62 (m, 1H, 
C5’-H), 3.52 (d, J = 11.6 Hz, 1H, C5’-H), 2.72 (ddd, J = 13.4, 8.0, 5.7 Hz, 1H, C2’-H), 2.26 
(ddd, J = 13.1, 6.1, 2.9 Hz, 1H, C2’-H) ppm. 
13C NMR (101 MHz, DMSO-d6) δ 155.0 (C6), 152.3 (C2), 147.8 (C4), 139.2 (C8), 119.7 (C5), 
88.0 (C4’), 83.9 (C1’), 70.9 (C3’), 61.9 (C5’), 39.4 (C2’), 26.4 (CD3) ppm. 
HR-MS (ESI+): m/z calculated for [C11H13D3N5O3]+ ([M+H]+): 269.1436, found: 269.1437. 
Cyanobacterial and Algal Strains, Culture Conditions and DNA Extraction 
 
For DNA extractions, 150 mL of wild-type Synechocystis sp. PCC6803 cultures were grown at 
30 °C in BG11 medium containing 5 mM glucose.[2] For Chlamydomonas reinhardtii the cell-
wall-deficient strain 3491 (cw15 mt-), obtained from the Chlamydomonas Center 
(http://www.chlamy.org/), and the cell-walled laboratory strain 7d+ were cultured in 150-
300 mL Tris-acetate-phosphate medium containing 1% sorbitol[3] at 25°C. All cultures were 
grown under orbital shaking and continuous irradiation with 30 µmol of photons m-2 s-1. 
For determination of N6-methyldeoxyadenosine and N4-methyldeoxycytidine, DNA was 
isolated by harvesting cells at 3000 g for 20 min, followed by resuspension of the pellets in 
4-8 mL DNA extraction buffer ((2% (w/v) cetyltrimethylammonium bromide (CTAB),100 mM 
Tris-HCl, pH 8; 1.4 M NaCl; 20 mM EDTA pH 8; 2% (v/v) β-mercaptoethanol)). Cells were 
lysed upon addition of ~300 μL glass beads for 1 h at 65 °C and vortexed every 15 min. Proteins 
were removed by extraction with phenol:chloroform:isoamylalcohol 25:24:1 solution. RNA in 
the water phase was digested at 37 °C for 1 h using 0.1 mg/mL RNase A. RNase A was removed 
by extraction with phenol:chloroform:isoamylalcohol 25:24:1 solution, followed by a 
chloroform/isoamylalcohol 24:1 extraction and isopropanol precipitation of the DNA. DNAs 
were dissolved in appropriate volumes of water at 4 °C overnight. 
 
Preparation of mouse tissues 
All mice used were on the wild-type C57-BL6 genetic background. All procedures concerning 
animals were performed with permission of the local authority (Regierung von Oberbayern). 
Brain und liver tissues of male wt mice (C57-BL6/N) were dissected at postnatal day 51 and 
immediately placed in 2 mL Eppendorf-tubes, snap frozen in liquid nitrogen and stored 
at -80 °C until use. 
 
Genomic DNA isolation 
Genomic DNA from murine tissues was extracted using the Qiagen Blood and Cell Culture 
DNA Midi Kit. Extraction was performed following the manufacturer's instructions for 
genomic DNA isolation from tissue samples. All buffers until loading of the sample on 
Genomic-tip 100/G were additionally supplemented with antioxidants 
3,5-di-tert-butyl-4-hydroxytoluene (BHT, 200 μM) and desferoxamine mesylate salt (desferal, 
200 μM). G2-buffer was additionally supplemented with the deaminase inhibitor 
tetrahydrouridine (THU, 200 μM), according to published methods, to reduce background 
oxidation or deamination.[4] Elution buffer QF was supplemented with 200 μM BHT. 
mESC and HeLa samples differentiated in the presence of growth factors were lysed directly in 
the plates with RLT buffer (Qiagen) supplemented with BHT and desferal as described above. 
DNA was isolated using the Zymo Quick gDNA Midi Kit according to the manufacturer's 
instruction, except that elution was performed with 100 μl of bidest. water supplemented with 
BHT (0.2 μM). 
 
Cell culture 
Feeder independent wt J1 cells (strain 129S4/SvJae)[5] were cultured in the presence of serum 
and LIF as previously described[6] and routinely maintained on gelatinized plates in DMEM 
(PAA or Sigma) supplemented with 10% FBS, 1×MEM-nonessential amino acids (NEAA), 0.2 
mM L-alanyl-L-glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin (all from PAA), 
0.1 mM β-mercaptoethanol, 20 ng/ml (≥1 ×103 U/ml) mouse recombinant LIF (ORF Genetics), 
1 μM PD 0325901 and 3 μM CHIR 99021 (2i; both from Axon Medchem). Before DNA 
isolation, 2i cultures were passaged twice (over 4 d and 5 d, respectively) in DMEM 
supplemented with FBS and LIF as above but lacking 2i. With this strategy, primed mESC 
cultures were obtained with no sign of overt differentiation. 
As an additional experiment for determination of m6dA as a marker of early embryogenesis, we 
cultured wt J1 cells in serum-free 2i/LIF on GelTrex-coated plates for more than 5 passages 
and harvested them with RLT buffer (Qiagen) supplemented with BHT and desferal. 
 
Feeder independent wt TT2 cells were cultured like wt J1 cells (as described above) and primed 
for 4 d, 10 d, 12 d and 14 d respectively. Feeding experiments with dimethylsulfate (DMS, 
<0.01% DMSO) were performed on day four of the priming process and the cells were 
incubated with DMS for 24 h. 
 
For isotope tracing with heavy methionine in serum-primed mESCs, 2i cultures of wt J1 cells 
were passaged twice (over 4 d or 5 d) without 2i in L-Metfree DMEM (Sigma) supplemented 
as above and with 0.2 mM of either [ -13C,D3]L-Met or natural L-Met. The medium was 
changed after 24 h. The experiment was performed in a biological duplicate. 
Feeding of wt J1 cells with m6dA was performed once by adding m6dA nucleoside (1µM, 0.1% 
DMSO) to the medium on day 0 of culturing in FBS/LIF and increasing the concentration on 
day 2 for another two days (1 mM, 1% DMSO). DMSO controls were only treated with the 
respective concentration of DMSO. 
HeLa cells were cultivated at 37 °C in water saturated, CO2-enriched (5%) atmosphere. DMEM 
(10% FBS) was used as growing medium. When reaching a confluence of 70% to 80% the cells 
were passaged or harvested with RLT buffer (Qiagen) supplemented with BHT and desferal, 
respectively. 
Digest of genomic DNA 
1 µg (10 μg) of genomic DNA in 35 μl H2O were digested as follows: An aqueous solution 
(7.5 μl) of 480 μM ZnSO4, containing 42 U (63 U) nuclease S1 (Aspergillus oryzae, Sigma-
Aldrich), 5 U (7.5 U) Antarctic phosphatase (New England BioLabs) and specific amounts of 
labeled internal standards were added, and the mixture was incubated at 37 °C for 3 h. After 
addition of 7.5 μl of a 520 μM [Na]2-EDTA solution, containing 0.15 U (0.2 U) snake venom 
phosphodiesterase I (Crotalus adamanteus, USB corporation), the sample was incubated for 
another 3 h (overnight) at 37 °C. Prior to LC-MS/MS analysis, samples were filtered by using 
an AcroPrep Advance 96 filter plate 0.2 μm Supor (Pall Life Sciences). 
For dilution experiments, m6dA and m4dC were not spiked during the digest step, but after a 
dilution of the digest of 1:20, or 1:200 respectively. 
Furthermore, a recovering experiment was performed as follows: a digest of 10 µg of murine 
DNA was spiked with a small amount of Chlamydomonas (CC-3491) DNA or synthetic m6dA-
nucleoside, which corresponds to a level of m6dA as described earlier in mouse tissue.[7] 
 
LC/MS analysis of DNA samples 
Quantitative LC/UV-ESI-MS/MS analysis of digested DNA samples was performed using an 
Agilent 1290 UHPLC system equipped with a UV detector and an Agilent 6490 triple 
quadrupole mass spectrometer coupled with the stable isotope dilution technique. An improved 
method, based on earlier published work,[8] was developed, which allowed the concurrent 
analysis of all nucleosides in one single analytical run. The source-dependent parameters were 
as follows: gas temperature 80 °C, gas flow 15 l/min (N2), nebulizer 30 psi, sheath gas heater 
275 °C, sheath gas flow 11 l/min (N2), capillary voltage 2,500 V in the positive ion mode, 
capillary voltage −2,250 V in the negative ion mode and nozzle voltage 500 V. The fragmentor 
voltage was 380 V. Delta EMV was set to 500 (positive mode) and 800 (negative mode). 
Compound-dependent parameters are summarized in Table S1. 
Exact quantification of the nucleosides m5dC, hmdC, fdC, cadC and 8oxodG was performed 
with a previously published method.[6]  
  
Table S1: Compound-dependent LC-MS/MS-parameters used for the analysis of genomic 
DNA. CE: collision energy; CAV: collision cell accelerator voltage; EMV: electron multiplier 
voltage. The nucleosides were analyzed in the positive ([M+H]+species) as well as in the 
negative ([M-H]-species) ion selected reaction monitoring mode (SRM). 
Compound Precursor 
ion (m/z) 
MS1 
resolution 
Product 
ion (m/z) 
MS2 
resolution 
Dwell 
time 
[ms] 
CE 
(V) 
CAV 
(V) 
Polarity 
Time segment 1.5–6 min 
[15N2]-cadC 274.08 Wide 158.03 Wide 50 5 5 Positive 
cadC 272.09 Wide 156.04 Wide 50 5 5 Positive 
[D2-15N2]-
hmdC 
262.12 Wide 146.07 Wide 50 27 1 Positive 
hmdC 258.11 Wide 142.06 Wide 50 27 1 Positive 
[D3]-m5dC 245.13 Wide 129.09 Wide 55 60 1 Positive 
[15N2]-m4dC 244.11 Wide 128.06 Wide 55 60 1 Positive 
m5dC/m4dC 242.11 Wide 126.07 Wide 55 60 1 Positive 
dC 228.1 Wide 112.05 Wide 1 1 0 Positive 
[15N2]-
cadC_2 
158.03 Wide 140.09 Wide 50 13 7 Positive 
cadC_2 156.04 Wide 138.03 Wide 50 13 7 Positive 
Time segment 6-8 min 
[D2]-hmdU  259.09 Wide 216.08 Wide 48 7 5 Negative 
[D2]-
hmdU_2 
259.09 Wide 126.05 Wide 48 7 5 Negative 
hmdU 257.08 Wide 214.07 Wide 48 7 5 Negative 
hmdU_2 257.08 Wide 124.04 Wide 48 7 5 Negative 
[15N2]-fdU 257.06 Wide 213.05 Wide 48 6 5 Negative 
[15N2]-fdU_2 257.06 Wide 141 Wide 48 6 5 Negative 
fdU 255.06 Wide 212.06 Wide 48 6 5 Negative 
fdU _2 255.06 Wide 140 Wide 48 6 5 Negative 
[15N2]-dU 229.06 Wide 185.06 Wide 48 5 5 Negative 
dU 229.06 Wide 185.06 Wide 48 5 5 Negative 
Time segment 8-12 min 
[15N5]-
8oxodG 
289.09 Wide 173.04 Wide 60 9 7 Positive 
8oxodG 284.1 Wide 168.05 Wide 60 9 7 Positive 
[D3]-m6dA 
sensitive 
269.14 Wide 153.1 Wide 55 30 1 Positive 
m6dA 
sensitive 
266.12 Wide 150.08 Wide 55 30 1 Positive 
[13CD3]-
m6dA 
270.15 Wide 154.14 Wide 55 30 1 Positive 
[D3]-m6dA 
insensitive 
269.14 Wide 153.1 Wide 55 60 5 Positive 
m6dA 
insensitive 
266.12 Wide 150.08 Wide 55 60 5 Positive 
[15N2]-fdC 258.09 Wide 142.04 Wide 60 5 5 Positive 
fdC 256.09 Wide 140.05 Wide 60 5 5 Positive 
[15N2]-fdC_2 142.04 Wide 98.04 Wide 60 13 7 Positive 
fdC _2 140.05 Wide 97.04 Wide 60 13 7 Positive 
 
  
Chromatography was performed by a Poroshell 120 SB-C18 column (Agilent, 2.7 μm, 
2.1 mm × 150 mm) at 30 °C using a previously published gradient[8] of water and MeOH, each 
containing 0.0075% (v/v) formic acid, at a flow rate of 0.35 ml/min. The effluent up to 1.5 min 
and after 12 min was diverted to waste by a Valco valve. The autosampler was cooled to 4 °C. 
The injection volume was amounted to 39 μl. Calibration curves are shown in Fig S4. 
Method validation and data processing were performed as described in earlier published work. 
Calibration curves were obtained by analyzing each standard (5–8 standard concentrations) as 
technical triplicate and applying linear regression Origin® 6.0 (Microcal™). Therefore, the 
ratio of the area under the curve (A/A*) of the natural nucleoside to the internal standard was 
plotted against the ratio of the amount of substance (n/n*) of the natural nucleoside to the 
internal standard (see Fig. S4). Additionally, acceptable accuracy (80–120%) as well as 
precision (<20% RSD) was required. Accuracy was proven by calculating the amount of 
substance n from the obtained A/A* ratios of the calibration standards using the respective 
calibration function. Here, accuracy was defined as the ratio of the used amount of substance 
to the calculated amount of substance in percent and had to be between 80–120% for each 
standard concentration. Precision was determined as follows: technical replicates of A/A* ratios 
for each calibration standard had to have relative standard deviations (RSD) smaller than 20%. 
The lower limit of quantification (LLOQ) was defined as the lowest concentration fulfilling the 
requirements of accuracy and precision and achieving a response of at least three times the 
response compared with the blank response. A compilation of absolute and relative LLOQs is 
shown in Table S2. 
 
 Figure S1: Calibration curves for m4dC (upper row; A for murine, cell culture and 
Chlamydomonas DNA, B for Synechocystis DNA) and m6dA (sensitive signals: C for mouse 
and cell culture DNA; insensitive signals: D for Chlamydomonas DNA and E for Synechocystis 
DNA); the ratio of the signal integral of unlabeled nucleoside towards labelled nucleoside is 
plotted against the ratio of the amount of natural nucleoside over the labelled nucleoside. 
  
Figure S2: UV Calibration curve ford G with the UV signal intensity plotted against the amount 
of nucleoside [pmol]. 
Table S2: Compilation of absolute lower limits of quantification [fmol] (LLOQ; see Fig. S1) 
and relative LLOQs [per dN]. The relative LLOQs were computed by generating ratios of the 
absolute LLOQ [pmol] to the total amount of nucleosides (dN; [pmol]) in 10 µg of DNA (for 
calibration curve A and C) or 1 µg of DNA (for calibration curve B and D) or 50 ng (for 
calibration curve E). The total amount of nucleosides was obtained by calculating the content 
of dG using the respective calibration curve (see Fig. S2) and taking into account that murine 
DNA contains 21% dG, DNA of Chlamydomonas contains 32% dG and DNA of Synechocystis 
contains 23.9% dG. 
 
Absolute 
ULOQ 
[fmol] 
Absolute 
LLOQ 
[fmol] 
Relative 
ULOQ 
[per dN] 
Relative 
LLOQ 
[per dN] 
Relative LOD 
[per dN] 
Absolute 
LOD 
[fmol] 
m4dC  
(small, A) 302.1 18.8 1.1*10
-5 6.6*10-7 
1.4*10-6 
(mouse/cell 
culture) 
4.8*10-5 
(Chlamydomonas) 
40 
m4dC  
(big, B) 48100 376 5.1*10
-2 3.9*10-4 4.2*10-5 40 
m6dA 
(sensitive, C) 203.8 1.6 7.4*10
-6 5.8*10-8 8.0*10-8 2.2 
m6dA 
(insensitive,D) 1162 18.2 1.4*10
-3 2.2*10-5 2.0*10-5 17 
m6dA 
(insensitive,E) 15500 60 2.6*10
-1 1.0*10-3 4.3*10-4 26 
 
 Figure S3: chromatogram of DNA from murine brain green: digest blank, in which everything 
was performed like in a real digest, but no DNA was added; red: calculated baseline, for which 
the chromatogram of the digest blank was subtracted from the chromatogram for DNA from 
murine brain. 
 
Figure S4: chromatogram of various cell culture samples; red: DNA from wt TT2 cells fed with 
1 µM DMS, blue: DNA from wt TT2 cells fed with 10 µM DMS, yellow: DNA from a wt TT2 
control, purple: DNA from wt TT2 cells after 14 d of priming, grey: DNA from wt TT2 cells 
after 12 d of priming, orange: DNA from wt TT2 cells after 10 d of priming, light blue: DNA 
from wt TT2 after 4 d of priming, green: DNA from wt J1 cells cultured in serum-free 2i/LIF, 
brown: digest blank, in which everything was performed like in a real digest, but no DNA was 
added 
 Figure S5: chromatogram of murine DNA from different tissues in different dilutions.; green: 
50 ng of DNA from murine brain, red: 500 ng of DNA from murine brain, blue: 50 ng of DNA 
from murine liver, yellow: 500 ng of DNA from murine liver, 6 µg of DNA from murine liver, 
grey: digest blank, in which everything was performed like in a real digest, but no DNA was 
added. 
 
 
Figure S6: chromatogram of murine DNA from different tissues spiked with DNA from 
Chlamydomonas reinhardtii (CC-3491) and m6dA nucleoside, respectively.; black: DNA from 
murine liver spiked with CC-3491; green: digest blank, in which everything was performed like 
in a real digest, but no DNA was added, red: DNA from murine brain with CC-3491, yellow: 
DNA from murine liver spiked with m6dA nucleoside. The shown peak seems shifted in 
contrast to the other two peaks, but this is due to a measurement at a different time. 
  
Figure S7: chromatograms for m6dA-fed cells (left) and the respective DMSO control (right) 
with the transition for the natural nucleoside (m/z 266.12 to m/z 150.08) displayed in the upper 
row and the transition for the spiked heavy labeled nucleoside (m/z 269.14 to m/z 153.10) 
displayed in the lower row. The red lines indicate the chromatogram for the measured samples, 
the black line indicates the respective digest blank, in which everything was performed like in 
a real digest, but without addition of DNA or D3-m6dA). 
 
 Figure S8: chromatograms for heavy methionine-fed cells (left) and the respective light 
methionine control (right) with the transition for the natural nucleoside (m/z 266.12 to m/z 
150.08) displayed in the upper row and the transition for the heavy labeled nucleoside (m/z 
270.15 to m/z 154.10; not formed) displayed in the lower row. The red lines indicate the 
chromatogram for the measured samples, the black line indicates the respective digest blank, in 
which everything was performed like in a real digest, but without addition of DNA. 
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Supplementary Results 
 
 
Supplementary Figure 1. Isotopically labeled nucleosides used as internal standards for quantitative LC-MS/MS 
analysis (dR = -2´-deoxyribose). 
 
 
Supplementary Figure 2. DNA modification levels per nucleoside (N) of different murine tissues from 3 month 
old individuals (n = 3). Depicted are biological mean values ±SD. 
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Supplementary Figure 3. hmU-levels normalized to the oxidative background marker 8-oxo-G in mESCs (nWT01 
= 7; nJ1 = 2, nR1 = 2) and murine tissues (n = 3, 3 month old individuals) in order to dissect ROS dependent and 
ROS independent processes. Normalization was necessary to take deviating background oxidation of DNA sample 
preparation into account. The light grey area reflect the hmU-level fractions, which are generated by ROS 
dependent processes. The green area reflect the hmU-level fractions, which are generated by ROS independent 
processes. The assignment is based on the assumption, that hmU-levels in somatic tissue are exclusively ROS 
created lesions (derived from the cluster analysis in Fig. 2b). The dark grey area reflect the mean value ±SD of 
hmU/8-oxo-G ratios of the tissue data. The difference between the height of the hmU/8-oxo-G ratios of mESCs 
and the mean of the tissue data give the hmU-fraction which is formed by ROS-independent processes. In WT01, 
J1 and R1 cells about 67%, 83% and 74%, respectively, of the global hmU-levels are estimated to be created by 
ROS independent processes. Bars reflect biological mean values ±SD. The differences between mESCs (WT01, 
J1) and murine tissues are significant (P = 9.3x10-5–5.0x10-3; unpaired two-tailed t-test) except for mESCs (WT01, 
J1) and liver (P = 0.081, 0.15). 
 
Supplementary Figure 4. Schematic representation of isotope tracing experiments with [13C,15N2]-T (left; blue) 
and [13C,D3]-methionine (right; red) and exchange rates of derived genomic isotopologues. Small negligible 
deviations in the exchange rates are due to differential noise sources. LOD = limit of detection. wt = wild type 
mESCs; Tdg cm = Tdg /  mESCs complemented with catalytic inactive Tdg (see Supplementary Fig. 6). 
 
Nature Chemical Biology: doi:10.1038/nchembio.1532
 4 
 
 
Supplementary Figure 5. (a) Effect of Smug1 depletion on modification levels in mESCs (R1). Effect of SMUG1 
(b) and TDG (c) depletion on modification levels in HEK-293T cells overexpressing Tet1cd. Shown is the percent 
change in modification content per nucleoside in cells co-transfected with esiRNAs targeting TDG or SMUG1 
relative to co-transfection with control esiRNA. Depicted are technical mean values ± SD. 
 
Supplementary Figure 6. Isotope tracing experiments with Tdg+/-, Tdg-/- mESCs as well as Tdg-/- mESCs 
complemented with a catalytic mutant of Tdg (Tdg cm) grown in the presence of [13C,D3]-methionine (200 µM). 
The catalytic mutant of Tdg is not completely inactive (fC levels are between Tdg +/- and Tdg -/- cells, left). Only 
in case of Tdg-/- cells complemented with a catalytic inactive Tdg (Tdg cm) labeled hmU was detected, which 
originated from the deamination of labeled hmC. ~7% [13C,D2]-hmU over total hmU was observed. This 
corresponds to ~0.06% deamination of hmC to hmU under these conditions (2.5x10-4 total hmC / N; 2.2x10-6 total 
hmU / N). Labeled fU was not observed. Depicted fC-levels represent technical mean values ±SD. 
 
Supplementary Figure 7. Tet1 and Tet2 generate hmU in HEK-293T and in vitro (a) Effect of Tet1 
overexpression on modified pyrimidines in HEK-293T cells. Modification levels in cells overexpressing wt and 
catalytic mutant versions of Tet1 catalytic domain (Tet1cd, blue bars and Tet1cm, gray bars, respectively), or a 
control construct (white bars). Depicted are mean values ±SD of technical triplicates on a logarithmic scale. (b) 
Pyrimidine modification levels in methylated plasmid DNA after treatment in vitro with Tet1cd. Depicted are 
mean values ±SD of technical duplicates. Note the logarithmic scale. 
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Supplementary Figure 8. Exponential models for fitting the decay curve of fC, caC and hmU in combined data 
sets from differentiation of R1 and C57Bl6/129-derived mESCs (6 biological independent experiments). In a 
simplified approach a single exponential decay model (y = y0 + A*exp(-x/t0)) was plotted using ORIGIN®. The 
parameters y0 (offset), t0 (time constant) and A (amplitude) of each decay function were iteratively optimized until 
the minimum of the Chi2 value of the fitting was reached. Half-life times (t1/2= t0*ln2) for fC, caC and hmU were 
7.2±1.2, 5.1±1.1 and 4.1 h, respectively. 
 
Supplementary Figure 9. Normalized transcript levels of Dnmts (c), Tet1–3 (d) and normalized modification 
levels of mC (c), hmC, fC and hmU (d) during differentiation of naïve mESCs in the presence of FGF-2 and ActA.  
 
 
Supplementary Figure 10. Expression level analysis of Tdg and Smug1 during differentiation of mESCs in the 
presence of FGF-2 and ActA. Expression levels were quantified with respect to the housekeeping gene Gapdh and 
normalized to time point 0 h. Depicted are technical mean values ± SD. 
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Supplementary Figure 11. (a) Scatterplot of proteins enriched with the hmU:A containing oligomer. Ratios of a 
forward and a reverse experiment are plotted. Specific readers in the forward and reverse experiment are marked 
in blue. Direct-specific readers are identified by the presence of the DNA-protein cross linker and marked in red. 
Gray dots are considered unspecific binders. See Fig. 6 for detailed view. (b) Gene Ontology Analysis performed 
with DAVID Bioinformatics Resources 6.74 
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Supplementary Figure 12. Effect on modified pyrimidines in HEK-293T cells upon Tet1cd and Uhrf1 (light gray 
bars) or Uhrf2 (gray bars) co-overexpression. Depicted are mean values ±SD of technical triplicates on a 
logarithmic scale. 
 
  
Nature Chemical Biology: doi:10.1038/nchembio.1532
 8 
 
Supplementary Table 1. Isotope tracing experiments by supplementing the growth medium of mES cells (LIF), 
differentiating mESCs (R1, without growth factors) and HEK-293T cells with either [13C,15N2]-T (50 or 100 µM) 
or [13C,D3]-methionine (0.2 mM). Small deviations in the exchange yields are due to differential noise sources and 
are negligible. LOD = Limit of detection. In case of [13C,D1]-fU no difference was observed compared to the 
natural control. 
cell type growth medium [
13C,15N2]-T /
T [%] 
[13C,15N2]-hmU /
hmU [%] 
[13C,15N2]-fU / 
fU [%]  
mESC (2i) 100 µM natural T 0.1 < LOD < LOD  
mESC (2i) 100 µM [13C,15N2]-T 76.0 78.2 74.6  
HEK + Tet1cd (72h) 50 µM [13C,15N2]-T 73.8 74.2 71.0  
      
cell type growth medium [
13C,D3]-mC /
mC [%] 
[13C,D2]-hmC / 
hmC [%] 
[13C,D2]-hmU / 
hmU [%] 
[13C,D1]-fU /
fU [%] 
mESC (LIF) natural methionine 0.1 < LOD < LOD 3.3 
mESC (LIF; 0 h) [13C,D3]-methionine 88.9 87.6 < LOD 3.0 
diff. mESC (12 h) [13C,D3]-methionine 89.3 88.4 < LOD 3.1 
diff. mESC (24 h) [13C,D3]-methionine 90.1 89.3 < LOD 3.2 
diff. mESC (48 h) [13C,D3]-methionine 90.4 90.5 < LOD 3.5 
mESC Tdg+/- [13C,D3]-methionine 88.0 87.6 < LOD 3.7 
mESC Tdg-/- [13C,D3]-methionine 87.4 87.2 < LOD < LOD 
mESC Tdg-/- + Tdg cm [13C,D3]-methionine 86.9 86.7 7.4 2.2 
HEK + Tet1cd (72h) [13C,D3]-methionine 87.4 83.4 < LOD < LOD 
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Supplementary Table 2. Assessment of ROS dependent hmU and fU product ratio of T-oxidation in HEK-293T 
wild type cells where TET activity is lowest (related to Fig. 3c). Modified nucleosides / N are given as mean values 
plus SD of three independent technical replicates. When T is oxidized by ROS about 9.8% hmU and 90.2% fU is 
generated. 
n 
mC / N hmC / N fC / N caC / N  
techn. 
mean SD 
techn. 
mean SD 
techn. 
mean SD 
techn. 
mean  
1 6.14E-03 1.97E-04 2.92E-05 9.90E-08 2.56E-07 2.59E-09 n.d.  
2 6.21E-03 1.32E-05 2.95E-05 2.21E-09 3.10E-07 2.06E-08 n.d.  
3 5.76E-03 4.36E-05 3.32E-05 6.55E-07 2.86E-07 2.95E-09 n.d.  
4 9.01E-03 2.87E-04 5.23E-05 5.01E-07 3.50E-07 5.00E-09 n.d.  
5 8.80E-03 9.62E-05 3.39E-05 5.44E-07 2.43E-07 2.41E-09 n.d.  
6 8.55E-03 7.69E-05 3.70E-05 2.17E-07 2.14E-07 1.30E-08 n.d.  
biol. mean 7.41E-03  3.59E-05  2.76E-07    
biol. SD 1.52E-03  8.56E-06  4.90E-08    
         
n 
hmU / N fU / N hmU/ (hmU+fU) 
fU/ 
(hmU+fU) 8-oxo-G / N 
techn. 
mean SD 
techn. 
mean SD [%] [%] 
techn. 
mean SD 
1 2.66E-07 5.54E-08 5.15E-06 1.59E-07 4.9 95.1 8.49E-06 1.30E-07 
2 1.21E-06 1.62E-07 8.02E-06 6.66E-07 13.1 86.9 1.00E-05 1.98E-07 
3 3.65E-08 7.35E-09 9.76E-07 8.75E-09 3.6 96.4 3.02E-06 7.02E-08 
4 6.31E-07 9.10E-10 3.51E-06 3.28E-08 15.3 84.7 7.43E-06 1.34E-07 
5 7.21E-07 5.93E-08 4.89E-06 1.59E-07 12.8 87.2 1.06E-05 1.14E-07 
6 3.58E-07 4.95E-08 3.56E-06 9.64E-09 9.1 90.9 7.22E-06 1.15E-08 
biol. mean 5.37E-07  4.35E-06  9.8 90.2 7.80E-06  
biol. SD 4.13E-07  2.33E-06  4.8 4.8 2.70E-06  
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Supplementary Note 1: oligonucleotide sequences for protein pull-down 
assays 
Supplementary Table 3. DNA oligonucleotides used in protein pull-down studies. 
ODN Sequence (5´o 3´) Modifications 
1 Biotin-GCA-TCC-GGT-CAY-CGT-TCC-TTC-GGA Y = 5-octadienyl-U 
2 Biotin-GCA-TCC-GGT-CAY-CAT-TCC-TTC-GGA Y = 5-octadienyl-U 
3 
TCC-GAA-GGA-AXG-ATG-ACC-GGA-TGC 
X= T 
4 X= hmU 
5 X= C 
6 X= hmC 
7 Biotin-GCT-CAC-GCT-AGY-CGA-CTC-CGT-GCA Y = 5-octadienyl-U 
8 TGC-ACG-GAG-TXG-ACT-AGC-GTG-AGC X = T 
9 Y = hmU 
 
Hybridization scheme: 
Pull-down 1: hmU:A vs. T:A : ODN4/2 vs. ODN3/2 
Pull-down 2: hmU:G vs. C:G = ODN4/1 vs. ODN5/1 
Pull-down 3: hmC:G vs. C:G = ODN6/1 vs. ODN5/1 
Pull-down 4 (scrambled sequence): hmU:A vs. T:A = ODN9/7 vs. ODN8/7 
 
Supplementary Note 2: LC-UV-ESI-MS/MS analysis of DNA 
Supplementary Table 4. Compound-dependent LC-MS/MS-parameters used for the analysis of genomic DNA. 
CE: collision energy; CAV: collision cell accelerator voltage; EMV: electron multiplier voltage. The nucleosides 
were analyzed in the positive ([M+H]+ species) as well as in the negative ([M-H]- species) ion selected reaction 
monitoring mode (SRM). 
compound Precursor Ion (m/z) 
MS1 
Resolution 
Product 
Ion (m/z) 
MS2 
Resolution 
Dwell 
time 
[ms] 
CE 
(V) 
CAV 
(V) Polarity 
time segment 1.5–4.0 min 
[15N2]-caC 274.08 Wide 158.03 Wide 170 5 5 Positive 
caC 272.09 Wide 156.04 Wide 170 5 5 Positive 
[15N2,D2]-hmC 262.12 enhanced 146.07 enhanced 40 27 1 Positive 
hmC 258.11 enhanced 142.06 enhanced 40 27 1 Positive 
[D3]-mC 245.13 enhanced 129.09 enhanced 30 60 1 Positive 
mC 242.11 enhanced 126.07 enhanced 30 60 1 Positive 
C 228.1 enhanced 112.05 enhanced 1 1 0 Positive 
time segment 4.0–6.0 min 
[D2]-hmU 259.09 Wide 216.08 Wide 48 7 5 Negative 
[D2]-hmU 259.09 Wide 126.05 Wide 48 7 5 Negative 
hmU 257.08 Wide 214.07 Wide 48 7 5 Negative 
hmU 257.08 Wide 124.04 Wide 48 7 5 Negative 
[15N2]-fU 257.06 Wide 213.05 Wide 48 6 5 Negative 
fU 255.06 Wide 212.06 Wide 48 6 5 Negative 
time segment 6.0–9.0 min 
[15N5]-8-oxo-G 289.08 Wide 173.04 Wide 120 9 7 Positive 
8-oxo-G 284.1 Wide 168.05 Wide 120 9 7 Positive 
[15N2]-fC 258.09 Wide 142.04 Wide 120 5 5 Positive 
fC 256.09 Wide 140.05 Wide 120 5 5 Positive 
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Supplementary Table 5. Compound-dependent LC-MS/MS-parameters used for the analysis of genomic DNA 
obtained from cells which were grown in medium supplemented with labeled thymidine ([13C,15N2]-T). CE: 
collision energy; CAV: collision cell accelerator voltage; EMV: electron multiplier voltage. The nucleosides were 
analyzed in the positive ([M+H]+ species) as well as in the negative ([M-H]- species) ion selected reaction 
monitoring mode (SRM). 
compound Precursor Ion (m/z) 
MS1 
Resolution 
Product 
Ion (m/z) MS2 Resolution 
Dwell 
time 
[ms] 
CE 
(V) 
CAV 
(V) Polarity 
time segment 1.5–4.0 min 
[13C,15N2]-caC 275.09 wide 159.04 wide 65 5 5 Positive 
caC 272.09 wide 156.04 wide 65 5 5 Positive 
[13C,15N2]-hmC 261.11 enhanced 145.06 enhanced 40 27 1 Positive 
hmC 258.11 enhanced 142.06 enhanced 40 27 1 Positive 
[13C,15N2]-mC 245.13 enhanced 129.09 enhanced 30 60 1 Positive 
mC 242.11 enhanced 126.07 enhanced 30 60 1 Positive 
[13C,15N2]-C 231.1 enhanced 115.05 enhanced 40 1 3 Positive 
C 228.1 enhanced 112.1 enhanced 40 1 3 Positive 
time segment 4.0–6.0 min 
[13C,15N2]-hmU 260.08 wide 215.07 wide 50 7 5 Negative 
hmU 257.08 wide 214.07 wide 50 7 5 Negative 
[13C,15N2]-fU 258.06 wide 213.05 wide 50 6 5 Negative 
fU 255.06 wide 212.06 wide 50 6 5 Negative 
time segment 6.0–9.0 min 
[15N5]-8-oxo-G 289.08 wide 173.04 wide 80 9 7 Positive 
8-oxo-G 284.1 wide 168.05 wide 80 9 7 Positive 
[13C,15N2]-fC 259.09 wide 143.04 wide 80 5 5 Positive 
fC 256.09 wide 140.05 wide 80 5 5 Positive 
[13C,15N2]-T 246.1 enhanced 130.05 enhanced 30 40 3 Positive 
T 243.1 enhanced 127.05 enhanced 30 40 3 Positive 
 
Supplementary Table 6. Compound-dependent LC-MS/MS-parameters used for the analysis of genomic DNA 
obtained from cells which were grown in medium supplemented with labeled (methyl-13C,D3)-methionine.CE: 
collision energy; CAV: collision cell accelerator voltage; EMV: electron multiplier voltage. The nucleosides were 
analyzed in the positive ([M+H]+ species) as well as in the negative ([M-H]- species) ion selected reaction 
monitoring mode (SRM). 
compound Precursor Ion (m/z) 
MS1 
Resolution 
Product 
Ion (m/z) MS2 Resolution 
Dwell 
time 
[ms] 
CE 
(V) 
CAV 
(V) Polarity 
time segment 1.5–4.0 min 
[13C]-caC 273.09 wide 157.04 wide 65 5 5 Positive 
caC 272.09 wide 156.04 wide 65 5 5 Positive 
[13C,D2]-hmC 261.12 enhanced 145.08 enhanced 40 27 1 Positive 
hmC 258.11 enhanced 142.06 enhanced 40 27 1 Positive 
[13C,D3]-mC 246.14 enhanced 130.09 enhanced 30 60 1 Positive 
mC 242.11 enhanced 126.07 enhanced 30 60 1 Positive 
C-dN 228.1 enhanced 112.1 enhanced 40 1 3 Positive 
time segment 4.0–6.0 min 
[13C,D2]-hmU 260.09 wide 217.09 wide 60 7 5 Negative 
hmU 257.08 wide 214.07 wide 60 7 5 Negative 
[13C,D]-fU 257.07 wide 214.07 wide 60 6 5 Negative 
fU 255.06 wide 212.06 wide 60 6 5 Negative 
time segment 6.0–9.0 min 
[15N5]-8-oxo-G 289.08 wide 173.04 wide 80 9 7 Positive 
8-oxo-G 284.1 wide 168.05 wide 80 9 7 Positive 
[13C,D]-fC 258.1 wide 142.06 wide 80 5 5 Positive 
fC 256.09 wide 140.05 wide 80 5 5 Positive 
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Spiking amounts of labeled internal standards for quantitative LC-MS/MS analysis 
The quantification of nucleosides of genomic DNA isolated from mESC or mouse tissue was carried 
out with the following amounts of internal standards: 51.03 pmol [D3]-mC, 7.655 pmol [15N2,D2]-hmC, 
45.6 fmol [15N2]-fC, 43.0 fmol [15N2]-caC, 108.9 fmol [15N5]-8-oxo-G; 160.1 fmol [D2]-hmU and 
180.0 fmol [15N2]-fU. The quantification of nucleosides of genomic DNA isolated from HEK293 cells 
overexpressing Tet was carried out with the following amounts of internal standards: 34.02 pmol [D3]-
mC, 5.103 pmol [15N2,D2]-hmC, 303.8 fmol [15N2]-fC, 215.1 fmol [15N2]-caC, 108.9 fmol [15N5]-8-oxo-
G; 160.1 fmol [D2]-hmU and 180.0 fmol [15N2]-fU. Genomic DNA samples isolated from cells grown 
in media supplemented with either [13C,15N2]-T or [13C,D3]-methionine were not spiked with internal 
standards except [15N5]-8-oxo-G. 
Validation of the LC-UV-MS/MS quantification method: 
Method validation, in particular linearity, precision, and accuracy (i.e. determined from matrix samples 
spiked with isotopically labeled internal standards) of the established method were investigated. 
Validation for the established LC-UV-ESI-MS/MS quantification method was based on three different 
series (i.e., calibration functions and quality control samples) accomplished on different days. Each 
calibration standard (5-8 standard concentrations) was analyzed five times. Each validation experiment 
was complemented by matrix blanks (analyzed in triplicates) to ensure selectivity and specificity of the 
method. Linear regression was applied by Origin® 6.0 (Microcal™) to obtain calibration curves. 
Therefore, the ratio of the area under the curve (A/A*) of the unlabeled nucleoside to the internal 
standard (*) was plotted against the ratio of the amount of substance (n/n*) of the unlabeled nucleoside 
to the internal standard (*) (see Supplementary Fig. 13). Calibration functions were calculated without 
weighting. Additionally, acceptable accuracy (80–120%) as well as precision (<20% RSD) was 
required. Accuracy was proven by computing the amount of substance n from the obtained A/A* ratios 
of the calibration standards using the respective calibration function. Here, accuracy was defined as the 
ratio of the used amount of substance to the calculated amount of substance in percent and had to be 
between 80–120% for each standard concentration. Precision was defined as follows: technical 
replicates of A/A* ratios for each calibration standard had to have relative standard deviations (RSD) 
smaller than 20%. The lower limit of quantification (LLOQ) was defined as the lowest concentration 
fulfilling the requirements of accuracy and precision and achieving a response of at least three times the 
response compared with the blank response. A compilation of absolute and relative LLOQs is shown in 
Supplementary Table 7. 
Quality control samples to evaluate intra-batch precision (see below) were investigated using a 
biological sample spiked with internal standards. Long-term stability of aqueous solutions of the labeled 
and unlabeled nucleosides at a storage temperature of −20 °C was investigated over two months 
including several freeze and thaw cycles by analyzing the MS/MS-responses with each batch. 
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Supplementary Table 7. Compilation of absolute lower limits of quantification [fmol] (LLOQ; see 
Supplementary Fig. 13) and relative LLOQs [per N] depending on the amount of DNA, which is digested. The 
relative LLOQs were computed by generating ratios of the absolute LLOQ [pmol] to the total amount of 
nucleosides (N; [pmol]) in the respective amount of DNA [µg]. The total amount of nucleosides was obtained by 
using the average molar mass of 308.91 g mol-1 for the monomeric DNA entity by taking the GC-content (21% C 
or G) in mouse into account. 
 
absolute
LLOQ  
[fmol] 
relative
LLOQ  
[per N] 
relative
LLOQ  
[per N] 
relative
LLOQ  
[per N] 
DNA amount  5 µg 10 µg 25 µg 
mC 104.5 6.5E-06 3.2E-06 1.3E-06 
hmC 100.8 6.2E-06 3.1E-06 1.2E-06 
fC 2.1 1.3E-07 6.5E-08 2.6E-08 
caC 2.0 1.2E-07 6.2E-08 2.5E-08 
8-oxo-G 2.0 1.2E-07 6.2E-08 2.5E-08 
dU 14.1 8.7E-07 4.4E-07 1.7E-07 
hmU 6.4 4.0E-07 2.0E-07 7.9E-08 
fU 5.7 3.5E-07 1.8E-07 7.0E-08 
 
 
Intra-batch assay and quantification data processing: 
In order to evaluate intra-batch precision (see below) quality samples were investigated using a 
biological sample spiked with internal standards. The intra-batch-assay was performed for the LC-ESI-
MS/MS analysis of the nucleosides G, C, mC, hmC, fC, caC, hmU, fU and 8-oxo-G. For this, a 
representative mESC DNA sample was analyzed. Technical replicates (n=5; each 4 µg DNA) were 
independently prepared using the below described digestion protocol. For data processing MassHunter 
Quantitative Analysis from Agilent was used. The area under the curve (A) was determined by LC-
MS/MS for mC, hmC, fC, caC, hmU, fU, 8-oxo-G and for the corresponding labeled internal standards 
(A*); the area under the curve (AUV) for G and C was determined by LC-UV. The amount of substance 
(n; pmol) of each nucleoside was computed by using the calibration curves (see Supplementary Fig. 
13). The total sample volume was 40 µL, the injection volume after sample filtration was 29 µL. 
Therefore, the obtained values of G and C by LC-UV quantification were corrected by the factor given 
by the ratio of 40 µL/29 µL. Careful monitoring of the exact pipetting and injection volumes was 
therefore necessary. The obtained absolute amounts (pmol) of the DNA modifications (X= C, mC, fC, 
caC, hmU, fU, 8-oxo-G) were then related to the amount of G (pmol) giving ratios of X / G in %. The 
sum of X / G was defined as 100%. These values were then transferred in X / N values, considering that 
the G content is 21% in mouse.  
The determined A/A* ratios of the DNA nucleosides to the labeled internal standards (see 
Supplementary Table 8) showed a high precision (RSD = 3.9-18%) for each nucleoside. The necessity 
in using labeled internal standards for quantification is shown by comparing these results with the 
relative standard deviation (RSD = 7.6-49.5%) of the uncorrected mass signal (A) of the respective DNA 
modification. Moreover, in order to gain precision between sample batches measured on different days 
(data not shown), it is even more important to use internal standards. No memory effect was observed 
during blank experiments performed after several measurements of a sample. The blank analyses were 
not contaminated by carry-over. 
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Supplementary Figure 13. UV and LC-MS/MS calibration curves and representative chromatograms of C (UV), 
G (UV), mC/[D3]-mC, hmC/[15N2,D2]-hmC, fC/[15N2]-fC, caC/[15N2]-caC, 8-oxo-G/[15N5]8-oxo-G, U/[15N2]-U, 
hmU/[D2]-hmU, fU/[15N2]-fU. These were obtained by applying the compound-dependent parameters summarized 
in Supplementary Table 4. For hmU the MS/MS transition 257→214 was used. Depicted are the means of five 
technical replicates of one sample batch. Error bars reflect SD. Linearity was given across the following compound 
amounts in 29 µL injection volume: 10.63–7751 pmol C; 19.11–4892 pmol G; 104.5 fmol–228.6 pmol mC; 
100.8 fmol–73.45 pmol hmC; 2.1–515.0 fmol fC; 2.0–496.6 fmol caC; 2.0–475.7 fmol 8-oxo-G; 6.4–519.3 fmol 
hmU; 5.7–459.6 fmol fU. The amounts of the labeled internal standards in 29 µL injection volume were as follows: 
51.03 pmol [D3]-mC; 7.655 pmol [15N2,D2]-hmC; 45.6 fmol [15N2]-fC; 43.0 fmol [15N2]-caC; 108.9 fmol [15N5]-8-
oxo-G; 96.1 fmol [D2]-hmU; 135.0 fmol [15N2]-fU. 
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Supplementary Table 8. Intra-batch-assay and quantification data processing. 
 AUV(G) n(G) [pmol] AUV(C) n(C) [pmol] C / G [%] C / N 
techn. replicate 1 956 2431 485 2341 96.3 2.02E-01 
techn. replicate 2 980 2493 495 2391 95.9 2.01E-01 
techn. replicate 3 1043 2654 531 2566 96.7 2.03E-01 
techn. replicate 4 979 2492 498 2406 96.5 2.03E-01 
techn. replicate 5 982 2498 498 2406 96.3 2.02E-01 
techn. mean value 988 2513 501 2422 96.4 2.02E-01 
SD 33 83 18 85 0.3 6.29E-04 
RSD [%] 3.3 3.3 3.5 3.5 0.3 0.3 
       
 A(mC) A([D3]-mC) A(mC)/ A([D3]-mC n(mC) [pmol] mC / G [%] mC / N 
techn. replicate 1 636358 510501 1.247 91.9 3.78 7.94E-03 
techn. replicate 2 678284 512180 1.324 97.7 3.92 8.23E-03 
techn. replicate 3 565889 447103 1.266 93.4 3.52 7.39E-03 
techn. replicate 4 664238 546597 1.215 89.6 3.60 7.56E-03 
techn. replicate 5 719777 570445 1.262 93.1 3.73 7.82E-03 
techn. mean value 652909 517365 1.263 93.1 3.71 7.79E-03 
SD 57206 46591 0.040 2.9 0.16 3.30E-04 
RSD [%] 8.8 9.0 3.1 3.1 4.2 4.2 
       
 A(hmC) A([D2,15N2]-hmC) 
A(hmC)/ 
A([D2,15N2]-
hmC) 
n(hmC) [pmol] hmC / G [%] hmC / N 
techn. replicate 1 80754 84338 0.958 8.51 0.350 7.35E-04 
techn. replicate 2 115869 108774 1.065 9.46 0.380 7.97E-04 
techn. replicate 3 264594 269496 0.982 8.72 0.329 6.90E-04 
techn. replicate 4 139093 133830 1.039 9.23 0.371 7.78E-04 
techn. replicate 5 116163 106074 1.095 9.73 0.389 8.18E-04 
techn. mean value 143295 140502 1.028 9.13 0.364 7.64E-04 
SD 70941 74213 0.057 0.51 0.024 5.12E-05 
RSD [%] 49.5 52.8 5.6 5.6 6.7 6.7 
       
 A(fC) A([15N2]-fC) A(fC)/ A([15N2]-fC) n(fC) [pmol] fC / G [%] fC / N 
techn. replicate 1 163427 31747 5.148 0.199 8.18E-03 1.72E-05 
techn. replicate 2 178366 32585 5.474 0.211 8.48E-03 1.78E-05 
techn. replicate 3 196827 35504 5.544 0.214 8.07E-03 1.69E-05 
techn. replicate 4 193392 33755 5.729 0.221 8.88E-03 1.86E-05 
techn. replicate 5 193493 35959 5.381 0.208 8.32E-03 1.75E-05 
techn. mean value 185101 33910 5.455 0.211 8.38E-03 1.76E-05 
SD 14070 1816 0.214 0.008 3.17E-04 6.66E-07 
RSD [%] 7.6 5.4 3.9 3.9 3.8 3.8 
 A(caC) A([15N2]-caC) A(caC)/ A([15N2]-caC) n(caC) [pmol] caC / G [%] caC / N 
techn. replicate 1 1444 6666 0.217 0.0104 4.28E-04 8.99E-07 
techn. replicate 2 1735 8205 0.211 0.0102 4.08E-04 8.57E-07 
techn. replicate 3 2111 9709 0.217 0.0104 3.93E-04 8.26E-07 
techn. replicate 4 1985 8301 0.239 0.0114 4.59E-04 9.63E-07 
techn. replicate 5 1927 8581 0.225 0.0108 4.31E-04 9.05E-07 
techn. mean value 1840 8292 0.222 0.0106 4.24E-04 8.90E-07 
SD 260 1089 0.011 0.0005 2.48E-05 5.20E-08 
RSD [%] 14.1 13.1 4.8 4.6 5.8 5.8 
       
 A(hmU) A([D2]-hmU) A(hmU)/ A([D2]-hmU) n(hmU) [pmol] hmU / G [%] hmU / N 
techn. replicate 1 894 5799 0.154 0.0090 3.69E-04 7.74E-07 
techn. replicate 2 1278 6368 0.201 0.0130 5.23E-04 1.10E-06 
techn. replicate 3 1561 7679 0.203 0.0133 5.00E-04 1.05E-06 
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techn. replicate 4 1695 8148 0.208 0.0137 5.49E-04 1.15E-06 
techn. replicate 5 1236 9010 0.137 0.0075 3.00E-04 6.29E-07 
techn. mean value 1333 7401 0.181 0.0113 4.48E-04 9.41E-07 
SD 312 1309 0.033 0.0029 1.08E-04 2.27E-07 
RSD [%] 23.4 17.7 18.1 25.3 24.2 24.2 
       
 A(fU) A([15N2]-fU) A(fU)/ A([15N2]-fU) n(fU) [pmol] fU / G [%] fU / N 
techn. replicate 1 7527 19661 0.383 0.0553 2.27E-03 4.78E-06 
techn. replicate 2 8672 22769 0.381 0.0550 2.21E-03 4.63E-06 
techn. replicate 3 11884 23930 0.497 0.0711 2.68E-03 5.63E-06 
techn. replicate 4 10143 27784 0.365 0.0528 2.12E-03 4.45E-06 
techn. replicate 5 14349 30152 0.476 0.0682 2.73E-03 5.73E-06 
techn. mean value 10515 24859 0.420 0.0605 2.40E-03 5.04E-06 
SD 2695 4148 0.061 0.0085 2.82E-04 5.93E-07 
RSD [%] 25.6 16.7 14.5 14.0 11.7 11.7 
       
 A(8oxo-G) A([15N5]-8oxo-G) 
A(8oxo-G)/
A([15N5]-
8oxo-G) 
n(8oxo-G) [pmol] 8oxo-G / G [%] 8oxoG / N
techn. replicate 1 237655 245919 0.966 0.113 4.63E-03 9.73E-06 
techn. replicate 2 256991 266182 0.965 0.113 4.51E-03 9.48E-06 
techn. replicate 3 310924 294412 1.056 0.123 4.64E-03 9.74E-06 
techn. replicate 4 282245 299479 0.942 0.110 4.41E-03 9.26E-06 
techn. replicate 5 327930 305105 1.075 0.125 5.01E-03 1.05E-05 
techn. mean value 283149 282219 1.001 0.117 4.64E-03 9.75E-06 
SD 37187 25225 0.060 0.007 2.28E-04 4.79E-07 
RSD [%] 13.1 8.9 6.0 6.0 4.9 4.9 
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Supplementary Note 3: LC-MS/MS quantification results of genomic DNA 
Supplementary Table 9. LC-MS/MS quantification results of mESC (WT01, J1 and R1) wild type, knock down 
(KD) and knock out cells (related to Fig. 1c,, 2a and 4a). The results of independent biological replicates are shown, 
the biological mean values / N and the biological standard deviation (SD). n.d. = not detected. 
biol. replicate C / N mC / N hmC / N fC / N caC / N hmU / N fU / N 8-oxo-G / N 
mESC (WT01) 1 2.01E-01 8.08E-03 6.53E-04 9.35E-06 6.01E-07 6.94E-07 3.51E-06 6.75E-06 
mESC (WT01) 2 2.02E-01 7.71E-03 6.41E-04 9.81E-06 5.90E-07 7.04E-07 2.52E-06 5.95E-06 
mESC (WT01) 3 2.02E-01 7.78E-03 6.82E-04 9.26E-06 5.24E-07 4.81E-07 1.60E-06 4.02E-06 
mESC (WT01) 4 2.01E-01 8.17E-03 6.92E-04 1.03E-05 6.44E-07 4.73E-07 2.17E-06 4.90E-06 
mESC (WT01) 5 2.02E-01 6.72E-03 8.63E-04 1.36E-05 7.25E-07 3.83E-07 4.34E-06 5.76E-06 
mESC (WT01) 6 2.03E-01 6.43E-03 7.70E-04 1.32E-05 3.81E-07 5.14E-07 1.30E-06 3.17E-06 
mESC (WT01) 7 2.03E-01 6.10E-03 8.18E-04 1.08E-05 6.77E-07 4.78E-07 1.03E-06 3.47E-06 
biol. mean value 2.02E-01 7.28E-03 7.31E-04 1.09E-05 5.92E-07 5.32E-07 2.35E-06 4.86E-06 
SD 7.75E-04 8.48E-04 8.63E-05 1.81E-06 1.13E-07 1.21E-07 1.21E-06 1.36E-06 
 
biol. replicate C / N mC / N hmC / N fC / N caC / N hmU / N fU / N 8-oxo-G / N 
Tet1 KD  (WT01) 1 2.01E-01 8.99E-03 2.76E-04 3.31E-06 2.21E-07 1.42E-07 7.98E-07 3.21E-06 
Tet1 KD  (WT01) 2 2.02E-01 7.77E-03 1.39E-04 2.53E-06 2.20E-07 6.44E-08 2.00E-06 3.73E-06 
Tet1 KD  (WT01) 3 2.03E-01 6.37E-03 2.36E-04 6.51E-06 2.07E-07 3.07E-07 4.13E-06 7.08E-06 
biol. mean value 2.02E-01 7.71E-03 2.17E-04 4.11E-06 2.16E-07 1.71E-07 2.31E-06 4.67E-06 
SD 1.33E-03 1.31E-03 7.03E-05 2.11E-06 7.87E-09 1.24E-07 1.69E-06 2.10E-06 
 
biol. replicate C / N mC / N hmC / N fC / N caC / N hmU / N fU / N 8-oxo-G / N 
Tet2 KD (WT01) 1 2.00E-01 9.41E-03 4.45E-04 6.12E-06 2.38E-07 9.51E-08 5.18E-07 2.82E-06 
Tet2 KD (WT01) 2 2.02E-01 7.25E-03 3.38E-04 4.52E-06 9.02E-08 3.23E-07 6.01E-07 1.78E-06 
Tet2 KD (WT01) 3 2.02E-01 7.36E-03 3.98E-04 6.25E-06 3.36E-07 1.21E-07 2.50E-06 5.21E-06 
Tet2 KD (WT01) 4 2.02E-01 7.69E-03 3.90E-04 6.78E-06 3.37E-07 n.d. 1.16E-06 6.52E-06 
biol. mean value 2.02E-01 7.93E-03 3.93E-04 5.92E-06 2.50E-07 1.80E-07 1.20E-06 4.08E-06 
SD 1.04E-03 1.01E-03 4.36E-05 9.73E-07 1.16E-07 1.25E-07 9.16E-07 2.17E-06 
 
biol. replicate C / N mC / N hmC / N fC / N caC / N hmU / N fU / N 8-oxo-G / N 
mESC (J1) 1 2.04E-01 5.53E-03 3.61E-04 2.18E-06 7.95E-07 1.48E-06 3.98E-06 6.68E-06 
mESC (J1) 2 2.04E-01 5.63E-03 3.32E-04 2.17E-06 9.30E-07 1.41E-06 4.19E-06 6.64E-06 
biol. mean value 2.04E-01 5.58E-03 3.47E-04 2.17E-06 8.62E-07 1.44E-06 4.08E-06 6.66E-06 
SD 4.96E-05 6.97E-05 2.06E-05 8.94E-09 9.55E-08 4.91E-08 1.51E-07 2.93E-08 
 
biol. replicate C / N mC / N hmC / N fC / N caC / N hmU / N fU / N 8-oxo-G / N 
DNMT1 -/- (J1) 1 2.07E-01 2.72E-03 1.80E-04 1.36E-06 3.10E-07 1.68E-06 4.56E-06 7.22E-06 
DNMT1 -/- (J1) 2 2.07E-01 2.71E-03 1.77E-04 1.55E-06 2.94E-07 1.56E-06 3.90E-06 6.73E-06 
biol. mean value 2.07E-01 2.72E-03 1.79E-04 1.46E-06 3.02E-07 1.62E-06 4.23E-06 6.97E-06 
SD 5.80E-06 3.35E-06 2.28E-06 1.31E-07 1.11E-08 8.47E-08 4.73E-07 3.45E-07 
 
biol. replicate C / N mC / N hmC / N fC / N caC / N hmU / N fU / N 8-oxo-G / N 
DNMT3ab -/- (J1) 1 2.10E-01 4.12E-04 3.01E-05 2.46E-07 n.d. 8.02E-07 6.25E-07 2.68E-06 
DNMT3ab -/- (J1) 2 2.10E-01 3.76E-04 3.54E-05 5.67E-07 n.d. 2.60E-06 7.86E-07 5.73E-06 
DNMT3ab -/- (J1) 3 2.10E-01 3.81E-04 3.03E-05 3.71E-07 n.d. 2.27E-06 3.94E-07 2.32E-06 
DNMT3ab -/- (J1) 4 2.10E-01 2.67E-04 2.67E-05 4.52E-07 n.d. 1.71E-06 4.50E-07 1.79E-06 
DNMT3ab -/- (J1) 5 2.10E-01 2.50E-04 1.07E-05 3.78E-07 n.d. 7.41E-07 4.51E-06 7.68E-06 
DNMT3ab -/- (J1) 6 2.10E-01 2.32E-04 1.60E-05 2.64E-07 n.d. 5.28E-07 2.87E-06 5.50E-06 
biol. mean value 2.10E-01 3.20E-04 2.48E-05 3.80E-07  1.44E-06 1.61E-06 4.28E-06 
SD 9.60E-05 7.83E-05 9.51E-06 1.19E-07  8.76E-07 1.70E-06 2.35E-06 
 
biol. replicate C / N mC / N hmC / N fC / N caC / N hmU / N fU / N 8-oxo-G / N 
mESC (R1) 1 2.01E-01 8.37E-03 2.00E-04 1.04E-06 n.d. 1.52E-06 2.56E-06 1.21E-05 
mESC (R1) 2 2.03E-01 6.76E-03 3.30E-04 2.00E-06 3.03E-07 9.23E-07 1.20E-06 n.d. 
mESC (R1) 3 2.01E-01 8.68E-03 2.70E-04 2.12E-06 n.d. 1.77E-06 4.67E-06 1.05E-05 
biol. mean value 2.02E-01 7.94E-03 2.67E-04 1.72E-06 3.03E-07 1.40E-06 2.81E-06 8.42E-06 
SD 9.92E-04 1.03E-03 6.52E-05 5.91E-07  4.35E-07 1.75E-06 5.00E-06 
Nature Chemical Biology: doi:10.1038/nchembio.1532
 19 
 
Supplementary Table 10. LC-MS/MS quantification results of different murine organs of 3 months old wild type 
individuals (n) (related to Fig. 1d, 2 and Supplementary Fig. 2). Compiled are mean values / N obtained from three 
independent technical replicates and the standard deviation (SD).  
n organ DNA isolation C / N mC / N hmC / N fC / N 
      techn. mean SD 
techn. 
mean SD 
techn. 
mean SD 
techn. 
mean SD 
1 cerebellum   2.01E-01 2.30E-04 8.06E-03 2.40E-04 6.59E-04 1.08E-05 3.45E-07 3.14E-08 
1 cerebellum BHT, + Desf., 2.01E-01 2.67E-04 8.27E-03 2.59E-04 7.37E-04 1.76E-05 2.86E-07 1.30E-08 
1 cerebellum BHT, + Desf., +THU 2.01E-01 3.66E-04 8.52E-03 3.45E-04 7.29E-04 2.14E-05 2.97E-07 2.03E-08 
2 cerebellum BHT, + Desf., +THU 2.00E-01 3.92E-04 9.81E-03 2.80E-04 6.37E-04 4.00E-05 2.73E-07 1.16E-08 
3 cerebellum BHT, + Desf., +THU 2.00E-01 3.95E-04 8.95E-03 3.45E-04 6.90E-04 2.91E-05 2.61E-07 1.57E-08 
4 cerebellum BHT, + Desf., +THU 2.00E-01 4.55E-04 9.46E-03 3.60E-04 6.69E-04 2.45E-05 2.59E-07 3.89E-09 
                      
1 kidney   2.01E-01 1.72E-04 8.13E-03 1.59E-04 4.37E-04 2.79E-05 2.27E-07 1.10E-08 
1 kidney BHT, + Desf. 2.02E-01 3.38E-04 7.79E-03 3.29E-04 4.33E-04 8.84E-06 2.25E-07 2.75E-08 
1 kidney BHT, + Desf., +THU 2.02E-01 1.70E-04 7.71E-03 1.76E-04 4.27E-04 2.15E-05 2.11E-07 1.19E-08 
2 kidney BHT, + Desf., +THU 2.01E-01 4.44E-04 8.59E-03 3.75E-04 3.78E-04 1.35E-05 1.86E-07 1.43E-08 
3 kidney BHT, + Desf., +THU 2.01E-01 1.46E-04 8.20E-03 1.02E-04 3.73E-04 1.67E-05 1.88E-07 8.82E-09 
4 kidney BHT, + Desf., +THU 2.01E-01 3.17E-04 8.30E-03 2.45E-04 3.79E-04 2.06E-05 1.94E-07 2.45E-08 
                      
1 cortex BHT, + Desf., +THU 2.00E-01 4.48E-04 9.06E-03 3.37E-04 1.12E-03 7.21E-05 4.09E-07 4.17E-08 
2 cortex BHT, + Desf., +THU 1.99E-01 2.05E-04 9.29E-03 1.48E-04 1.37E-03 2.05E-05 4.34E-07 1.14E-08 
3 cortex BHT, + Desf., +THU 2.00E-01 4.65E-04 9.23E-03 3.73E-04 1.14E-03 7.48E-06 4.24E-07 1.92E-08 
                      
1 hippocampus BHT, + Desf., +THU 1.98E-01 1.88E-04 1.08E-02 2.11E-04 1.56E-03 6.83E-05 4.49E-07 2.82E-08 
2 hippocampus BHT, + Desf., +THU 1.98E-01 2.13E-04 1.08E-02 1.73E-04 1.55E-03 3.08E-05 7.08E-07 4.67E-08 
3 hippocampus BHT, + Desf., +THU 1.97E-01 1.78E-04 1.09E-02 1.44E-04 1.71E-03 2.66E-05 3.89E-07 2.66E-08 
                      
1 heart BHT, + Desf., +THU 2.02E-01 3.25E-04 7.96E-03 2.87E-04 4.08E-04 3.32E-05 1.85E-07 1.66E-08 
2 heart BHT, + Desf., +THU 2.02E-01 1.68E-04 7.87E-03 1.31E-04 3.84E-04 2.30E-05 1.48E-07 2.64E-09 
3 heart BHT, + Desf., +THU 2.01E-01 4.25E-04 8.07E-03 3.42E-04 4.56E-04 4.39E-05 1.41E-07 1.35E-08 
                      
1 liver BHT, + Desf., +THU 2.01E-01 2.32E-04 8.35E-03 1.92E-04 2.44E-04 3.24E-06 1.66E-07 2.23E-08 
2 liver BHT, + Desf., +THU 2.02E-01 3.16E-04 8.10E-03 2.61E-04 2.73E-04 8.57E-06 1.78E-07 2.26E-08 
3 liver BHT, + Desf., +THU 2.01E-01 3.04E-04 8.42E-03 2.39E-04 2.82E-04 3.44E-05 1.81E-07 2.91E-08 
           
n organ DNA isolation hmU / N fU / N 8-oxo-G / N  
      
techn. 
mean SD 
techn. 
mean SD 
techn. 
mean SD   
1 cerebellum   7.27E-08   2.03E-06 2.29E-07 5.09E-06 1.92E-07   
1 cerebellum BHT, + Desf., n.d.   6.89E-07 2.65E-08 2.96E-06 6.04E-08   
1 cerebellum BHT, + Desf., +THU n.d.   8.05E-07 7.34E-08 3.30E-06 3.79E-08   
2 cerebellum BHT, + Desf., +THU 1.30E-07 7.94E-08 1.02E-06 4.83E-08 3.86E-06 2.70E-07   
3 cerebellum BHT, + Desf., +THU 6.01E-08 3.67E-08 9.33E-07 9.52E-08 3.66E-06 2.26E-07   
4 cerebellum BHT, + Desf., +THU 1.07E-07 7.00E-08 1.03E-06 8.63E-08 4.67E-06 5.69E-07   
                    
1 kidney   n.d.   7.58E-07 7.38E-08 3.66E-06 2.63E-07   
1 kidney BHT, + Desf. n.d.   7.00E-07 5.30E-08 3.24E-06 3.73E-07   
1 kidney BHT, + Desf., +THU n.d.   7.16E-07 1.73E-08 3.48E-06 2.63E-07   
2 kidney BHT, + Desf., +THU 1.08E-07 7.89E-08 1.08E-06 1.45E-07 3.73E-06 1.42E-07   
3 kidney BHT, + Desf., +THU 1.29E-07 9.06E-08 1.17E-06 1.67E-07 3.91E-06 5.99E-08   
4 kidney BHT, + Desf., +THU n.d.   9.34E-07 6.36E-08 3.65E-06 1.57E-07   
                    
1 cortex BHT, + Desf., +THU 1.46E-07 6.19E-09 1.28E-06 1.22E-07 2.51E-06 3.74E-08   
2 cortex BHT, + Desf., +THU 8.24E-08 2.81E-08 1.30E-06 7.35E-08 3.13E-06 1.16E-07   
3 cortex BHT, + Desf., +THU 2.05E-07 5.83E-08 1.43E-06 3.72E-08 3.58E-06 2.83E-07   
                    
1 hippocampus BHT, + Desf., +THU 2.74E-07 6.06E-08 2.18E-06 1.29E-07 6.30E-06 2.17E-07   
2 hippocampus BHT, + Desf., +THU 6.00E-07 5.50E-08 3.20E-06 3.46E-07 1.31E-05 7.69E-07   
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3 hippocampus BHT, + Desf., +THU 4.68E-08 1.85E-08 9.85E-07 2.26E-07 5.03E-06 8.96E-08   
                    
1 heart BHT, + Desf., +THU 4.14E-07 7.28E-08 1.97E-06 3.46E-07 7.85E-06 1.69E-06   
2 heart BHT, + Desf., +THU 9.81E-08 4.23E-09 1.15E-06 7.63E-08 2.48E-06 1.18E-07   
3 heart BHT, + Desf., +THU 1.04E-07 3.36E-08 1.55E-06 7.55E-08 3.14E-06 2.27E-07   
                    
1 liver BHT, + Desf., +THU n.d.   1.13E-06 9.97E-08 2.69E-06 3.93E-07   
2 liver BHT, + Desf., +THU 1.48E-07 8.67E-08 1.09E-06 1.96E-07 2.43E-06 9.41E-08   
3 liver BHT, + Desf., +THU 2.34E-08   1.05E-06 1.18E-07 2.39E-06 4.69E-08   
 
Supplementary Table 11. LC-MS/MS quantification results of n = 6 independent mESC differentiation 
experiments without growth factors (related to Fig. 5a,b). Compiled are mean values / N obtained from three 
independent technical measurements and their standard deviation (SD). K = C57Bl6/129 derived mES cell line. 
n Sample C / N mC / N hmC / N fC / N caC / N 
 mESC diff. time 
techn. 
mean SD 
techn. 
mean SD 
techn. 
mean SD 
techn. 
mean SD 
techn. 
mean SD 
1 K, t= 0h 2.06E-01 1.47E-04 3.79E-03 1.52E-04 4.25E-04 8.84E-06 1.68E-05 9.20E-07 1.21E-06 5.80E-08 
1 K, t= 8h 2.06E-01 9.23E-05 3.43E-03 9.96E-05 5.33E-04 1.27E-05 1.71E-05 7.46E-07 1.09E-06 2.97E-08 
1 K, t= 16h 2.06E-01 1.07E-04 3.88E-03 1.15E-04 4.93E-04 9.98E-06 6.69E-06 2.33E-07 3.92E-07 4.81E-08 
                       
2 R1, t= 0h 2.08E-01 1.38E-04 1.87E-03 1.05E-04 3.89E-04 3.33E-05 2.17E-05 5.00E-07 1.52E-06 6.10E-08 
2 R1, t= 8h 2.08E-01 2.55E-05 1.60E-03 1.73E-05 5.50E-04 1.14E-05 2.91E-05 1.12E-06 1.91E-06 3.30E-08 
2 R1, t= 16h 2.08E-01 7.54E-05 1.74E-03 7.53E-05 5.87E-04 1.28E-05 1.89E-05 4.48E-07 1.04E-06 2.38E-08 
                       
3 K, t= 0h 2.05E-01 6.83E-05 4.24E-03 6.36E-05 3.84E-04 6.03E-06 9.95E-06 1.46E-07 1.74E-07 1.70E-08 
3 K, t= 8h 2.05E-01 7.08E-05 4.08E-03 7.14E-05 4.85E-04 5.17E-06 1.47E-05 7.35E-07 2.60E-07 1.84E-08 
3 K, t= 24h 2.05E-01 5.00E-05 4.65E-03 5.74E-05 4.48E-04 7.86E-06 4.00E-06 1.67E-07 8.74E-08 2.02E-08 
                       
4 R1, t= 0h 2.07E-01 6.37E-05 2.49E-03 5.86E-05 4.61E-04 1.43E-05 1.71E-05 4.28E-07 3.25E-07 4.80E-08 
4 R1, t= 8h 2.07E-01 5.45E-05 2.27E-03 4.25E-05 5.53E-04 1.69E-05 2.63E-05 8.05E-07 5.71E-07 2.45E-08 
4 R1, t= 24h 2.06E-01 5.12E-05 3.00E-03 5.28E-05 5.93E-04 7.13E-06 8.39E-06 2.73E-07 1.74E-07 2.04E-08 
                       
5 K, t=0 h 2.04E-01 1.02E-04 5.38E-03 1.04E-04 3.89E-04 4.27E-06 7.66E-06 2.13E-07 2.29E-07 1.73E-08 
5 K, t=8 h 2.04E-01 1.74E-04 5.10E-03 1.72E-04 4.65E-04 4.64E-06 1.01E-05 5.36E-07 2.37E-07 8.38E-10 
5 K, t=16 h 2.04E-01 2.04E-04 5.88E-03 2.09E-04 5.22E-04 9.13E-06 4.40E-06 2.13E-07 1.92E-07 1.34E-08 
5 K, t=24 h 2.04E-01 1.84E-04 5.40E-03 1.79E-04 4.01E-04 6.47E-06 2.06E-06 1.87E-07 1.00E-07 1.16E-08 
5 K, t=40 h 2.04E-01 1.71E-04 5.72E-03 1.71E-04 3.00E-04 1.20E-06 1.20E-06 5.32E-08 7.93E-08   
                       
6 R1, t=0 h 2.06E-01 2.16E-05 3.56E-03 3.01E-05 5.85E-04 1.80E-05 2.08E-05 4.72E-07 5.49E-07 5.15E-08 
6 R1, t=8 h 2.05E-01 9.98E-05 3.83E-03 8.48E-05 7.63E-04 1.51E-05 2.05E-05 5.32E-07 8.74E-07 9.94E-09 
6 R1, t=16 h 2.06E-01 4.53E-05 3.44E-03 3.95E-05 6.89E-04 7.42E-06 1.20E-05 5.65E-07 3.03E-07 8.59E-09 
6 R1, t=24 h 2.06E-01 1.19E-04 3.57E-03 8.65E-05 6.16E-04 3.52E-05 7.18E-06 2.03E-07 1.55E-07 2.87E-08 
6 R1, t=40 h 2.05E-01 6.38E-06 4.95E-03 1.56E-05 4.42E-04 1.11E-05 1.97E-06 4.48E-08 9.46E-08 1.84E-08 
            
n Sample hmU / N fU / N 8-oxo-G / N    
 mESC diff. time 
techn. 
mean SD 
techn. 
mean SD 
techn. 
mean SD     
1 K, t= 0h 3.75E-07 1.67E-09 3.89E-06 2.73E-07 6.66E-06 2.74E-07     
1 K, t= 8h 1.08E-06 1.57E-07 4.83E-06 3.45E-07 7.79E-06 3.05E-07     
1 K, t= 16h 1.01E-06 1.76E-07 5.11E-06 5.69E-07 8.07E-06 5.57E-07     
                   
2 R1, t= 0h 1.14E-06 3.65E-07 3.82E-06 4.10E-07 6.70E-06 1.72E-07     
2 R1, t= 8h 2.97E-06 4.13E-07 5.23E-06 9.97E-08 9.08E-06 5.89E-07     
2 R1, t= 16h 3.75E-06 6.55E-07 5.15E-06 5.72E-07 8.81E-06 5.37E-07     
                   
3 K, t= 0h 8.76E-07 2.02E-08 8.86E-06 9.44E-07 1.35E-05 9.84E-07     
3 K, t= 8h 1.29E-06 1.76E-07 6.90E-06 9.81E-07 1.00E-05 6.53E-07     
3 K, t= 24h 6.55E-07 5.89E-08 6.72E-06 7.12E-07 9.73E-06 5.55E-07     
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4 R1, t= 0h 1.22E-06 1.58E-07 8.62E-06 7.83E-07 1.26E-05 8.90E-08     
4 R1, t= 8h 1.91E-06 2.69E-07 6.02E-06 4.56E-07 8.05E-06 2.35E-07     
4 R1, t= 24h 1.82E-06 3.67E-07 6.60E-06 6.25E-07 1.06E-05 6.27E-07     
                   
5 K, t=0 h 9.98E-07 2.95E-07 7.04E-06 1.35E-06 9.98E-06 9.08E-07     
5 K, t=8 h 2.97E-06 2.62E-07 6.89E-06 5.67E-07 9.64E-06 5.85E-07     
5 K, t=16 h 1.43E-06 3.46E-07 2.71E-06 1.92E-07 3.82E-06 3.04E-07     
5 K, t=24 h 8.01E-07 2.16E-07 6.60E-06 5.93E-07 9.72E-06 1.33E-07     
5 K, t=40 h 8.30E-07 3.44E-08 7.78E-06 1.31E-07 1.13E-05 3.07E-07     
                   
6 R1, t=0 h 1.85E-06 3.00E-07 8.62E-06 1.94E-07 1.12E-05 7.13E-07     
6 R1, t=8 h 3.77E-06 6.22E-07 4.01E-06 7.44E-07 6.02E-06 1.41E-06     
6 R1, t=16 h 3.94E-06 8.01E-08 5.93E-06 3.24E-07 7.61E-06 2.01E-07     
6 R1, t=24 h 3.84E-06 3.90E-07 8.92E-06 1.03E-06 1.23E-05 2.83E-07     
6 R1, t=40 h 1.84E-06 9.73E-08 8.44E-06 2.94E-07 1.26E-05 1.02E-06     
 
Supplementary Table 12. Relative modification levels of combined data sets from differentiation (0–40 h) of R1 
and C57Bl6/129-derived mESCs without growth factors (related to Fig. 5a and Supplementary Fig. 8). In order to 
obtain these, the absolute modification levels of t = 0 h time points compiled in Supplementary Table 11 were set 
as 1 and the modification levels of later time points respectively related to these. Summarized are the biological 
mean values at each differentiation time point and the standard deviation (SD). 
  relative C / N relative mC / N relative hmC / N 
time biol. mean SD biol. mean SD biol. mean SD 
t = 0 h 1.00000E+00  1.000E+00  1.000E+00  
t = 8 h 1.00024E+00 1.2480E-03 9.435E-01 7.579E-02 1.270E+00 8.082E-02 
t = 16 h 9.98952E-01 1.4308E-03 1.004E+00 7.157E-02 1.296E+00 1.629E-01 
t = 24 h 9.98556E-01 1.4742E-03 1.077E+00 9.513E-02 1.133E+00 1.176E-01 
t = 40 h 9.96347E-01 3.4067E-03 1.228E+00 2.314E-01 7.634E-01 1.034E-02 
       
  relative fC / N relative caC / N  
time biol. mean SD biol. mean SD   
t = 0 h 1.000E+00  1.000E+00    
t = 8 h 1.280E+00 2.318E-01 1.339E+00 3.329E-01   
t = 16 h 6.051E-01 1.980E-01 5.991E-01 2.175E-01   
t = 24 h 3.769E-01 9.373E-02 4.393E-01 1.122E-01   
t = 40 h 1.255E-01 4.352E-02 2.589E-01 1.225E-01   
       
  relative hmU / N relative fU / N relative 8-oxo-G / N 
time biol. mean SD biol. mean SD biol. mean SD 
t = 0 h 1.000E+00  1.000E+00  1.000E+00  
t = 8 h 2.258E+00 6.597E-01 9.221E-01 3.417E-01 9.024E-01 3.178E-01 
t = 16 h 2.390E+00 8.012E-01 9.337E-01 4.755E-01 8.978E-01 4.410E-01 
t = 24 h 1.278E+00 6.283E-01 8.742E-01 1.357E-01 9.086E-01 1.623E-01 
t = 40 h 9.129E-01 1.155E-01 1.043E+00 8.856E-02 1.129E+00 3.665E-04 
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Supplementary Table 13. LC-MS/MS quantification results of mESC differentiation with the growth factors 
FGF-2 and ActA (related to Supplementary Fig. 9). Modified nucleosides / N are given as mean values plus SD 
of three independent technical replicates. 
Sample C / N mC / N hmC / N fC / N 
EpiLC diff. time techn. mean SD 
techn. 
mean SD 
techn. 
mean SD 
techn. 
mean SD 
t= 0h 2.096E-01 1.40E-05 3.92E-04 1.35E-05 4.57E-05 6.48E-07 2.88E-07 4.52E-09 
t= 12h 2.093E-01 1.01E-05 5.80E-04 4.94E-06 6.85E-05 5.47E-06 1.65E-06 1.34E-07 
t= 24h 2.074E-01 1.17E-04 2.29E-03 1.02E-04 2.60E-04 1.41E-05 4.45E-06 6.30E-09 
t= 36h 2.044E-01 9.71E-05 4.96E-03 7.38E-05 5.81E-04 2.30E-05 6.16E-06 5.27E-08 
t= 48h 2.020E-01 8.85E-05 7.23E-03 8.83E-05 7.53E-04 8.90E-07 4.92E-06 1.31E-07 
 
Sample hmU / N fU / N 8-oxo-G / N 
EpiLC diff. time techn. mean SD 
techn. 
mean 
techn. 
mean SD 
techn. 
mean 
t= 0h 4.76E-07 7.05E-08 1.87E-06 9.10E-08 4.00E-06 1.10E-07 
t= 12h 2.01E-06 1.90E-07 3.91E-06 7.84E-07 9.80E-06 3.07E-07 
t= 24h 2.78E-06 7.20E-07 2.42E-06 3.65E-07 5.19E-06 1.45E-07 
t= 36h 2.10E-06 5.82E-07 2.20E-06 1.51E-07 5.42E-06 4.12E-07 
t= 48h 1.90E-06 1.03E-07 3.74E-06 3.74E-07 6.69E-06 3.08E-07 
 
Supplementary Table 14. HEK-293T wild type vs. HEK + Tet1cm vs. HEK + Tet1cd (related to Supplementary 
Fig. 7a). Modified nucleosides / N are given as mean values of three independent technical replicates. 
  HEK-293T wild type  HEK + Tet1cm  HEK + Tet1cd  
Nucleosides techn. mean SD techn. mean SD techn. mean SD 
C / N 2.01E-01 9.67E-05 2.02E-01 1.09E-04 2.03E-01 3.91E-04 
mC / N 8.80E-03 9.62E-05 8.04E-03 1.09E-04 4.18E-03 3.93E-05 
hmC / N 3.39E-05 5.44E-07 4.95E-05 1.04E-06 2.21E-03 9.42E-05 
fC / N 2.43E-07 2.41E-09 2.18E-07 1.17E-08 2.48E-04 5.96E-06 
caC / N n.d.  n.d.  1.29E-04 3.35E-06 
hmU / N 7.21E-07 5.93E-08 1.51E-07 9.07E-09 4.24E-05 2.51E-06 
fU / N 4.89E-06 1.59E-07 1.42E-06 6.66E-08 8.79E-06 1.07E-07 
8-oxo-G / N 1.06E-05 1.14E-07 6.83E-06 1.47E-07 8.31E-06 9.03E-07 
 
Supplementary Table 15. DNA modification levels of Tet1 in vitro assay (related to Supplementary Fig. 7b). 
Plasmid DNA with full CpG methylation was treated with commercially available Tet1. 
 plasmid mC / N hmC / N fC / N caC / N hmU / N fU / N 8-oxo-G / N 
untreated 4.8E-02 n.d. n.d. n.d. n.d. 4.4E-06 8.6E-06 
untreated 4.6E-02 n.d. n.d. n.d. n.d. 4.0E-06 9.4E-06 
+Tet1 7.6E-04 4.8E-03 5.0E-03 9.0E-03 3.8E-04 1.5E-04 4.0E-05 
+Tet1 6.5E-04 4.7E-03 4.8E-03 9.3E-03 4.4E-04 1.6E-04 3.7E-05 
-Tet1 4.8E-02 n.d. 3.5E-05 n.d. 1.6E-05 2.5E-04 4.0E-05 
-Tet1 4.7E-02 n.d. 3.5E-05 n.d. 1.2E-05 2.3E-04 4.5E-05 
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Supplementary Table 16. Effect of Smug1 depletion on modification levels in mESCs (R1) and effect of TDG 
and SMUG1 depletion on modification levels in HEK-293T cells overexpressing Tet1cd (related to Supplementary 
Fig. 5). Percent change values for modified nucleosides of cells treated with esiRNA (targeting Smug1/SMUG1 
or TDG) with respect to unrelated control esiRNA. The absolute modification content of HEK-293T cells was 
normalized based on Tet1cd expression levels (determined by TECAN reading). The percent change is given as a 
mean value of three independent technical replicates. 
  mESC  Smug1 KD HEK-293T + Tet1cd / TDG KD HEK-293T + Tet1cd / SMUG1 KD 
Nucleosides Percent change SD Percent change SD Percent change SD 
hmC -0.15 4.07 -2.22 2.61 -3.43 2.24 
fC -1.26 3.29 38.15 1.25 0.77 2.05 
caC 14.04 29.24 33.51 2.72 6.59 3.24 
hmU 37.14 9.47 -10.41 4.74 46.46 5.65 
fU 71.00 15.73 -4.36 2.34 22.66 1.91 
8-oxo-G 17.27 14.26 -5.36 2.04 -6.97 1.77 
 
Supplementary Table 17. HEK-293T wild type, HEK with Tet1cd-overexpression, Tet1cd/Uhrf1 co-
overexpression or Tet1cd/Uhrf2 co-overexpression (related to Supplementary Fig. 12). Modified nucleosides / N 
are given as mean values of three independent technical replicates. 
 HEK-293T wt  
HEK 
+ Tet1cd  
HEK 
+ Tet1cd 
+ Uhrf1
 
HEK 
+ Tet1cd 
+ Uhrf2 
 
Nucleosides techn. mean SD 
techn. 
mean SD 
techn. 
mean SD 
techn. 
mean SD 
C / N 2.04E-01 2.97E-05 2.04E-01 1.24E-04 2.05E-01 8.32E-05 2.04E-01 1.15E-04 
mC / N 6.01E-03 2.74E-05 5.29E-03 1.22E-04 4.63E-03 8.93E-05 5.11E-03 1.15E-04 
hmC / N 2.86E-05 1.57E-06 4.29E-04 1.85E-05 3.31E-04 1.93E-05 5.13E-04 9.85E-06 
fC / N 4.51E-07 5.21E-08 5.97E-05 3.43E-06 7.21E-05 4.24E-06 1.39E-04 5.61E-06 
caC / N 1.77E-07 2.67E-09 2.32E-05 8.50E-07 2.23E-04 1.84E-05 1.66E-04 1.21E-06 
hmU / N 8.18E-07 8.89E-08 2.55E-06 6.26E-08 1.27E-05 4.30E-07 6.74E-06 1.59E-06 
fU / N 7.60E-06 3.39E-07 5.40E-06 5.26E-07 5.64E-06 8.42E-07 1.22E-05 2.10E-06 
8-oxo-G / N 1.27E-05 7.08E-07 9.23E-06 3.22E-07 6.93E-06 1.09E-06 1.62E-05 8.43E-07 
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Supplementary Note 4: materials in cell culture 
 
Supplementary Table 18. Overexpression plasmids and esiRNAs used in HEK-293T cell experiments. 
Figure Experiment Sample Plasmid DNA esiRNA 
S7a HEK-293T +/- Tet1xx 
HEK + Tet1cd GFP-Tet1cd (7.5 µg) x 
HEK + Tet1cm mCh-Tet1cm (7.5 µg) x 
Wild type pCMV6-Cdk5Rap1-v2 (7.5 µg) x 
S5b,S5c Tet1cd with TDG or SMUG1 KD 
HEK + Tet1cd GFP-Tet1cd (10 µg) 
CDK5RAP1 esiRNA 
(5 µg) 
HEK + Tet1cd 
with TDG KD 
GFP-Tet1cd 
(10 µg) 
TDG esiRNA 
(5 µg) 
HEK + Tet1cd 
with SMUG1 KD 
GFP-Tet1cd 
(10 µg) 
SMUG1 esiRNA 
(5 µg) 
 HEK-293T Tet1cd GFP-Tet1cd (6 µg) x 
S12 HEK-293T Tet1cd + Uhrf1 GFP-Tet1cd, GFP-Uhrf1
1 
(each 6 µg) x 
 HEK-293T Tet1cd + Uhrf2 GFP-Tet1cd, GFP-Uhrf2
1 
(each 6 µg) x 
 
Supplementary Table 19. Knockdown (KD) efficiencies by Tet relative to SCR shRNAs. 
  FWD REV Reference 
Tet1 GAGCCTGTTCCTCGATGTGG  CAAACCCACCTGAGGCTGTT Ito et. al.2 
Tet2 TGTTGTTGTCAGGGTGAGAATC  TCTTGCTTCTGGCAAACTTACA Ito et. al.2 
actin AAGGCCAACCGTGAAAAGAT GTGGTACGACCAGAGGCATAC This work 
 
 
Supplementary Table 20. Primers for qPCR analysis of Tet, Dnmt, Tdg and Smug1 of EpiLC differentiation and 
Smug1 knockdown samples. 
  FWD REV Reference 
Gapdh CATGGCCTTCCGTGTTCCTA CTTCACCACCTTCTTGATGTCATC Szwagierzcak et al.3 
Tet1 CCAGGAAGAGGCGACTACGTT TTAGTGTTGTGTGAACCTGATTTATTGT Szwagierzcak et al.3 
Tet2 ACTTCTCTGCTCATTCCCACAGA TTAGCTCCGACTTCTCGATTGTC Szwagierzcak et al.3 
Tet3 GAGCACGCCAGAGAAGATCAA CAGGCTTTGCTGGGACAATC Szwagierzcak et al.3 
Dnmt1 CCTAGTTCCGTGGCTACGAGGAG TCTCTCTCCTCTGCAGCCGACTC This work 
Dnmt3a GCTTTCTTCTCAGCCTCCCT CCATGCCAAGACTCACCTTC This work 
Dnmt3b CTGGCACCCTCTTCTTCATT ATCCATAGTGCCTTGGGACC This work 
Tdg GTCTGTTCATGTCGGGGCTGAGTGAG CTGCAGTTTCTGCACCAGGATGCGC This work 
Smug1 CACTGGGGCCTACCCATGA CTCCCAAGCATAATCCACCG This work 
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Supplementary Note 5: correlation analysis results of modification levels 
 
Supplementary Table 21. Correlation analysis of DNA modification levels comparing murine tissues from three 
months old individuals (cortex, hippocampus, cerebellum, heart, liver and kidney). Pearson coefficients (p) and 
significance values (s) are summarized. n=24 independent DNA samples (see Supplementary Table 10). 
Highlighted in gray are strong to very strong correlations (│p│> 0.7) with significance levels (s) lower than 0.001 
(marked with *). Additionally, moderate correlations (0.7 > │p│> 0.6) with significance level lower than 0.001 
are highlighted in light gray.  
 C mC hmC fC 8-oxo-G hmU fU 
C 
p 1.000 -0.986* -0.935* -0.832* -0.534 -0.466 -0.479 
s  0.000 0.000 0.000 0.007 0.022 0.018 
mC p 
-0.986* 1.000 0.863* 0.769* 0.534 0.464 0.460 
s 0.000  0.000 0.000 0.007 0.022 0.024 
hmC p 
-0.935* 0.863* 1.000 0.887* 0.481 0.420 0.472 
s 0.000 0.000  0.000 0.017 0.041 0.020 
fC p 
-0.832* 0.769* 0.887* 1.000 0.663* 0.586 0.649* 
s 0.000 0.000 0.000  0.000 0.003 0.001 
8-oxo-G p 
-0.534 0.534 0.481 0.663* 1.000 0.837* 0.835* 
s 0.007 0.007 0.017 0.000  0.000 0.000 
hmU p 
-0.466 0.464 0.420 0.586 0.837* 1.000 0.871* 
s 0.022 0.022 0.041 0.003 0.000  0.000 
fU 
p -0.479 0.460 0.472 0.649* 0.835* 0.871* 1.000 
s 0.018 0.024 0.020 0.001 0.000 0.000  
 
Supplementary Table 22. Correlation analysis of DNA modification levels during early mESC differentiation (0-
40 h). Pearson coefficients (p) and significance values (s) are summarized. n=22 independent DNA samples (see 
Supplementary Table 11). Highlighted in gray are strong to very strong correlations (│p│> 0.7) with significance 
levels (s) lower than 0.001 (marked with *). Additionally, weak correlations of hmC/hmU with mC/C are 
highlighted in pale pink.  
 C mC hmC fC caC 8-oxo-G hmU fU 
C p 
1 -0.997* 0.324 0.806* 0.699* -0.032 0.299 -0.145 
s  0.000 0.141 0.000 0.000 0.889 0.176 0.518 
mC p 
-0.997* 1 -0.399 -0.815* -0.693* 0.057 -0.356 0.160 
s 0.000  0.066 0.000 0.000 0.801 0.104 0.476 
hmC p 
0.324 -0.399 1 0.404 0.182 -0.312 0.783* -0.227 
s 0.141 0.066  0.062 0.417 0.157 0.000 0.309 
fC p 
0.806* -0.815* 0.404 1 0.797* -0.266 0.303 -0.299 
s 0.000 0.000 0.062  0.000 0.232 0.170 0.177 
caC p 
0.699* -0.693* 0.182 0.797* 1 -0.435 0.165 -0.567 
s 0.000 0.000 0.417 0.000  0.043 0.463 0.006 
8-oxo-G p 
-0.032 0.057 -0.312 -0.266 -0.435 1 -0.080 0.959* 
s 0.889 0.801 0.157 0.232 0.043  0.723 0.000 
hmU p 
0.299 -0.356 0.783* 0.303 0.165 -0.080 1 -0.022 
s 0.176 0.104 0.000 0.170 0.463 0.723  0.921 
fU 
p -0.145 0.160 -0.227 -0.299 -0.567 0.959* -0.022 1 
s 0.518 0.476 0.309 0.177 0.006 0.000 0.921  
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